1001390|ENG|Renal and urinary disorders|
1001940|ENG|Renal|
1002881|ENG|Alti-Mercaptopurine|
100503|ENG|Hexahydropyridine|
1008351|ENG|Reproductive System Disease|
1008354|ENG|reproductive system disorder|
1008355|ENG|Reproductive System Disorder|
1008405|ENG|Reproductive tract disorder NOS|
1008843|ENG|Research Activities|
1008844|ENG|Research Activity|
1008908|ENG|research|
1008909|ENG|Research|
1009036|ENG|research study|
1009052|ENG|Research survey clerk|
1009053|ENG|Research survey clerk (occupation)|
1010862|ENG|Respaire|
1010966|ENG|Respiration Disorder|
1010967|ENG|Respiration Disorders|
1011332|ENG|Respiratory disease|
1011342|ENG|Respiratory disease NOS|
1011347|ENG|Respiratory Diseases|
1011358|ENG|respiratory disorder|
1011361|ENG|Respiratory disorder|
1011362|ENG|Respiratory Disorder|
1011373|ENG|Respiratory disorder NOS|
1011385|ENG|Respiratory disorder, unspecified|
1012104|ENG|Respiratory system disease|
1012110|ENG|Respiratory system disorder|
1012111|ENG|Respiratory System Disorder|
1012212|ENG|Respiratory Tract Disease|
1012213|ENG|Respiratory Tract Diseases|
1016897|ENG|Retrieval, Data|
1020001|ENG|Reyataz|
1022179|ENG|RH|
1022873|ENG|Rheumatoid arthritis, leucopenia AND splenomegaly|
1022874|ENG|Rheumatoid arthritis, leukopenia AND splenomegaly|
1022999|ENG|Rheumatoid arthritis with splenoadenomegaly and leukopenia|
102344|ENG|HGNC|
102493|ENG|H hernia|
102514|ENG|HH - Hiatus hernia|
1026|ENG|GIT diseases|
102748|ENG|Hiatal hernia (disorder)|
102750|ENG|hiatal hernia|
102752|ENG|Hiatal hernia|
102753|ENG|Hiatal Hernia|
102754|ENG|HIATAL HERNIA|
102759|ENG|Hiatal Hernias|
102808|ENG|Hiatus hernia (diagnosis)|
102809|ENG|Hiatus hernia|
103048|ENG|hiccough|
103050|ENG|Hiccough|
103051|ENG|HICCOUGH|
103058|ENG|Hiccoughs|
103059|ENG|Hiccoughs (finding)|
103063|ENG|hiccup|
103064|ENG|Hiccup|
103066|ENG|Hiccups|
1032604|ENG|RI|
1035|ENG|GIT - Gastrointestinal tract haemorrhage|
1036|ENG|GIT - Gastrointestinal tract hemorrhage|
1045356|ENG|Roberts Brand of Acetylcysteine|
1046282|ENG|roentgenography|
1047908|ENG|root (of NCBI Taxonomy)|
1048057|ENG|root (of UWDA hierarchy)|
1050664|ENG|ROU - Recurrent oral ulceration|
1054107|ENG|RT|
1056611|ENG|Rumination disorder (disorder)|
1056613|ENG|Rumination disorder|
1056614|ENG|Rumination Disorder|
1056619|ENG|Rumination Disorders|
1056621|ENG|Rumination|
1056631|ENG|Rumination psychogenic|
1056632|ENG|Ruminations|
1059|ENG|GI tract bleed|
1059635|ENG|RXNORM|
1062002|ENG|1H-Imidazole-4-ethanaminium, alpha-carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-, inner salt, (S)-|
1063551|ENG|Sacrosidase 8500iu/mL solution|
1063552|ENG|Sacrosidase 8500iu/mL solution (product)|
1063557|ENG|Sacrosidase 8500 UNT/ML Oral Solution|
1063561|ENG|SACROSIDASE 8500 UNT/ML SOLN,ORAL|
1063564|ENG|sacrosidase|
1063565|ENG|Sacrosidase|
1063566|ENG|SACROSIDASE|
1063569|ENG|Sacrosidase (product)|
1063571|ENG|Sacrosidase (substance)|
1068447|ENG|1H-Indene-2-ethanamine, N,N-dimethyl-3-(1-(2-pyridinyl)ethyl)-|
107632|ENG|HIST|
1081327|ENG|Sanigen, Muco|
1089465|ENG|SC|
1089697|ENG|SCH 23390|
1092627|ENG|Science, Information|
1092630|ENG|Science, Library|
1092656|ENG|Sciences, Information|
1092659|ENG|Sciences, Library|
109603|ENG|history|
1097595|ENG|SD|
1099913|ENG|Secondary acquired hypogammaglobulinaemia|
1099915|ENG|Secondary acquired hypogammaglobulinemia|
1100626|ENG|Secondary immune deficiency disorder (disorder)|
1100627|ENG|Secondary immune deficiency disorder|
1100637|ENG|Secondary immunodeficiency|
1103996|ENG|Secretion, Cellular|
1104000|ENG|secretion|
1104001|ENG|Secretion|
1104027|ENG|secretion process|
1104442|ENG|Security, Computer|
1105893|ENG|SE|
1112584|ENG|sense of pain|
1112903|ENG|Sensory aberrations|
1112995|ENG|Sensory disorder (disorder)|
1112996|ENG|sensory disorder|
1112997|ENG|Sensory disorder|
1112998|ENG|Sensory Disorder|
1113002|ENG|Sensory Disorders|
1113012|ENG|sensory disturbance|
1113013|ENG|Sensory disturbance|
1113014|ENG|SENSORY DISTURBANCE|
1113018|ENG|Sensory disturbance NOS|
1113036|ENG|sensory function defect|
1113319|ENG|sensory system disorder|
1115383|ENG|Sequence Data, Molecular|
1115542|ENG|Sequencing Data, Molecular|
1116171|ENG|aminopyridine|
1116193|ENG|Aminopyridines|
1119129|ENG|Serum Albumin, Radio Iodinated|
1119130|ENG|Serum Albumin, Radio-Iodinated|
1119131|ENG|Serum Albumin, Radioiodinated|
1119992|ENG|serum hepatitis|
1119995|ENG|Serum hepatitis|
1121248|ENG|Service, Information|
1121367|ENG|Services, Information|
1132457|ENG|SH - Serum hepatitis|
1134227|ENG|side effects|
1135534|ENG|Signs and Symptoms|
1135553|ENG|sign/symptom|
1140824|ENG|Singultation|
1140825|ENG|Singultous|
1140828|ENG|Singultus|
1141439|ENG|Sinus|
1145796|ENG|Skin and Connective Tissue Diseases|
1145815|ENG|Skin and subcutaneous tissue disease|
1145821|ENG|Skin and subcutaneous tissue disorders|
1146334|ENG|skin disease|
1146335|ENG|Skin disease|
1146336|ENG|Skin Disease|
1146346|ENG|Skin Diseases and Manifestations|
1146353|ENG|Skin Diseases|
1146378|ENG|skin disorder diagnosis|
1146386|ENG|skin disorder|
1146388|ENG|Skin disorder|
1146389|ENG|Skin Disorder|
1146390|ENG|SKIN DISORDER|
1146402|ENG|Skin disorder NOS|
1146447|ENG|Skin|
1152389|ENG|SL|
1153420|ENG|SLS|
1155878|ENG|Smelly breath|
1157670|ENG|1,1,3-Propanetricarboxylic acid, 3-amino-|
1158051|ENG|SN|
1158276|ENG|S-Nitrosothiol|
1158277|ENG|S-Nitrosothiols|
1158333|ENG|SNOMED Clinical Term|
1158334|ENG|SNOMED Clinical Terms|
1158340|ENG|SNOMED CT Concept|
1158341|ENG|SNOMED CT Concept (SNOMED RT+CTV3)|
1158342|ENG|SNOMED CT|
1158346|ENG|SNOMED|
1160545|ENG|Sodium 2-Mercaptoethane Sulfonate|
1160546|ENG|Sodium 2-Mercaptoethanesulphonate|
1163800|ENG|sodium dodecyl sulfate|
1163801|ENG|Sodium Dodecyl Sulfate|
1165824|ENG|Sodium Lauryl Sulfate|
1165825|ENG|SODIUM LAURYL SULFATE|
1167784|ENG|sodium tetradecyl sulfate|
1167785|ENG|Sodium tetradecyl sulfate|
1167786|ENG|Sodium Tetradecyl Sulfate|
1167787|ENG|SODIUM TETRADECYL SULFATE|
1167793|ENG|Sodium tetradecyl sulfate (product)|
1167795|ENG|Sodium tetradecyl sulfate (substance)|
1167802|ENG|Sodium tetradecyl sulphate|
1174387|ENG|Sore, Canker|
1174446|ENG|Sores, Canker|
1175191|ENG|Sotradecol|
1175193|ENG|Sotradecol Sodium|
1177951|ENG|Spastic colitis|
1177953|ENG|spastic colon|
1177955|ENG|Spastic colon|
1177956|ENG|SPASTIC COLON|
1179446|ENG|Specific enzyme deficiency (disorder)|
1179447|ENG|Specific enzyme deficiency|
1191745|ENG|SPN|
1193448|ENG|1 Methyl 2 mercaptoimidazole|
1193559|ENG|1-Methyl-2-mercaptoimidazole|
1195522|ENG|Sprue, Celiac|
1195525|ENG|Sprue|
1195528|ENG|Sprue, Nontropical|
1198271|ENG|SRC|
1202670|ENG|1-methyl-3-phenyl-1,2,3,6-tetrahydropyridine|
1205003|ENG|1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine|
1205114|ENG|1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine|
1205225|ENG|1-methyl-4-(2-(fluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine|
1205448|ENG|1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine|
1205738|ENG|Staging system (attribute)|
1205739|ENG|Staging system|
1205740|ENG|Staging System|
1206225|ENG|1-methyl-4-(3-hydroxyphenyl)-1,2,3,6-tetrahydropyridine|
1206282|ENG|Standard Product Nomenclature, 2003|
1206283|ENG|Standard Product Nomenclature|
1206336|ENG|1-methyl-4-(3-methoxyphenyl)-1,2,3,6-tetrahydropyridine|
1206892|ENG|1-methyl-4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine|
1207003|ENG|1-methyl-4-(4-dimethylaminophenylethenyl)-1,2,3,6-tetrahydropyridine|
1207336|ENG|1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine|
1207670|ENG|1-methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine|
1208641|ENG|state of health|
1209447|ENG|1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol|
1209558|ENG|1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|
1209669|ENG|1-methyl-4-phenyl-1,2,3,6-(tetrahydropyridine)-N-oxide|
1209923|ENG|STD - Sodium tetradecyl sulfate|
1209924|ENG|STD - Sodium tetradecyl sulphate|
1210558|ENG|1 Methyl 4 phenylpyridine|
1210669|ENG|1-Methyl-4-phenylpyridine|
1211003|ENG|1 Methyl 4 phenylpyridinium|
1211114|ENG|1-Methyl-4-phenylpyridinium|
1211206|ENG|ST|
1211225|ENG|1 Methyl 4 phenylpyridinium Ion|
1211336|ENG|1-Methyl-4-phenylpyridinium Ion|
1217118|ENG|stomach cancer|
1217119|ENG|Stomach cancer|
1217120|ENG|Stomach Cancer|
1217151|ENG|Stomach carcinoma|
1217152|ENG|Stomach Carcinoma|
1217153|ENG|STOMACH CARCINOMA|
1217208|ENG|Stomach Disease|
1217209|ENG|Stomach Diseases|
1217210|ENG|stomach disorder|
1217212|ENG|Stomach Disorder|
1217215|ENG|Stomach Disorders|
1217241|ENG|Stomach|
1217666|ENG|Stomatitides, Aphthous|
1217675|ENG|Stomatitis and related lesions|
1217681|ENG|Stomatitis aphthous|
1217683|ENG|Stomatitis, Aphthous|
1217784|ENG|Stomatodysodia|
1217786|ENG|Stomatognathic Disease|
1217787|ENG|Stomatognathic Diseases|
1231171|ENG|[AN700] PROTECTIVE AGENTS|
1233571|ENG|anabolism|
123820|ENG|Hormone disturbance|
123821|ENG|Hormone disturbance NOS|
1243383|ENG|STS|
1247659|ENG|anal cancer|
1247672|ENG|Anal Cancer|
1247727|ENG|Anal cancer, NOS|
1247760|ENG|Anal Cancers|
1248116|ENG|Anal carcinoma|
1248127|ENG|Anal Carcinoma|
1248160|ENG|Anal carcinoma NOS|
1248894|ENG|ANAL|
125005|ENG|1,4-dihydropyridine|
1250607|ENG|sublingual administration|
1250608|ENG|Sublingual Administration|
1250609|ENG|Sublingual Administrations|
1250618|ENG|Sublingual Drug Administration|
1250619|ENG|Sublingual Drug Administrations|
1250622|ENG|Sublingual|
1250623|ENG|SUBLINGUAL|
1250656|ENG|Sublingual route|
1250657|ENG|Sublingual Route of Drug Administration|
1250658|ENG|Sublingual route (qualifier value)|
1250684|ENG|Sublingual use|
1253570|ENG|Succimer|
1253572|ENG|SUCCIMER|
1253579|ENG|Succimer (product)|
1253583|ENG|Succimer (substance)|
1254454|ENG|Sucraid|
1255227|ENG|SU|
1256481|ENG|Analyses, Systems|
1257548|ENG|Analysis, Systems|
1258508|ENG|Sulfate, Sodium Dodecyl|
1258509|ENG|Sulfate, Sodium Lauryl|
1258510|ENG|Sulfate, Sodium Tetradecyl|
1258817|ENG|Sulfhydryl Compounds|
1258821|ENG|sulfhydryl group|
1258834|ENG|Sulfhydryls|
1258836|ENG|Sulfhydryls (substance)|
1259662|ENG|sulfonate|
1259667|ENG|Sulfonates, Alkyl|
1259669|ENG|Sulfonates|
1260309|ENG|Sulfuric acid monododecyl ester sodium salt|
1261203|ENG|Sulphydryls|
1263181|ENG|a- Naphthylamine|
1270559|ENG|1-Naphthalenamine|
1273687|ENG|SURG|
1273829|ENG|surgery|
1274021|ENG|Surgical abdomen|
1274329|ENG|surgical construction of a stoma|
1274333|ENG|Surgical construction of stoma|
1276370|ENG|ANAT|
1278034|ENG|Swallowing difficult|
1278035|ENG|swallowing disorder|
1278036|ENG|Swallowing disorder|
1278038|ENG|Swallowing Disorder|
1278039|ENG|Swallowing Disorders|
1278062|ENG|Swallowing painful|
1278063|ENG|Swallowing painful (finding)|
1278325|ENG|Anatomical structure (body structure)|
1278337|ENG|Anatomical structure|
1278747|ENG|Anatomic structures|
1279005|ENG|anatomy|
1279016|ENG|Anatomy|
1281789|ENG|Symptoms and General Pathology|
1281794|ENG|Symptoms and Signs|
1281912|ENG|Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified|
1281914|ENG|symptoms, signs, and ill-defined conditions|
1281917|ENG|SYMPTOMS, SIGNS, AND ILL-DEFINED CONDITIONS|
1282967|ENG|Syndrome abdominal acute|
1283337|ENG|1 Naphthylamine|
1283341|ENG|Syndrome, Dumping|
1283372|ENG|syndrome|
1283373|ENG|Syndrome|
1283412|ENG|Syndrome, Felty's|
1283448|ENG|1-Naphthylamine|
1283534|ENG|Syndrome, Hereditary Cancer|
1283535|ENG|Syndrome, Hereditary Neoplastic|
1283590|ENG|Syndrome, Immunological Deficiency|
1283591|ENG|Syndrome, Immunologic Deficiency|
1283614|ENG|Syndrome, Irritable Bowel|
1283711|ENG|Syndrome malabsorption|
1283712|ENG|Syndrome, Malabsorption|
1283875|ENG|Syndrome of the genitourinary system|
1283877|ENG|Syndrome of urinary tract|
1283921|ENG|Syndrome peptic ulcer|
1283967|ENG|Syndrome, Post-Cholecystectomy|
1283968|ENG|Syndrome, Postcholecystectomy|
1284176|ENG|Syndromes, Dumping|
1284184|ENG|Syndromes|
1284224|ENG|Syndromes, Hereditary Cancer|
1284227|ENG|Syndromes, Hereditary Neoplastic|
1284261|ENG|Syndromes, Immunological Deficiency|
1284262|ENG|Syndromes, Immunologic Deficiency|
1284267|ENG|Syndromes, Irritable Bowel|
1284289|ENG|Syndromes, Malabsorption|
1284343|ENG|Syndromes, Post-Cholecystectomy|
1284344|ENG|Syndromes, Postcholecystectomy|
1286670|ENG|1-Naththylamine|
1286781|ENG|1-Naththylamine (substance)|
1290325|ENG|systematic biology|
1290331|ENG|Systematics|
1290351|ENG|Systematized Nomenclature of Medicine|
1290410|ENG|System Disease, Digestive|
1290411|ENG|System Disease, Endocrine|
1290412|ENG|System Diseases, Digestive|
1290413|ENG|System Diseases, Endocrine|
1290839|ENG|System, Information|
1290958|ENG|Systems Analyses|
1290960|ENG|Systems Analysis|
1291025|ENG|Systems, Information|
1298874|ENG|Tapazole|
1300097|ENG|Tarry stools|
1301134|ENG|Taufon|
1301153|ENG|Tauphon|
1301291|ENG|taurine|
1301292|ENG|Taurine|
1301294|ENG|TAURINE|
1301351|ENG|Taurine (substance)|
1301835|ENG|Taxonomies|
1301839|ENG|taxonomy|
1301840|ENG|Taxonomy|
1301841|ENG|Taxonomy, General|
1305528|ENG|TD|
1308691|ENG|Teeth gnashing|
1308693|ENG|Teeth grating|
1308695|ENG|Teeth Grinding Disorder|
1308697|ENG|Teeth Grinding Disorders|
1308698|ENG|teeth grinding|
1308699|ENG|Teeth grinding|
1308700|ENG|Teeth-grinding|
1309568|ENG|telecommunication|
1309569|ENG|Telecommunication|
1309579|ENG|Telecommunications|
1312360|ENG|AN|
1322633|ENG|Tetradecyl Sulfate, Sodium|
132479|ENG|human hepatitis C virus|
132480|ENG|human hepatitis C virus HCV|
132481|ENG|human hepatitis virus C HCV|
1328022|ENG|The Magic Bullet 10 MG Rectal Suppository|
1328100|ENG|TH|
1329699|ENG|Theories, Information|
1329728|ENG|Theory, Information|
1329989|ENG|Therapeutic agent toxicity|
1330996|ENG|therapy|
1331361|ENG|Theriacs|
1332859|ENG|Thesaurismoses|
1332860|ENG|Thesaurismosis|
1332867|ENG|Thesaurus|
1333132|ENG|Thiamazole|
1334479|ENG|Thiemann Brand of Acetylcysteine|
1334785|ENG|Thimazol|
1335214|ENG|Thiocholine|
1335623|ENG|Thioglycolates|
1335630|ENG|Thioglycollates|
1335764|ENG|thiol|
1335797|ENG|thiols|
1335798|ENG|Thiols|
1335822|ENG|Thiomalates|
1335940|ENG|Thioneine|
1338906|ENG|Thoracic pain|
1339925|ENG|THPHP-CMP|
1339934|ENG|THPP-CMP|
13477|ENG|Gluten Enteropathies|
13478|ENG|gluten enteropathy|
13479|ENG|Gluten enteropathy|
134796|ENG|human resources|
13480|ENG|Gluten Enteropathy|
1348325|ENG|Tiamazol|
1349596|ENG|TIC protocol|
1349597|ENG|TIC regimen|
1353235|ENG|TIP regimen|
1355186|ENG|Tixair|
1356434|ENG|TM|
1360473|ENG|Tolperisone|
136095|ENG|Humoral immune defect|
136096|ENG|Humoral immune defect (finding)|
136101|ENG|Humoral immunity deficiency|
136152|ENG|Humoural immune defect|
136154|ENG|Humoural immunity deficiency|
1363892|ENG|1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))-|
13658|ENG|Gluten-induced enteropathy syndrome|
13662|ENG|Gluten intolerance|
13664|ENG|Gluten-responsive sprue|
13666|ENG|Gluten-Sensitive Enteropathies|
1366695|ENG|TOX|
13668|ENG|Gluten sensitive enteropathy|
13669|ENG|Gluten Sensitive Enteropathy|
13670|ENG|Gluten-sensitive enteropathy|
13671|ENG|Gluten-Sensitive Enteropathy|
1367411|ENG|Toxicities, Drug|
1367418|ENG|toxicity, drug|
1367419|ENG|Toxicity, Drug|
1367424|ENG|toxicity|
136796|ENG|Hustengetränk, Optipect|
1368070|ENG|Toxins, Marine|
1369303|ENG|TPPCMP|
1373416|ENG|Tract Disease, Biliary|
1373417|ENG|Tract Disease, Respiratory|
1373418|ENG|Tract Diseases, Biliary|
1373419|ENG|Tract Diseases, Respiratory|
137893|ENG|Hyaluronidase 1 MG/ML Topical Lotion|
1381024|ENG|transplantation aspects|
1381050|ENG|transplantation|
1381058|ENG|Transplantation, Hepatic|
1381066|ENG|Transplantation, Islands of Langerhans|
1381067|ENG|Transplantation, Islands of Pancreas|
1381068|ENG|Transplantation, Islet|
1381069|ENG|Transplantation, Islets of Langerhans|
1381074|ENG|Transplantation, Liver|
1381156|ENG|Transplantation of islet cells|
1381157|ENG|Transplantation of islets of Langerhans|
1381173|ENG|Transplantation of liver|
1381176|ENG|Transplantation of liver (procedure)|
1381198|ENG|Transplantation of pancreas|
1381201|ENG|Transplantation of pancreas (procedure)|
1381347|ENG|Transplantation, Pancreas|
1381348|ENG|Transplantation, Pancreatic Islets|
1381374|ENG|Transplantations, Hepatic|
1381378|ENG|Transplantations, Islet|
1381383|ENG|Transplantations, Liver|
1381389|ENG|Transplantations, Pancreas|
1381523|ENG|Transplant of pancreas|
13841|ENG|gluttony|
1384160|ENG|trauma|
1384161|ENG|Trauma|
13842|ENG|Gluttony|
1384236|ENG|Traumas|
1385443|ENG|Traumatic injury|
1387003|ENG|1-palmitoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine|
1387931|ENG|TR|
1398314|ENG|Anomaly congenital gastrointestinal|
1400881|ENG|triprolidine|
1400882|ENG|Triprolidine|
1400883|ENG|TRIPROLIDINE|
1400930|ENG|Triprolidine (product)|
1400944|ENG|Triprolidine (substance)|
1404301|ENG|Tropicacyl|
1404470|ENG|Tropicamide|
1404472|ENG|TROPICAMIDE|
1404484|ENG|Tropicamide (product)|
1404487|ENG|Tropicamide (substance)|
1411488|ENG|t-THP|
1416125|ENG|TU|
1416784|ENG|tumor|
1416785|ENG|Tumor|
1416786|ENG|TUMOR|
1417546|ENG|Tumor, NOS|
1418503|ENG|Antagonists, Dopamine|
1418514|ENG|Antagonists, Dopamine Receptor|
1418525|ENG|Antagonists, Dopaminergic|
1418807|ENG|Tumors|
1419290|ENG|Tumour|
1422662|ENG|Tx - Liver transplantation|
1424075|ENG|Type B viral hepatitis|
1427954|ENG|U-4748|
1429958|ENG|UCB 3983|
1429960|ENG|UCB-3983|
1429961|ENG|UCB3983|
1432351|ENG|Ulcer aphthous|
1432352|ENG|Ulcer, Aphthous|
1432355|ENG|Ulcer aphthous oral|
1432760|ENG|Ulcer gastroduodenal|
1432761|ENG|Ulcer, Gastroduodenal|
1433043|ENG|Ulcer peptic|
1433044|ENG|Ulcer, Peptic|
1433079|ENG|Ulcers, Aphthous|
1433081|ENG|Ulcers aphthous oral|
1433098|ENG|Ulcers, Gastroduodenal|
1433123|ENG|Ulcers, Peptic|
1433157|ENG|Ulcer syndrome peptic|
1434070|ENG|ultrasonic diagnosis|
1434204|ENG|ultrasonography|
1434722|ENG|Ultreon|
1435413|ENG|UMD|
1435415|ENG|UMDNS|
1435417|ENG|UMDNS: product category thesaurus|
1435456|ENG|UMLS Metathesaurus|
1443057|ENG|Universal Medical Device Nomenclature System: product category thesaurus|
1443120|ENG|University of Washington Digital Anatomist, 1.7.3|
1443121|ENG|University of Washington Digital Anatomist|
1443817|ENG|Unspecified abdominal hernia|
1444043|ENG|Unspecified arthropathy|
1444150|ENG|Unspecified chest pain|
1444185|ENG|Unspecified circulatory system disorder|
1444282|ENG|Unspecified congenital anomaly of digestive system|
1444442|ENG|Unspecified disease of pancreas|
1444446|ENG|Unspecified disease of respiratory system|
1444457|ENG|Unspecified diseases of blood and blood-forming organs|
1444468|ENG|Unspecified disorder of biliary tract|
1444478|ENG|Unspecified disorder of ear|
1444479|ENG|Unspecified disorder of esophagus|
1444482|ENG|Unspecified disorder of eye and adnexa|
1444484|ENG|Unspecified disorder of eye|
1444489|ENG|Unspecified disorder of gallbladder|
1444490|ENG|Unspecified disorder of globe|
1444493|ENG|Unspecified disorder of immune mechanism|
1444494|ENG|Unspecified disorder of intestine|
1444496|ENG|Unspecified disorder of joint|
1444499|ENG|Unspecified disorder of joint, site unspecified|
1444511|ENG|Unspecified disorder of liver|
1444515|ENG|Unspecified disorder of metabolism|
1444519|ENG|Unspecified disorder of oesophagus|
1444526|ENG|Unspecified disorder of peritoneum|
1444533|ENG|Unspecified disorder of skin and subcutaneous tissue|
1444534|ENG|Unspecified disorder of stomach and duodenum|
1444541|ENG|Unspecified disorder of the teeth and supporting structures|
1444546|ENG|Unspecified disorder of urethra and urinary tract|
1444552|ENG|Unspecified disorders of nervous system|
1444620|ENG|Unspecified endocrine disorder|
1444765|ENG|Unspecified haemorrhoids without complication|
1444766|ENG|Unspecified haemorrhoids without mention of complication|
1444786|ENG|Unspecified hemorrhoids without complication|
1444787|ENG|Unspecified hemorrhoids without mention of complication|
1444868|ENG|Unspecified immunity deficiency|
1444976|ENG|Unspecified inflammatory polyarthropathy|
1445024|ENG|Unspecified intestinal malabsorption|
1445026|ENG|Unspecified intestinal obstruction|
1445048|ENG|Unspecified jaundice|
1445049|ENG|Unspecified jaundice (R17)|
1445553|ENG|Unspecified perinatal disorder of digestive system|
1445575|ENG|Unspecified peritonitis|
1446914|ENG|Upper abdominal pain|
1446915|ENG|Upper abdominal pain (finding)|
1447468|ENG|Upper gastrointestinal disorders|
1448314|ENG|UPSA Brand of Acetylcysteine|
1450369|ENG|UR|
1453677|ENG|Urinary system disease|
1453678|ENG|urinary system disorder|
1453743|ENG|Urinary Tract Disease|
1453744|ENG|Urinary Tract Diseases|
1453747|ENG|urinary tract disorder|
1453749|ENG|Urinary tract disorder|
1453750|ENG|Urinary Tract Disorder|
1453752|ENG|Urinary tract disorder NOS|
1453753|ENG|Urinary tract disorder of|
1454550|ENG|urine|
1454552|ENG|URINE|
1456308|ENG|Urogenital disease|
1456311|ENG|urogenital disorder|
1456312|ENG|Urogenital disorder|
1456313|ENG|Urogenital disorder NOS|
1456641|ENG|Urological Disease|
1456642|ENG|Urological Diseases|
1456643|ENG|Urological disorder|
1456644|ENG|Urological Disorders|
1456701|ENG|urologic disease|
1456702|ENG|Urologic disease|
1456703|ENG|Urologic Disease|
1456704|ENG|Urologic Diseases|
1456706|ENG|Urologic Disorder|
1456800|ENG|uromitexan|
1456801|ENG|Uromitexan|
1456930|ENG|Uropathy|
1456931|ENG|UROPATHY|
1457233|ENG|Uroprotectants|
1457234|ENG|Uroprotective Agent|
1457235|ENG|Uroprotective Drugs|
1458158|ENG|US|
1458262|ENG|use of ultrasonography|
1460115|ENG|1-Propanol, 2,3-dimercapto-|
1461764|ENG|UWDA|
1462722|ENG|VACIME protocol|
1465670|ENG|1-Propanone, 2-methyl-1,2-di-3-pyridinyl-|
1466003|ENG|1-Propanone, 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-|
1473809|ENG|VE|
147931|ENG|Hydroxytyramine|
1485966|ENG|VI|
1485974|ENG|VIE protocol|
1488273|ENG|VIMP protocol|
1489462|ENG|Viologen, Methyl|
1489977|ENG|Viral disease (disorder)|
1489978|ENG|viral disease|
1489980|ENG|Viral disease|
1489981|ENG|Viral Disease|
1489991|ENG|Viral Diseases|
1490199|ENG|Viral hepatitis A|
1490208|ENG|Viral hepatitis B|
1490209|ENG|Viral Hepatitis B|
1490253|ENG|Viral hepatitis, type A (disorder)|
1490254|ENG|Viral hepatitis, type A|
1490267|ENG|Viral illness|
1490378|ENG|viral infection|
1490380|ENG|Viral infection|
1490381|ENG|Viral Infection|
1490383|ENG|VIRAL INFECTION|
1490422|ENG|Viral infection NOS|
1490430|ENG|Viral infection of unspecified site|
1490458|ENG|Viral Infections|
1490467|ENG|Viral infection, unspecified|
1490477|ENG|Viral infectious disease|
1490478|ENG|Viral Infectious Disease|
1490878|ENG|Viramune|
1491287|ENG|Virological|
1491288|ENG|Virologic|
1491289|ENG|Virologic (qualifier value)|
1491299|ENG|virology|
1491500|ENG|virus disease|
1491501|ENG|Virus Disease|
1491503|ENG|Virus Diseases|
1491650|ENG|Virus-Hepatitis C|
1491792|ENG|virus infection|
1492508|ENG|Visible peristalsis|
1492509|ENG|Visible peristalsis (finding)|
1495949|ENG|vitamin B6|
1495950|ENG|vitamin-B6|
1495951|ENG|Vitamin B>6<|
1495952|ENG|Vitamin B 6|
1495953|ENG|Vitamin B6|
1495954|ENG|VITAMIN B6|
1495973|ENG|Vitamin B>6< preparation|
1495974|ENG|Vitamin B6 preparation|
1495980|ENG|Vitamin B6 (substance)|
1496413|ENG|Vitamin B<sub>6</sub>|
1496415|ENG|Vitamin B<sub>6</sub> preparation|
1498882|ENG|Vitamins - Vitamin B6|
1499172|ENG|VIT B6|
1500546|ENG|VlhP protocol|
1501147|ENG|Vocabularies, Controlled|
1501150|ENG|Vocabulary, Controlled|
1502818|ENG|vomiting and nausea|
1502819|ENG|Vomiting and Nausea|
1502835|ENG|Vomiting blood|
1502880|ENG|vomiting of blood|
1502882|ENG|Vomiting of blood|
1503289|ENG|Voracious appetite|
1503794|ENG|VP-16/IFF/Mesna/TOPO|
150531|ENG|Hyperalimentation NOS|
1506615|ENG|antidote|
1506626|ENG|Antidote|
1506682|ENG|Antidote (product)|
1506726|ENG|Antidotes|
1506815|ENG|Antidote (substance)|
1512368|ENG|WD|
1512516|ENG|WD - Wilson's disease|
1513727|ENG|Weight Loss Surgery|
1515233|ENG|Westphal pseudosclerosis|
1515238|ENG|Westphal Strumpell disease|
1515241|ENG|Westphal-Strumpell syndrome (disorder)|
1515242|ENG|Westphal Strumpell Syndrome|
1515243|ENG|Westphal-Strumpell syndrome|
1515244|ENG|Westphal-Strumpell Syndrome|
1515245|ENG|Westphal-Strumpell Syndromes|
1515807|ENG|Wheat-sensitive enteropathy|
1517975|ENG|WHO tumor classification|
1517978|ENG|WHO tumour classification|
1518899|ENG|Wilson Disease|
1518900|ENG|WILSON DISEASE|
1518902|ENG|Wilson Disease, Hepato-Neurologic|
1518906|ENG|Wilson Diseases, Hepato-Neurologic|
1518923|ENG|Wilson's disease (disorder)|
1518924|ENG|Wilson's disease|
1518925|ENG|Wilson's Disease|
1518927|ENG|Wilsons Disease|
1520340|ENG|WND|
1522809|ENG|wound|
1522810|ENG|Wound|
1523143|ENG|Wounds and Injuries|
1523144|ENG|Wounds and Injury|
1523166|ENG|Wounds, Injury|
152319|ENG|hyperphagia|
152320|ENG|Hyperphagia|
1523480|ENG|WR-2785|
1526447|ENG|1-Tetradecanol, hydrogen sulfate, sodium salt|
152909|ENG|Hypersensitivities, Drug|
152948|ENG|Hypersensitivity, Drug|
1531614|ENG|Anti-Lewisite Agent, British|
1531625|ENG|Anti-Lewisite, British|
1543012|ENG|X-ray diagnosis|
1543050|ENG|X-ray|
15479|ENG|Glycerophospholipids, Choline|
1553427|ENG|Zambon Brand of Acetylcysteine|
1553429|ENG|Zambon, NAC|
1554307|ENG|Zebrafish|
1555574|ENG|Ziken|
1559688|ENG|Zithromax 250 MG Oral Tablet|
1559697|ENG|Zithromax|
155970|ENG|Hypogammaglobulinaemia|
1559714|ENG|Zitromax|
155973|ENG|Hypogammaglobulinaemia NOS|
155974|ENG|Hypogammaglobulinaemia, unspecified|
155977|ENG|hypogammaglobulinemia|
155978|ENG|Hypogammaglobulinemia|
155979|ENG|HYPOGAMMAGLOBULINEMIA|
155980|ENG|Hypogammaglobulinemia (finding)|
155985|ENG|Hypogammaglobulinemia NOS|
155987|ENG|Hypogammaglobulinemias|
155991|ENG|Hypogammaglobulinemia, unspecified|
1563611|ENG|Zyma Brand of Acetylcysteine|
156387|ENG|hypoimmunity|
1563939|ENG|anus cancer|
1563940|ENG|Anus Cancer|
1563944|ENG|Anus Cancers|
1564731|ENG|AOD|
1566523|ENG|AP - Abdominal pain|
1568795|ENG|Aphthae|
1568800|ENG|Aphthae minor|
1568801|ENG|Aphtha|
1568807|ENG|Aphtha (morphologic abnormality)|
1568827|ENG|Aphthous Stomatitides|
1568828|ENG|aphthous stomatitis|
1568830|ENG|Aphthous stomatitis|
1568831|ENG|Aphthous Stomatitis|
1568834|ENG|aphthous ulcer|
1568836|ENG|Aphthous ulcer|
1568838|ENG|Aphthous Ulcer|
1568839|ENG|APHTHOUS ULCER|
1568843|ENG|Aphthous Ulcers|
1572732|ENG|Appendix disorder NOS|
1574905|ENG|APTP, pyridine|
1580254|ENG|argimesna|
1580346|ENG|arginine 2-mercaptoethane sulfonate|
1581365|ENG|Arg-MES|
1584258|ENG|arranging, organizing|
1585937|ENG|2,2 Bipyridine|
1585948|ENG|2,2-Bipyridine|
1585959|ENG|2,2' Bipyridine|
1585971|ENG|2,2'-Bipyridine|
1586048|ENG|2,2 Bipyridyl|
1586059|ENG|2,2-Bipyridyl|
1589077|ENG|arthropathic|
1589083|ENG|Arthropathies and related disorders|
1589084|ENG|ARTHROPATHIES AND RELATED DISORDERS|
1589085|ENG|Arthropathies and related disorders (navigational concept)|
1589086|ENG|Arthropathies|
1589087|ENG|Arthropathies in other diseases classified elsewhere|
1589091|ENG|Arthropathies, Neurogenic|
1589112|ENG|Arthropathy associated with a neurological disorder (disorder)|
1589113|ENG|Arthropathy associated with a neurological disorder|
1589117|ENG|Arthropathy associated with another disorder (disorder)|
1589118|ENG|Arthropathy associated with another disorder|
1589171|ENG|Arthropathy associated with neurological disorders|
1589207|ENG|Arthropathy associated with other disorders classified elsewhere|
1589257|ENG|Arthropathy (disorder)|
1589268|ENG|arthropathy|
1589269|ENG|Arthropathy|
1589271|ENG|ARTHROPATHY|
1589444|ENG|Arthropathy neurogenic|
1589445|ENG|Arthropathy, Neurogenic|
1589458|ENG|Arthropathy (NOS)|
1589460|ENG|Arthropathy NOS|
1589461|ENG|ARTHROPATHY, NOS|
1589550|ENG|Arthropathy, unspecified|
1589561|ENG|Arthropathy, unspecified, site unspecified|
1590149|ENG|Arthrosis|
1590162|ENG|Arthrosis NOS|
1590173|ENG|Arthrosis, unspecified|
1590559|ENG|2,2 Dipyridyl|
1590570|ENG|2,2-Dipyridyl|
1590581|ENG|2,2' Dipyridyl|
1590592|ENG|2,2'-Dipyridyl|
1590882|ENG|2,2'-dithiodiethanesulfonic acid|
1594818|ENG|ASA|
1602305|ENG|Aspergum|
1602714|ENG|2-(3,6-bis(dimethylamino)-10-acridinyl)ethyl-(2,3-di-O-palmitoylglycero)phosphate|
1604999|ENG|aspirin|
1605000|ENG|Aspirin|
1605001|ENG|ASPIRIN|
1605318|ENG|Aspirin (product)|
1605402|ENG|Aspirin (substance)|
160602|ENG|IBD|
1607185|ENG|ASTA D 7093|
1607186|ENG|ASTA-D 7093|
1607187|ENG|ASTAD 7093|
160818|ENG|ibotenate|
160944|ENG|IBS|
160946|ENG|IBS - Irritable bowel syndrome|
1609886|ENG|ATAZANAVIR SO4|
1609900|ENG|Atazanavir sulfate|
1609901|ENG|ATAZANAVIR SULFATE|
1609903|ENG|Atazanavir sulfate (substance)|
1609908|ENG|Atazanavir sulphate|
1613215|ENG|2,3 Dimercaptopropanol|
1613226|ENG|2,3-Dimercaptopropanol|
1615047|ENG|2,3 Dithiopropan 1 o1|
1615058|ENG|2,3-Dithiopropan-1-o1|
162000|ENG|ICD-10-CM|
162001|ENG|ICD-10|
162002|ENG|ICD10|
162013|ENG|ICD-9-CM|
162014|ENG|ICD9CM|
1620597|ENG|Ausobronc|
1622098|ENG|Automated Pattern Recognition|
162229|ENG|ICE protocol 5|
162312|ENG|ICH|
1626828|ENG|Azadose|
1627168|ENG|azathiopurine|
1627170|ENG|Azathiopurine|
1627751|ENG|Azithromycin 250 MG|
1627758|ENG|Azithromycin 250 MG Oral Tablet|
1627762|ENG|Azithromycin 250 MG Oral Tablet [Zithromax]|
1627763|ENG|AZITHROMYCIN 250MG TAB|
1627765|ENG|AZITHROMYCIN 250MG TAB,PKT,6|
1627835|ENG|Azithromycin dihydrate 250mg tablet|
1627837|ENG|Azithromycin dihydrate 250mg tablet (product)|
1627850|ENG|azithromycin|
1627851|ENG|Azithromycin|
1627852|ENG|AZITHROMYCIN|
1627878|ENG|Azithromycin Pfizer Brand|
1627886|ENG|Azithromycin (product)|
1627889|ENG|Azithromycin (substance)|
1627910|ENG|Azitrocin|
1628835|ENG|Azythromycin|
1629663|ENG|B6 vitamin|
163041|ENG|IC - Irritable colon|
163255|ENG|ICPC|
163458|ENG|Icteric|
163489|ENG|icterus|
163490|ENG|Icterus|
163520|ENG|Icterus NOS|
1635246|ENG|Bacterial infection due to helicobacter pylori (H. pylori)|
1639142|ENG|Bad breath|
1639143|ENG|Bad breath - halitosis|
1640441|ENG|BAL - British Anti-Lewisite|
1640462|ENG|BAL-Dimercaprol|
1640498|ENG|BAL|
1643551|ENG|Bariatric Surgery|
1649662|ENG|Bayer Brand of Azithromycin Dihydrate|
165032|ENG|idiopathic steatorrhea|
165034|ENG|Idiopathic steatorrhea|
165035|ENG|Idiopathic steatorrhoea|
1651161|ENG|B-Cell Deficiency|
1652162|ENG|BCNU/CTX/Mesna/VP-16|
165506|ENG|IDV|
1655267|ENG|behavioral and mental disorder|
1655470|ENG|Behavior, Choice|
1655641|ENG|Behaviors, Choice|
165803|ENG|IFF/Mesna/VP-16|
1659259|ENG|25 Hydroxycalciferol|
1659270|ENG|25-Hydroxycalciferol|
1659681|ENG|25 Hydroxyergocalciferol|
1659692|ENG|25-Hydroxy ergocalciferol|
1659703|ENG|25-Hydroxyergocalciferol|
1659714|ENG|25-Hydroxy ergocalciferol (substance)|
1659848|ENG|25 Hydroxyvitamin D 2|
1659860|ENG|25 Hydroxyvitamin D2|
1659871|ENG|25-Hydroxyvitamin D>2<|
1659882|ENG|25-Hydroxyvitamin D 2|
1659893|ENG|25-Hydroxyvitamin D2|
1660315|ENG|25-Hydroxyvitamin D<sub>2</sub>|
166151|ENG|Ifosfa/Mesna/Etop|
166165|ENG|IFOSFAMIDE 1GM/VIL/MESNA 1GM/AMP PKG INJ|
166166|ENG|IFOSFAMIDE 1GM/VIL/MESNA 200MG/AMP PKG INJ|
166187|ENG|IFOSFAMIDE 3GM/VIL/MESNA 1GM/AMP PKG INJ|
166188|ENG|IFOSFAMIDE 3GM/VIL/MESNA 400MG/AMP PKG INJ|
166251|ENG|IFOSFAMIDE/MESNA|
166252|ENG|Ifosfamide / Mesna Injectable Solution|
166255|ENG|ifosfamide/mesna/mitoxantrone|
166256|ENG|Ifosfamide/Mesna/Mitoxantrone|
1665378|ENG|Benzamide, 3,5-dichloro-N-((1-ethyl-2-pyrrolidinyl)-methyl)-2-hydroxy-6-methoxy-|
1665906|ENG|Benzeneacetamide, N-ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)-|
1669332|ENG|Benzoic acid, 2-(acetyloxy)-|
1676807|ENG|Betahistine|
1676808|ENG|BETAHISTINE|
1676841|ENG|Betahistine (product)|
1679609|ENG|beta Pyridyl carbinol|
1679610|ENG|beta Pyridylcarbinol|
1679611|ENG|beta-Pyridylcarbinol|
1679612|ENG|beta Pyridyl carbinol (substance)|
167990|ENG|IH - Infectious hepatitis|
1680381|ENG|2-(Acetyloxy)benzoic Acid|
1682933|ENG|BI|
1684709|ENG|Bile duct adenocarcinoma|
1684757|ENG|Bile Duct Calculus|
1684791|ENG|Bile duct cancer|
1684793|ENG|Bile Duct Cancer|
1684797|ENG|Bile duct cancer NOS|
1684802|ENG|Bile Duct Cancers|
1684812|ENG|Bile duct carcinoma|
1684813|ENG|Bile Duct Carcinoma|
1684815|ENG|BILE DUCT CARCINOMA|
1685001|ENG|Bile Duct Stone|
1685235|ENG|biliary and gallbladder disorder|
1685253|ENG|Biliary calculi|
1685462|ENG|Biliary stone|
1685466|ENG|Biliary stone (substance)|
1685499|ENG|Biliary tract disease|
1685500|ENG|Biliary Tract Disease|
1685501|ENG|BILIARY TRACT DISEASE, NOS|
1685502|ENG|Biliary Tract Diseases|
1685506|ENG|biliary tract disorder|
1685508|ENG|Biliary tract disorder NOS|
1687438|ENG|bioinformatics|
1687439|ENG|Bio-Informatics|
1687440|ENG|Bioinformatics|
1687721|ENG|biological structure|
1687722|ENG|Biological structure|
1689618|ENG|biosynthesis|
1691166|ENG|BI-RG-587|
1692101|ENG|Bisacodyl 0.333 MG/ML Enema|
1692108|ENG|BISACODYL 10MG/30ML ENEMA,RTL|
1692116|ENG|Bisacodyl 10 MG Enema|
1692117|ENG|BISACODYL 10MG ENEMA|
1692121|ENG|BISACODYL 10MG (MAGIC BULLET) SUPP,RTL|
1692134|ENG|Bisacodyl 10 MG Rectal Suppository|
1692143|ENG|Bisacodyl 10 MG Rectal Suppository [The Magic Bullet]|
1692149|ENG|Bisacodyl 10mg suppository|
1692150|ENG|Bisacodyl 10mg suppository (product)|
1692152|ENG|BISACODYL 10MG SUPP,RTL|
1692154|ENG|BISACODYL 10MG TAB,EC|
1692179|ENG|Bisacodyl 5mg e/c tablet|
1692180|ENG|Bisacodyl 5mg e/c tablet (product)|
1692214|ENG|Bisacodyl 5mg paediatric suppository|
1692216|ENG|Bisacodyl 5mg pediatric suppository|
1692217|ENG|Bisacodyl 5mg pediatric suppository (product)|
1692219|ENG|Bisacodyl 5 MG Rectal Suppository|
1692221|ENG|BISACODYL 5MG SUPP,RTL|
1692222|ENG|BISACODYL 5MG TAB #4/BISACODYL 10MG SUPP|
1692224|ENG|BISACODYL 5MG TAB,EC|
1692225|ENG|BISACODYL 5MG TAB,EC,UD|
1692279|ENG|bisacodyl|
1692280|ENG|Bisacodyl|
1692282|ENG|BISACODYL|
1692323|ENG|Bisacodyl (product)|
1692339|ENG|Bisacodyl (substance)|
1694486|ENG|Bistropamide|
1696524|ENG|Black, tarry stool|
1696902|ENG|Bladder Disease, Gall|
1696905|ENG|Bladder Diseases, Gall|
1697066|ENG|Bladder infection|
1698799|ENG|bleeding|
1698800|ENG|Bleeding|
1698801|ENG|BLEEDING|
1698816|ENG|Bleeding (finding)|
1698869|ENG|Bleeding gastrointestinal|
1698870|ENG|Bleeding, Gastrointestinal|
1699147|ENG|BL|
1702228|ENG|Blood Disease|
1702230|ENG|Blood diseases|
1702231|ENG|Blood Diseases|
1702240|ENG|blood disorder diagnosis|
1702241|ENG|blood disorder|
1702242|ENG|Blood disorder|
1702254|ENG|Blood disorder NOS|
1702324|ENG|Blood dyscrasia|
1702325|ENG|Blood Dyscrasia|
1702330|ENG|Blood dyscrasia NOS|
1702350|ENG|blood|
1702352|ENG|BLOOD|
1709053|ENG|Blood in vomit - symptom|
1709054|ENG|Blood in vomit - symptom (finding)|
1709144|ENG|blood loss|
1709145|ENG|Blood loss|
1709152|ENG|Blood loss of (NOS)|
1709215|ENG|2'-CF(3)-MPTP|
1709281|ENG|2'-CH3-MPTP|
1710066|ENG|Blood staining of periumbilical area|
1710119|ENG|blood supply|
1710120|ENG|blood system disorder|
1712798|ENG|BMS 232632|
1712799|ENG|BMS-232632|
1712800|ENG|BMS232632|
1712911|ENG|BMTP|
1713247|ENG|BnCPTHP|
1715087|ENG|Body System, Gastrointestinal|
171853|ENG|IM|
1728440|ENG|Bowel cancer|
1728441|ENG|Bowel Cancer|
1728484|ENG|bowel disease|
1728575|ENG|Bowel incontinence|
1728576|ENG|Bowel Incontinence|
1728629|ENG|bowel obstruction|
1728631|ENG|Bowel obstruction|
1728632|ENG|Bowel Obstruction|
1728687|ENG|Bowels: incontinent|
1731836|ENG|2'-Et-MPTP|
1734603|ENG|2'-fluoro-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|
1735058|ENG|2'F-MPTP|
173584|ENG|Immune defect|
173585|ENG|Immune defect (finding)|
173586|ENG|immune deficiency disorder|
173591|ENG|Immune Disease|
173592|ENG|Immune Diseases|
173595|ENG|immune disorder|
173597|ENG|Immune Disorder|
173600|ENG|Immune disorder (NOS)|
173601|ENG|Immune disorder, NOS|
173603|ENG|Immune Disorders|
173609|ENG|Immune Dysfunction|
1737977|ENG|Breath odor|
1737980|ENG|Breath odor NOS|
1737982|ENG|BREATH ODOR NOS|
1737985|ENG|Breath odour|
1737987|ENG|Breath odour NOS|
1738020|ENG|Breath smells offensive|
1738021|ENG|Breath smells unpleasant|
1738022|ENG|Breath smells unpleasant (finding)|
173825|ENG|Immune System and Disorders|
173826|ENG|Immune System and Related Disorders|
173834|ENG|Immune System Disease|
173835|ENG|Immune System Diseases|
173836|ENG|Immune system disorder|
173837|ENG|Immune System Disorder|
173839|ENG|Immune system disorder (NOS)|
173840|ENG|Immune system disorder NOS|
173842|ENG|Immune system disorders|
173962|ENG|Immunity disorders|
1739917|ENG|Bristol Myers Squibb Brand of Acetylcysteine|
1739918|ENG|Bristol-Myers Squibb Brand of Acetylcysteine|
1739919|ENG|Bristol Myers Squibb Brand of Acetylcysteine Sodium Salt|
1739920|ENG|Bristol-Myers Squibb Brand of Acetylcysteine Sodium Salt|
1739982|ENG|British Anti Lewisite Agent|
1739983|ENG|British Anti-Lewisite Agent|
1739984|ENG|British anti-lewisite|
1739985|ENG|British Anti Lewisite|
1739986|ENG|British Anti-Lewisite|
1741615|ENG|2H-Imidazole-2-thione, 1,3-dihydro-1-methyl-|
174352|ENG|Immunodeficiencies, Common Variable|
174357|ENG|Immunodeficiency and Immunosuppression Disorders|
174384|ENG|Immunodeficiency common variable|
174385|ENG|Immunodeficiency, Common Variable|
174391|ENG|Immunodeficiency disease|
174392|ENG|Immunodeficiency disorder (disorder)|
174393|ENG|Immunodeficiency disorder|
174395|ENG|Immunodeficiency Disorder|
174398|ENG|immunodeficiency|
174399|ENG|Immunodeficiency|
174411|ENG|Immunodeficiency NOS|
1744313|ENG|Broncholysin|
174451|ENG|immunodeficiency syndrome|
174452|ENG|Immunodeficiency Syndrome|
174455|ENG|Immunodeficiency syndromes|
174458|ENG|Immunodeficiency, unspecified|
1744949|ENG|Bronzed diabetes|
1744950|ENG|Bronze diabetes (disorder)|
1744951|ENG|Bronze diabetes|
1744952|ENG|Bronze Diabetes|
1746667|ENG|Brunac|
1746917|ENG|bruxism|
1746918|ENG|Bruxism|
1746919|ENG|BRUXISM|
1746927|ENG|Bruxism (teeth grinding) (disorder)|
1746928|ENG|Bruxism (teeth grinding)|
1746929|ENG|Bruxomania|
1747421|ENG|BS|
1754609|ENG|Burning reflux|
1757410|ENG|Butanamide, 2,4-dihydroxy-N-(3-((2-mercaptoethyl)amino)-3-oxopropyl)-3,3-dimethyl-, (R)-|
1757465|ENG|Butanedioic acid, 2,3-dimercapto-, (R*,S*)-|
1759292|ENG|2-ME|
1759607|ENG|Bw 57-323H|
1759608|ENG|BW 57 323H|
1759609|ENG|BW 57-323H|
1759610|ENG|BW 57323H|
1760037|ENG|2-mercaptoethanesulfonate-cysteine disulfide|
1760048|ENG|2 Mercaptoethanesulfonate|
1760059|ENG|2-Mercaptoethanesulfonate|
1760070|ENG|2-mercaptoethanesulfonic acid albumin|
1760082|ENG|2-Mercaptoethanesulphonate, Sodium|
1760115|ENG|2 Mercaptoethanol|
1760126|ENG|2-Mercaptoethanol|
1760137|ENG|2-Mercaptoethanol (substance)|
1760637|ENG|2-MESCD|
1764445|ENG|CA - Cancer of bowel|
1764453|ENG|CA - Cancer of esophagus|
1764457|ENG|CA - Cancer of intestine|
1764465|ENG|CA - Cancer of oesophagus|
176484|ENG|Immunological Deficiency Syndrome|
176485|ENG|Immunological Deficiency Syndromes|
176490|ENG|Immunological Disease|
176491|ENG|Immunological Diseases|
176576|ENG|Immunologic defect|
176577|ENG|IMMUNOLOGIC DEFICIENCY|
176580|ENG|Immunologic Deficiency Syndrome|
176581|ENG|Immunologic Deficiency Syndromes|
176587|ENG|Immunologic Disease|
176588|ENG|Immunologic Diseases|
176726|ENG|immunology|
176813|ENG|immunopathology|
1770381|ENG|2'-methyl-MPTP|
1771781|ENG|2-(methylthio)ethanesulfonate|
1771792|ENG|2-(methylthio)ethanesulfonic acid|
177314|ENG|impaction|
177458|ENG|impaired health|
177459|ENG|Impaired health|
1776937|ENG|2'-NH2-MPTP|
1777444|ENG|CA - Liver cancer|
1777970|ENG|1,2,3,6-tetrahydro-4-(4-hydroxyphenyl)-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine|
1778192|ENG|1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine|
1778525|ENG|1,2,3,6-tetrahydro-4-(p-hydroxyphenyl)-1-((3-(p-hydroxyphenyl)-3-cyclohexen-1-yl)methyl)pyridine|
1782827|ENG|Cancer, Anal|
1782953|ENG|Cancer, Bile Duct|
1783095|ENG|Cancer, Digestive System|
1783125|ENG|Cancer, Esophageal|
1783127|ENG|Cancer, Esophagus|
1783134|ENG|Cancer, Gallbladder|
1783136|ENG|Cancer, Gastrointestinal|
1783161|ENG|Cancer, Hepatic|
1783199|ENG|cancer information system|
1783207|ENG|Cancer, Intestinal|
1783208|ENG|Cancer, Intestines|
1783219|ENG|Cancer, Liver|
1783258|ENG|Cancer of Anus|
1783261|ENG|Cancer of Bile Duct|
1783274|ENG|Cancer of bowel|
1783306|ENG|Cancer of Digestive System|
1783321|ENG|Cancer of esophagus|
1783322|ENG|Cancer of Esophagus|
1783330|ENG|Cancer of Gallbladder|
1783335|ENG|Cancer of Gastrointestinal Tract|
1783353|ENG|Cancer of intestine|
1783354|ENG|Cancer of Intestine|
1783355|ENG|Cancer of Intestines|
1783393|ENG|Cancer of Liver|
1783429|ENG|Cancer of oesophagus|
1783508|ENG|Cancer of stomach|
1783509|ENG|Cancer of Stomach|
1783517|ENG|Cancer of the Anus|
1783519|ENG|Cancer of the Bile Duct|
1783567|ENG|Cancer of the Digestive System|
1783585|ENG|Cancer of the Esophagus|
1783591|ENG|Cancer of the Gallbladder|
1783597|ENG|Cancer of the Gastrointestinal Tract|
1783604|ENG|Cancer of the Intestine|
1783605|ENG|Cancer of the Intestines|
1783615|ENG|Cancer of the Liver|
1783691|ENG|Cancer of the Stomach|
1783967|ENG|Cancers, Anal|
1783972|ENG|Cancers, Bile Duct|
1783989|ENG|Cancers, Digestive System|
1784001|ENG|Cancers, Esophageal|
1784002|ENG|Cancers, Esophagus|
1784005|ENG|Cancers, Gallbladder|
1784007|ENG|Cancers, Gastrointestinal|
1784011|ENG|Cancers, Hepatic|
1784019|ENG|Cancers, Intestinal|
1784020|ENG|Cancers, Intestines|
1784031|ENG|Cancers, Liver|
1784157|ENG|Cancer Syndrome, Hereditary|
1784159|ENG|Cancer Syndromes, Hereditary|
1784177|ENG|Cancer Therapy Evaluation Program (CTEP)|
1786687|ENG|canker sore|
1786688|ENG|Canker sore|
1786689|ENG|Canker Sore|
1786690|ENG|CANKER SORE|
1786692|ENG|Canker sores|
1786694|ENG|Canker Sores|
1786695|ENG|Canker sores oral|
1787132|ENG|Cannot get food down|
1787457|ENG|Can't get food down|
1787703|ENG|Ca oesophagus|
1794983|ENG|carboline|
1794984|ENG|Carbolines|
1796518|ENG|carboplatin/filgrastim/ifosfamide/mercaptoethane sulfonate|
1796519|ENG|carboplatin/filgrastim/ifosfamide/mesna|
1796520|ENG|Carboplatin/filgrastim/Ifosfamide/Mesna|
1796565|ENG|carboplatin/ifosfamide/mercaptoethane sulfonate|
1796566|ENG|carboplatin/ifosfamide/mesna|
1796567|ENG|Carboplatin/Ifosfamide/Mesna|
1798337|ENG|2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-|
1798382|ENG|Carcinoma bile duct|
1798543|ENG|Carcinoma gastric|
1798548|ENG|2-Pyridineethanamine, N-methyl-|
1798603|ENG|2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-|
1798614|ENG|2-Pyridinepropanamine, N,N-dimethyl-gamma-phenyl-|
1799886|ENG|Carcinoma of Anus|
1799898|ENG|CARCINOMA OF BILE DUCT|
1800024|ENG|Carcinoma of gallbladder (disorder)|
1800025|ENG|Carcinoma of gallbladder|
1800027|ENG|Carcinoma of Gallbladder|
1800028|ENG|CARCINOMA OF GALLBLADDER|
1800269|ENG|Carcinoma of stomach (disorder)|
1800271|ENG|Carcinoma of stomach|
1800272|ENG|Carcinoma of Stomach|
1800273|ENG|CARCINOMA OF STOMACH|
1800308|ENG|Carcinoma of the Anus|
1800385|ENG|Carcinoma of the Gallbladder|
1800507|ENG|Carcinoma of the Stomach|
1800790|ENG|Carcinoma stomach|
1805659|ENG|2 Thiol L histidine betaine|
1805670|ENG|2-Thiol-L-histidine-betaine|
1806563|ENG|carmustine/cyclophosphamide/etoposide/mesna|
1806564|ENG|Carmustine/Cyclophosphamide/Etoposide/Mesna|
1810535|ENG|Casanthranol|
1810536|ENG|CASANTHRANOL|
1810542|ENG|Casanthranol (product)|
1810543|ENG|Casanthranol (substance)|
1812414|ENG|1,2,4-Benzenetriol, 5-(2-aminoethyl)-|
1812423|ENG|castor oil|
1812424|ENG|Castor oil|
1812425|ENG|Castor Oil|
1812427|ENG|CASTOR OIL|
1812436|ENG|Castor oil liquid|
1812439|ENG|Castor oil liquid (product)|
1812469|ENG|Castor oil (substance)|
1813967|ENG|categorization|
1819271|ENG|CBDCA/G-CSF/IFF/mesna|
1819287|ENG|CBDCA/IFF/mesna|
1820452|ENG|CCHPR|
1821131|ENG|CCS|
1824619|ENG|CD - Celiac disease|
1824620|ENG|CDC|
1824743|ENG|CD - Coeliac disease|
1825018|ENG|CDDP/IFF/mesna/MITO|
1825660|ENG|C.difficile colitis|
1829114|ENG|3,3-trimethyl-MPTP|
1831999|ENG|Celiac disease (disorder)|
1832000|ENG|celiac disease|
1832001|ENG|Celiac disease|
1832002|ENG|Celiac Disease|
1832003|ENG|CELIAC DISEASE|
1832062|ENG|celiac sprue|
1832063|ENG|Celiac sprue|
1832064|ENG|Celiac Sprue|
1832065|ENG|CELIAC SPRUE|
1832068|ENG|Celiac syndrome|
183497|ENG|incontinence|
183498|ENG|Incontinence|
183499|ENG|INCONTINENCE|
183500|ENG|Incontinence (excluding P12)|
183501|ENG|Incontinence faecal|
183503|ENG|Incontinence fecal|
183504|ENG|Incontinence, Fecal|
183507|ENG|Incontinence (finding)|
183509|ENG|Incontinence NOS|
183511|ENG|Incontinence of bowel|
183512|ENG|Incontinence of faeces|
183513|ENG|Incontinence of feces|
183514|ENG|Incontinence of feces (finding)|
183559|ENG|Incontinences, Fecal|
1836162|ENG|Cellular Secretion|
183623|ENG|Incontinent of faeces|
183624|ENG|Incontinent of feces|
1836417|ENG|Cellulitis and abscess of mouth|
1838379|ENG|Center, Information|
1838431|ENG|Centers, Information|
1840003|ENG|3,4 Dihydroxyphenethylamine|
1840014|ENG|3,4-Dihydroxyphenethylamine|
1845239|ENG|Cerebral Pseudoscleroses|
1845240|ENG|Cerebral pseudosclerosis (disorder)|
1845241|ENG|Cerebral pseudosclerosis|
1845242|ENG|Cerebral Pseudosclerosis|
1845766|ENG|cerebrospinal fluid|
1846694|ENG|Certain conditions originating in the perinatal period|
1846695|ENG|CERTAIN CONDITIONS ORIGINATING IN THE PERINATAL PERIOD|
1846701|ENG|Certain disorders involving the immune mechanism|
1846706|ENG|Certain infectious and parasitic diseases|
1847147|ENG|3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-6-(((1-oxohexadecyl)oxy)methyl)-, hydroxide, inner salt, 4-oxide|
1847291|ENG|3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxo-9-hexadecenyl)oxy)-, hydroxide, inner salt, 4-oxide, (R-(Z))-|
1847314|ENG|3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxohexadecyl)oxy)-, inner salt, 4-oxide|
1847491|ENG|3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxotetradecyl)oxy)-, inner salt, 4-oxide|
1849947|ENG|3,5-Dichloro-2,6-dimethyl-4-pyridinol|
1851102|ENG|CF|
185220|ENG|Increased Renal Organic Ion Excretion|
1852388|ENG|CGP 73547|
1852389|ENG|CGP-73547|
1852851|ENG|CH3-S-coenzyme M|
1856146|ENG|Charcot arthropathy|
1856160|ENG|Charcot Joint|
1856162|ENG|CHARCOT JOINT|
1856232|ENG|Charcot's arthropathy (disorder)|
1856233|ENG|Charcot's arthropathy|
1856241|ENG|Charcot's joint|
1856242|ENG|Charcot's Joint|
1856243|ENG|Charcots Joint|
1857978|ENG|CHEM|
1857984|ENG|Chemet|
1858295|ENG|chemical informatics|
1858535|ENG|chemical synthesis|
1858601|ENG|cheminformatics|
1858635|ENG|chemistry|
1859306|ENG|chemotherapy|
1859444|ENG|CH|
1860184|ENG|Chest pain|
1860185|ENG|Chest Pain|
1860186|ENG|CHEST PAIN|
1860191|ENG|Chest pain (finding)|
1860198|ENG|Chest pain NOS|
1860217|ENG|Chest Pains|
1860244|ENG|Chest pain, unspecified|
186190|ENG|Index|
1861962|ENG|Child Development Disorder|
1861963|ENG|child development disorders|
1861964|ENG|Child Development Disorders|
186224|ENG|indexing|
186225|ENG|Indexing|
1863601|ENG|Child Mental Disorder|
1863602|ENG|Child Mental Disorders|
186614|ENG|indigestion|
186615|ENG|Indigestion|
186617|ENG|INDIGESTION|
186618|ENG|Indigestion (finding)|
186622|ENG|Indigestions|
186818|ENG|indinavir|
186819|ENG|Indinavir|
186820|ENG|INDINAVIR|
186831|ENG|Indinavir (product)|
186834|ENG|Indinavir (substance)|
1870548|ENG|3-Amino-1,1,3-propanetricarboxylic Acid|
1873374|ENG|chlorphenamine|
1873375|ENG|Chlorphenamine|
1874703|ENG|chlorpheniramine|
1874705|ENG|Chlorpheniramine|
1874706|ENG|CHLORPHENIRAMINE|
1875395|ENG|Chlorpheniramine (product)|
1875453|ENG|Chlorpheniramine (substance)|
1876267|ENG|Chlorprophenpyridamine|
1877246|ENG|choice behavior|
1877247|ENG|Choice Behavior|
1877249|ENG|Choice Behaviors|
1877264|ENG|choice|
1877265|ENG|choice-making behavior|
187914|ENG|indolizine|
187917|ENG|Indolizines|
1879963|ENG|Choline Glycerophospholipids|
1880054|ENG|Choline phosphoglyceride|
1880055|ENG|Choline Phosphoglycerides|
1887923|ENG|Chronic digestive system disorder (disorder)|
1887924|ENG|Chronic digestive system disorder|
1887983|ENG|Chronic disease of digestive system|
1888039|ENG|Chronic disorder of digestive system|
1894516|ENG|CI|
1897921|ENG|circulatory disorder|
1897927|ENG|Circulatory Disorders|
1898434|ENG|Cirrhoses, Hepatic|
1898435|ENG|Cirrhoses, Liver|
1898461|ENG|cirrhosis|
1898462|ENG|Cirrhosis|
1898463|ENG|CIRRHOSIS|
1898467|ENG|Cirrhosis, Hepatic|
1898476|ENG|Cirrhosis liver|
1898477|ENG|Cirrhosis, Liver|
1898496|ENG|Cirrhosis of liver (disorder)|
1898497|ENG|Cirrhosis of liver|
1899995|ENG|cisplatin/ifosfamide/mesna/mitomycin|
1899996|ENG|Cisplatin/Ifosfamide/Mesna/Mitomycin|
1904476|ENG|Class (attribute)|
1904506|ENG|Class|
1904507|ENG|CLASS|
1904510|ENG|Classes|
1904511|ENG|Classes (qualifier value)|
1904799|ENG|Classification (attribute)|
1904801|ENG|classification|
1904802|ENG|Classification|
1904806|ENG|Classifications|
1904807|ENG|classification system|
1904808|ENG|Classification system|
1904809|ENG|Classification system (qualifier value)|
1904810|ENG|Classified|
1904811|ENG|Classified (qualifier value)|
1904813|ENG|classifying, categorizing|
1906052|ENG|CL - Cirrhosis of liver|
1907456|ENG|CL|
1908414|ENG|12-aza-13-carboxy-14-hydroxy-11-oxo-3,4-dithiapentadecanesulfonic acid 14-phosphate|
1908891|ENG|Clinical Classifications for Health Policy Research|
1908894|ENG|Clinical Classifications Software|
1908965|ENG|Clinical disease AND/OR syndrome|
1908966|ENG|Clinical disease AND/OR syndrome present|
1909019|ENG|Clinical finding|
1909020|ENG|Clinical finding (finding)|
1909085|ENG|Clinical Information Systems|
1909436|ENG|Clinical Term, SNOMED|
1909438|ENG|Clinical Terms, SNOMED|
1909504|ENG|Clinical Trials Information for Patients|
1909506|ENG|Clinical Trials Information for Physicians|
1910248|ENG|3H-Purine-6-thiol|
1912516|ENG|Clopidol|
1912517|ENG|Clopidol (substance)|
1912519|ENG|Clopindol|
1916636|ENG|1,2-Benzenediol, 4-(2-aminoethyl)-|
1917101|ENG|Clostridium difficile colitis|
1917124|ENG|Clostridium difficile gastrointestinal tract infection|
1917127|ENG|Clostridium difficile infection (disorder)|
1917128|ENG|Clostridium difficile infection|
1921037|ENG|3 Hydroxymethylpyridine|
1921048|ENG|3-Hydroxymethylpyridine|
1921206|ENG|CMe-THpyr|
1922130|ENG|CN - Constipation|
1922196|ENG|CN|
1926371|ENG|CoB-S-S-CoM|
1930492|ENG|3 Mercaptopropanoic Acid|
1930503|ENG|3-Mercaptopropanoic Acid|
1930514|ENG|3 Mercaptopropionic Acid|
1930526|ENG|3-Mercaptopropionic Acid|
1930750|ENG|Coeliac disease|
1930783|ENG|Coeliac sprue|
1930785|ENG|Coeliac syndrome|
1931010|ENG|CO|
1931368|ENG|Coenzyme M|
193162|ENG|Infection of digestive system (disorder)|
193163|ENG|Infection of digestive system|
1933776|ENG|colfosceril palmitate|
1933777|ENG|Colfosceril palmitate|
1933778|ENG|COLFOSCERIL PALMITATE|
1933782|ENG|Colfosceril palmitate (product)|
1933783|ENG|Colfosceril palmitate (substance)|
1934387|ENG|Colitides, Mucous|
1934463|ENG|Colitis mucous|
1934464|ENG|Colitis, Mucous|
1935915|ENG|Collection, Data|
1937622|ENG|colon disorder|
1937743|ENG|Colonic Disease|
1937745|ENG|Colonic Diseases|
1937749|ENG|colonic disorder|
1937967|ENG|Colon, Irritable|
1938317|ENG|Colon spasm|
1938320|ENG|Colon spastic|
193953|ENG|Infections, Viral|
194149|ENG|Infection viral|
1942467|ENG|Common Terminology Criteria for Adverse Events|
1942478|ENG|Common Toxicity Criteria|
1942495|ENG|Common variable agammaglobulinaemia|
1942496|ENG|Common variable agammaglobulinemia (disorder)|
1942498|ENG|Common variable agammaglobulinemia|
1942499|ENG|Common variable hypogammaglobulinaemia|
1942500|ENG|Common variable hypogammaglobulinemia|
1942501|ENG|Common Variable Immunodeficiencies|
1942504|ENG|Common variable immunodeficiency|
1942505|ENG|Common Variable Immunodeficiency|
1942506|ENG|Common variable immunodeficiency, unspecified|
1942934|ENG|Communication (attribute)|
1942946|ENG|communication channel|
1942974|ENG|communication|
1942975|ENG|Communication|
1942976|ENG|COMMUNICATION|
1943006|ENG|communication media|
1943050|ENG|Communications Media|
194585|ENG|Infectious disease of digestive tract (disorder)|
194586|ENG|Infectious disease of digestive tract|
194595|ENG|Infectious disease of intestine|
194762|ENG|Infectious Hepatitides|
194764|ENG|infectious hepatitis|
194766|ENG|Infectious hepatitis|
194767|ENG|Infectious Hepatitis|
194768|ENG|infectious hepatitis (hepatitis A)|
194928|ENG|Infectious Viral Hepatitis|
1949977|ENG|Complications of pregnancy, childbirth and the puerperium|
1949979|ENG|COMPLICATIONS OF PREGNANCY, CHILDBIRTH, AND THE PUERPERIUM|
1951127|ENG|Compounds, Mercapto|
1951198|ENG|Compounds, Pyridinium|
1951208|ENG|Compounds, Sulfhydryl|
1951937|ENG|Computational Biology|
1952495|ENG|Computer Retrieval of Information on Scientific Projects Database|
1952496|ENG|Computer Retrieval of Information on Scientific Projects Thesaurus|
1952517|ENG|Computer Security|
1952565|ENG|Computer-Stored Ambulatory Records|
1952605|ENG|Computing Methodologies|
1952606|ENG|Computing Methodology|
1955679|ENG|Congenital agammaglobulinaemia|
1955680|ENG|Congenital agammaglobulinemia (disorder)|
1955682|ENG|Congenital agammaglobulinemia|
1955693|ENG|Congenital alimentary tract anomaly|
1955886|ENG|Congenital anomaly NOS of digestive system NOS|
1955906|ENG|Congenital anomaly of alimentary tract|
1956005|ENG|Congenital anomaly of digestive system (disorder)|
1956006|ENG|Congenital anomaly of digestive system|
1956007|ENG|Congenital anomaly of digestive tract (disorder)|
1956008|ENG|Congenital anomaly of digestive tract|
1956074|ENG|Congenital anomaly of gastrointestinal tract (disorder)|
1956075|ENG|Congenital anomaly of gastrointestinal tract|
1957442|ENG|Congenital deformity NOS of digestive system NOS|
1957465|ENG|Congenital deformity of digestive system|
1957572|ENG|Congenital digestive system anomalies|
1957573|ENG|Congenital digestive tract anomaly|
1957651|ENG|Congenital disease (disorder)|
1957652|ENG|Congenital disease|
1957701|ENG|congenital disorder|
1957702|ENG|Congenital disorder|
1957704|ENG|Congenital Disorder|
1957712|ENG|Congenital Disorders|
1957864|ENG|Congenital dysgammaglobulinemia|
1958416|ENG|Congenital gastrointestinal malformations|
1958595|ENG|Congenital, Hereditary, and Neonatal Diseases and Abnormalities|
1959111|ENG|Congenital immunodeficiency disease (disorder)|
1959112|ENG|Congenital immunodeficiency disease|
1959540|ENG|Congenital malformation of digestive system, unspecified|
1959616|ENG|Congenital malformation of the digestive system|
1959661|ENG|Congenital malformations, deformations and chromosomal abnormalities|
1960431|ENG|Congenital non-sex-linked hypogammaglobulinemia|
1961946|ENG|3-Pyridinemethanol|
1963611|ENG|Connective and Soft Tissue Finding|
1964139|ENG|conotoxin|
1964140|ENG|Conotoxin|
1964173|ENG|Conotoxins|
1964175|ENG|Conotoxin (substance)|
1964648|ENG|Constipated|
1964661|ENG|Constipation (disorder)|
1964664|ENG|constipation|
1964665|ENG|Constipation|
1964666|ENG|CONSTIPATION|
1964675|ENG|constipation, impaction, and bowel obstruction|
1964680|ENG|Constipation NOS|
1964684|ENG|Constipation, unspecified|
1965139|ENG|Construction of stoma|
1965140|ENG|Construction of stoma (procedure)|
1968327|ENG|Controlled Vocabularies|
1968328|ENG|Controlled Vocabulary|
1968726|ENG|3'-trifluoro-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|
1971799|ENG|Copper storage disease|
1972545|ENG|copying|
1972549|ENG|Copying Process|
1972550|ENG|Copying Processes|
1975626|ENG|4-(2-Aminoethyl)-1,2-benzenediol|
197680|ENG|Infirmity|
198162|ENG|Inflammatory disease of liver (disorder)|
198163|ENG|Inflammatory disease of liver|
1981839|ENG|COSTAR, 1989-1995|
1981841|ENG|COSTAR (Computer-Stored Ambulatory Records), 1989-1995|
1981842|ENG|COSTAR|
1981952|ENG|Costiveness|
198199|ENG|Inflammatory disorder of digestive system (disorder)|
198200|ENG|Inflammatory disorder of digestive system|
198219|ENG|Inflammatory disorder of liver|
198334|ENG|Inflammatory liver disease|
198335|ENG|Inflammatory liver disease, unspecified|
198404|ENG|Inflammatory polyarthritis|
198405|ENG|Inflammatory polyarthropathies|
198406|ENG|Inflammatory polyarthropathy (disorder)|
198407|ENG|inflammatory polyarthropathy|
198408|ENG|Inflammatory polyarthropathy|
198411|ENG|Inflammatory polyarthropathy or polyarthritis NOS|
1984426|ENG|4,4'-Bipyridinium, 1,1'-dimethyl-|
1984835|ENG|Cow's milk enteropathy|
1986524|ENG|CP 62993|
1986525|ENG|CP-62993|
1986528|ENG|CP62993|
1987311|ENG|CPh-THpyr|
1989681|ENG|4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine|
1990519|ENG|CRCH|
1991003|ENG|creating order|
1993964|ENG|CRISP|
1993976|ENG|CRISP Thesaurus|
199980|ENG|informatics|
199982|ENG|Informatics|
199998|ENG|information bank|
199999|ENG|information center|
200000|ENG|Information Center|
200001|ENG|Information Centers|
200013|ENG|information display|
200014|ENG|Information Display|
200016|ENG|Information Displays|
200017|ENG|information dissemination|
200018|ENG|Information Dissemination|
200034|ENG|information management|
200035|ENG|Information Management|
200058|ENG|Information Processing/Storage/Retrieval|
200068|ENG|Information Resources Management|
200071|ENG|information retrieval|
200072|ENG|Information Retrieval|
200077|ENG|Information Science|
200078|ENG|information science (field)|
200082|ENG|Information Sciences|
200088|ENG|information service|
200089|ENG|Information Service|
200091|ENG|Information Services|
2000931|ENG|CS - Celiac sprue|
2000941|ENG|CS - Coeliac sprue|
2001002|ENG|CS|
200105|ENG|information storage and retrieval|
200106|ENG|Information Storage and Retrieval|
200112|ENG|information system|
200113|ENG|Information System|
2001164|ENG|CSF|
2001647|ENG|CSP|
200167|ENG|Information Systems|
200208|ENG|Information Technology|
200212|ENG|Information Theories|
200213|ENG|information theory|
200215|ENG|Information Theory|
2002254|ENG|CTCAE|
2002747|ENG|1,2 Dihexadecyl sn Glycerophosphocholine|
2002858|ENG|1,2-Dihexadecyl-sn-Glycerophosphocholine|
2007235|ENG|CTC|
2007349|ENG|CT|
2007436|ENG|4'-amino-1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|
2007621|ENG|CTEP04|
2007622|ENG|CTEP|
2010090|ENG|Cullen's sign|
2010091|ENG|Cullen's sign (finding)|
2012981|ENG|4'-amino-MPTP|
2013268|ENG|Cutaneous Disorder|
2014660|ENG|CVAG|
2014860|ENG|CVI - Common variable immunodeficiency|
2014862|ENG|CVID - Common variable immunodeficiency|
2015000|ENG|CVX|
2018624|ENG|4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridine|
2018638|ENG|4-benzyl-1-methyl-1,2,3,6-tetrahydropyridine|
201900|ENG|Inherited disease|
202176|ENG|inhibitor/antagonist|
2022749|ENG|CY|
2024642|ENG|Cyperquat|
2025710|ENG|Cys|
2025948|ENG|Cystalgia|
2026553|ENG|cysteine|
2026554|ENG|Cysteine|
2026555|ENG|CYSTEINE|
2026652|ENG|Cysteine preparation|
2026654|ENG|Cysteine preparation (product)|
2026793|ENG|Cysteine (substance)|
2027840|ENG|Cystitides|
2027874|ENG|Cystitis (disorder)|
2027882|ENG|cystitis|
2027883|ENG|Cystitis|
2027884|ENG|CYSTITIS|
2027926|ENG|Cystitis NOS|
2027945|ENG|Cystitis, unspecified|
2028052|ENG|Cyst, Nonodontogenic|
2028287|ENG|Cyst of Mouth|
2028298|ENG|Cyst of Oral Cavity|
2028299|ENG|Cyst of oral region, unspecified|
2028383|ENG|Cyst of the Mouth|
2028387|ENG|Cyst of the Oral Cavity|
2029059|ENG|Cysts, Nonodontogenic|
2029072|ENG|Cysts of oral region, not elsewhere classified|
2029760|ENG|4-cyclopropyl-1-methyl-1,2,3,6-tetrahydropyridine|
20315|ENG|Gnashing tooth|
2032083|ENG|cytology|
2032747|ENG|1,2 Dimyristoyl glycero 3 phosphorylcholine|
2032858|ENG|1,2-Dimyristoyl-glycero-3-phosphorylcholine|
2033202|ENG|Cytoprotectants|
2033206|ENG|Cytoprotective agent|
2033207|ENG|Cytoprotective Agent|
2033208|ENG|Cytoprotective agent (product)|
2033209|ENG|Cytoprotective agent (substance)|
2033210|ENG|Cytoprotective Drugs|
2034391|ENG|D-7093|
2034973|ENG|dacarbazine/doxorubicin/ifosfamide/mesna|
2034974|ENG|Dacarbazine/Doxorubicin/Ifosfamide/Mesna|
2035005|ENG|Dacarbazine/Mesna|
203637|ENG|Acetadote|
2040003|ENG|4-FMe-MPTP|
2040026|ENG|data bank|
2040027|ENG|databank|
2040028|ENG|Data Bank|
2040050|ENG|Database, Electronic|
2040051|ENG|data base|
2040052|ENG|database|
2040053|ENG|Data Base|
2040054|ENG|Database|
2040089|ENG|Databases|
2040107|ENG|data collection|
2040108|ENG|Data Collection|
2040109|ENG|DATA COLLECTION|
2040123|ENG|Data Display|
2040124|ENG|Data Displays|
2040155|ENG|Data, Molecular Sequence|
2040156|ENG|Data, Molecular Sequencing|
2040186|ENG|Data Retrieval|
2041616|ENG|DB|
2042698|ENG|DCP|
2046969|ENG|1,2 Dipalmitoyl Glycerophosphocholine|
2047080|ENG|1,2-Dipalmitoyl-Glycerophosphocholine|
2047413|ENG|1,2 Dipalmitoylphosphatidylcholine|
2047525|ENG|1,2-Dipalmitoylphosphatidylcholine|
2048302|ENG|1,2-dipalmitoyl-sn-glycero-3-ethylphosphocholine|
204894|ENG|Injuries and Wounds|
2049127|ENG|DE|
204924|ENG|Injuries|
205019|ENG|Injuries, Wounds|
205053|ENG|Injury and poisoning|
205054|ENG|INJURY AND POISONING|
205057|ENG|Injury and Wounds|
2051984|ENG|Deficiencies of humoral immunity|
2051985|ENG|Deficiencies of humoral immunity (finding)|
2053357|ENG|Deficiency of humoral immunity|
2053358|ENG|Deficiency of Humoral Immunity|
2054491|ENG|Deficiency Syndrome, Immunological|
2054493|ENG|Deficiency Syndrome, Immunologic|
2054498|ENG|Deficiency Syndromes, Immunological|
2054499|ENG|Deficiency Syndromes, Immunologic|
205513|ENG|Injury - disorder|
2055733|ENG|degeneration|
2055734|ENG|Degeneration|
2055754|ENG|Degeneration, Hepatocerebral|
2055756|ENG|Degeneration, Hepatolenticular|
2055873|ENG|Degeneration (morphologic abnormality)|
2055900|ENG|Degeneration, Neurohepatic|
2055969|ENG|1,2 Ditetradecanoyl glycero 3 phosphocholine|
2055983|ENG|Degeneration, Progressive Lenticular|
2056005|ENG|Degenerations, Hepatocerebral|
2056018|ENG|Degenerations, Neurohepatic|
2056073|ENG|Degenerative abnormality|
2056074|ENG|Degenerative abnormality (morphologic abnormality)|
2056080|ENG|1,2-Ditetradecanoyl-glycero-3-phosphocholine|
2056102|ENG|Degenerative change|
2056122|ENG|degenerative disease|
2056123|ENG|Degenerative Disease|
2056134|ENG|Degenerative disorder (disorder)|
2056135|ENG|Degenerative disorder|
2056137|ENG|Degenerative Disorder|
2056191|ENG|1,2 Ditetradecyl glycero 3 phosphocholine|
2056302|ENG|1,2-Ditetradecyl-glycero-3-phosphocholine|
2056397|ENG|Deglutition disorder|
2056398|ENG|Deglutition Disorder|
2056399|ENG|Deglutition Disorders|
205941|ENG|injury|
205942|ENG|Injury|
205943|ENG|INJURY|
2063996|ENG|dental disorder|
2063998|ENG|DENTAL DISORDER|
2063999|ENG|Dental disorder NOS|
206744|ENG|Injury NOS|
2067678|ENG|DEPN 8|
2067679|ENG|DEPN-8|
2069894|ENG|Dermatological disease|
2069895|ENG|Dermatological disorder|
2070490|ENG|Dermatoses|
2070576|ENG|dermatosis|
2070577|ENG|Dermatosis|
2070604|ENG|Dermatosis NOS|
2070958|ENG|4-MZTP|
2071770|ENG|DESC|
2076976|ENG|developmental delay disorders|
2076989|ENG|developmental disabilities|
2076990|ENG|Developmental Disabilities|
2076992|ENG|developmental disability|
2076994|ENG|Developmental Disability|
2076995|ENG|developmental disease/disorder|
2077016|ENG|Developmental disorder (disorder)|
2077017|ENG|developmental disorder|
2077018|ENG|Developmental disorder|
2077050|ENG|Developmental disorder NOS|
2077185|ENG|Developmental (nonodontogenic) cysts of oral region|
2077322|ENG|Development Disorder, Child|
2077325|ENG|Development Disorders, Child|
208233|ENG|Injury, poisoning and certain other consequences of external causes|
2084180|ENG|4-phenyl-1,2,3,6-tetrahydropyridine|
2084972|ENG|DHAD/IFF/mesna|
2084973|ENG|DHAD/IFF/mesna/VP-16|
2085654|ENG|DHP|
2086113|ENG|diabetes bronze|
2086114|ENG|Diabetes, Bronze|
2087880|ENG|DIAG|
2088005|ENG|diagnosis|
2088237|ENG|4-Pyridinemethanol, 3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl- )|
2088304|ENG|4-Pyridinol, 3,5-dichloro-2,6-dimethyl-|
2091291|ENG|Diaphragmatic/hiatus hernia|
209293|ENG|Injury, unspecified|
209813|ENG|innervation|
2098631|ENG|DI|
2100116|ENG|diet therapy|
2100568|ENG|Difficult passing motion|
2100861|ENG|Difficulty defaecating|
2100862|ENG|Difficulty defecating|
2101079|ENG|Difficulty in swallowing|
2101289|ENG|Difficulty opening bowels|
2101313|ENG|Difficulty passing stool|
2101697|ENG|Difficulty swallowing|
2101698|ENG|Difficulty swallowing (finding)|
2103537|ENG|5-(2-Aminoethyl)-1,2,4-benzenetriol|
2103540|ENG|digestion|
2103541|ENG|Digestion|
2103567|ENG|digestive cancer|
2103571|ENG|Digestive congenital anomalies|
2103572|ENG|Digestive Diseases|
2103573|ENG|digestive disorder|
2103579|ENG|DIGESTIVE|
2103612|ENG|digestive neoplasm|
2103665|ENG|Digestive structure|
2103668|ENG|Digestive System Abnormalities|
2103669|ENG|Digestive System Abnormality|
2103674|ENG|Digestive system (all sites)|
2103683|ENG|digestive system cancer|
2103684|ENG|Digestive System Cancer|
2103685|ENG|Digestive System Cancers|
2103691|ENG|digestive system diagnosis|
2103697|ENG|Digestive system disease|
2103698|ENG|Digestive System Disease|
2103699|ENG|Digestive system disease screening|
2103700|ENG|Digestive system disease screening (procedure)|
2103701|ENG|Digestive System Diseases|
2103705|ENG|digestive system disorder|
2103712|ENG|digestive system|
2103713|ENG|Digestive system|
2103715|ENG|Digestive System|
2103716|ENG|Digestive system finding|
2103717|ENG|Digestive system finding (finding)|
2103718|ENG|Digestive System Fistula|
2103719|ENG|Digestive System Fistulas|
2103724|ENG|digestive system function|
2103726|ENG|Digestive system function|
2103727|ENG|Digestive system function (observable entity)|
2103728|ENG|Digestive system functions|
2103730|ENG|Digestive system hereditary disorder (disorder)|
2103731|ENG|Digestive system hereditary disorder|
2103733|ENG|digestive system neoplasm|
2103734|ENG|Digestive System Neoplasm|
2103735|ENG|Digestive System Neoplasms|
2103737|ENG|Digestive System, NOS|
2103740|ENG|Digestive system observation|
2103751|ENG|digestive system symptom|
2103839|ENG|Digital Anatomist|
2106279|ENG|dihydropyridine|
2106281|ENG|Dihydropyridine|
2106287|ENG|Dihydropyridines|
2107196|ENG|Diisopyramide|
2109318|ENG|DIME protocol|
2109353|ENG|Dimercaprol|
2109354|ENG|DIMERCAPROL|
2109358|ENG|Dimercaprol (product)|
2109360|ENG|Dimercaprol (substance)|
2109364|ENG|Dimercaptopropanol|
2109910|ENG|Dimethindene|
2109930|ENG|Dimethindene (product)|
2109931|ENG|Dimethindene (substance)|
2110030|ENG|Dimethpyrindene|
2110900|ENG|Dimetindene|
2111129|ENG|Dimyristoyllecithin|
2111143|ENG|Dimyristoylphosphatidylcholine|
2112779|ENG|Dipalmitoylglycerophosphocholine|
2112782|ENG|Dipalmitoyllecithin|
2112793|ENG|Dipalmitoyl Phosphatidylcholine|
2112794|ENG|Dipalmitoylphosphatidylcholine|
211362|ENG|Inpharzam Brand of Acetylcysteine|
2116942|ENG|Dipyridoxolyldisulfide|
2116943|ENG|Dipyridyl, 2,2|
2116944|ENG|Dipyridyl, 2,2'|
2118145|ENG|Disabilities, Developmental|
2118148|ENG|Disabilities|
2118168|ENG|Disability, Developmental|
2118171|ENG|disability|
2118172|ENG|Disability|
2118173|ENG|DISABILITY|
2118274|ENG|Disability (finding)|
2118286|ENG|Disability NOS|
2120094|ENG|Discomfort abdominal|
2120549|ENG|Disease AND/OR syndrome present|
2120601|ENG|Disease, Biliary Tract|
2120606|ENG|Disease, Blood|
2120634|ENG|Disease by Site|
2120661|ENG|Disease caused by parasite (disorder)|
2120662|ENG|Disease caused by parasite|
2120669|ENG|Disease caused by virus|
2120674|ENG|Disease, Celiac|
2120696|ENG|disease classification|
2120705|ENG|Disease, Colonic|
2120784|ENG|Disease, Digestive System|
2120787|ENG|disease/disorder classification|
2120788|ENG|disease/disorder|
2120789|ENG|Disease (disorder)|
2121136|ENG|Disease, Ear|
2121147|ENG|Disease, Endocrine|
2121149|ENG|Disease, Endocrine System|
2121152|ENG|Disease|
2121157|ENG|Disease, Esophageal|
2121166|ENG|Disease, Eye|
2121222|ENG|Disease gallbladder|
2121223|ENG|Disease, Gall Bladder|
2121224|ENG|Disease, Gallbladder|
2121228|ENG|Disease, Gastric|
2121229|ENG|Disease, Gastrointestinal|
2121271|ENG|Disease, Hematological|
2121272|ENG|Disease, Hematologic|
2121280|ENG|Disease hepatocellular|
2121282|ENG|Disease, Hereditary|
2121329|ENG|Disease, Immune|
2121330|ENG|Disease, Immune System|
2121331|ENG|Disease, Immunological|
2121332|ENG|Disease, Immunologic|
2121342|ENG|Disease, Intestinal|
2121352|ENG|Disease, Joint|
2121388|ENG|Disease, Liver|
2121399|ENG|Disease, Lymphatic|
2121440|ENG|Disease, Metabolic|
2121473|ENG|Disease, Mouth|
2121477|ENG|Disease, Musculoskeletal|
2121484|ENG|Disease, Nervous System|
2121496|ENG|Disease, Occupational|
2121523|ENG|Disease of appendix, unspecified|
2121540|ENG|Disease of biliary system|
2121543|ENG|Disease of biliary tract, unspecified|
2121546|ENG|Disease of blood and blood-forming organs, unspecified|
2121547|ENG|Disease of blood AND/OR blood forming organ|
2121595|ENG|Disease of digestive system, unspecified|
2121604|ENG|Disease of endocrine gland|
2121612|ENG|Disease of esophagus|
2121613|ENG|Disease of esophagus, unspecified|
2121620|ENG|Disease of eyeball|
2121639|ENG|Disease of gallbladder, unspecified|
2121676|ENG|Disease of intestine, unspecified|
2121698|ENG|Disease of liver|
2121729|ENG|Disease of mouth|
2121755|ENG|Disease of oesophagus, unspecified|
2121773|ENG|Disease of pancreas, unspecified|
2121878|ENG|Disease of stomach and duodenum, unspecified|
2123222|ENG|Disease, Otorhinolaryngological|
2123223|ENG|Disease, Otorhinolaryngologic|
2123235|ENG|Disease, Pancreatic|
2123240|ENG|Disease, Parasitic|
2123277|ENG|Disease, Plant|
2123320|ENG|Disease, Rectal|
2123345|ENG|Disease, Respiratory Tract|
2123377|ENG|Diseases and Disorders|
2123378|ENG|DISEASES AND INJURIES|
2123406|ENG|Diseases, Biliary Tract|
2123409|ENG|Diseases, Blood|
2123454|ENG|Diseases, Colonic|
2123467|ENG|Diseases, Digestive System|
2123473|ENG|Diseases, Ear|
2123484|ENG|Diseases, Endocrine|
2123485|ENG|Diseases, Endocrine System|
2123488|ENG|Diseases|
2123493|ENG|Diseases, Esophageal|
2123497|ENG|Diseases, Eye|
2123517|ENG|Diseases, Gall Bladder|
2123518|ENG|Diseases, Gallbladder|
2123519|ENG|Diseases, Gastric|
2123520|ENG|Diseases, Gastrointestinal|
2123538|ENG|Diseases, Hematological|
2123539|ENG|Diseases, Hematologic|
2123544|ENG|Diseases, Hepato-Neurologic Wilson|
2123545|ENG|Diseases, Hereditary|
2123566|ENG|Diseases, Immune|
2123567|ENG|Diseases, Immune System|
2123568|ENG|Diseases, Immunological|
2123569|ENG|Diseases, Immunologic|
2123578|ENG|Diseases, Intestinal|
2123587|ENG|Diseases, Joint|
2123589|ENG|Disease, Skin|
2123591|ENG|Diseases, Kinnier-Wilson|
2123601|ENG|Diseases, Liver|
2123607|ENG|Diseases, Lymphatic|
2123611|ENG|Diseases, Manifestations or Physiologic States|
2123618|ENG|Diseases (MeSH Category)|
2123620|ENG|Diseases, Metabolic|
2123624|ENG|Diseases, Mouth|
2123627|ENG|Diseases, Musculoskeletal|
2123631|ENG|Diseases, Nervous System|
2123639|ENG|Diseases, Occupational|
2123641|ENG|Diseases of appendix|
2123649|ENG|Diseases of blood and blood-forming organs|
2123652|ENG|Diseases of Endocrine System|
2123653|ENG|Diseases of esophagus|
2123654|ENG|DISEASES OF ESOPHAGUS|
2123657|ENG|Diseases of esophagus, stomach and duodenum|
2123658|ENG|DISEASES OF ESOPHAGUS, STOMACH, AND DUODENUM|
2123664|ENG|Diseases of Immune System|
2123669|ENG|Diseases of liver|
2123684|ENG|Diseases of oesophagus|
2123686|ENG|Diseases of oesophagus, stomach and duodenum|
2123687|ENG|Diseases of oral cavity, salivary glands and jaws|
2123688|ENG|DISEASES OF ORAL CAVITY, SALIVARY GLANDS, AND JAWS|
2123691|ENG|Diseases of pancreas|
2123695|ENG|Diseases of peritoneum|
2123701|ENG|Diseases of the blood and blood-forming organs|
2123702|ENG|DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS|
2123705|ENG|Diseases of the circulatory system|
2123706|ENG|DISEASES OF THE CIRCULATORY SYSTEM|
2123708|ENG|Diseases of the digestive system complicating pregnancy, childbirth and the puerperium|
2123709|ENG|Diseases of the digestive system|
2123710|ENG|DISEASES OF THE DIGESTIVE SYSTEM|
2123711|ENG|Diseases of the ear and mastoid process|
2123712|ENG|DISEASES OF THE EAR AND MASTOID PROCESS|
2123713|ENG|Diseases of the eye and adnexa|
2123715|ENG|Diseases of the genitourinary system|
2123716|ENG|DISEASES OF THE GENITOURINARY SYSTEM|
2123719|ENG|Diseases of the musculoskeletal system and connective tissue|
2123720|ENG|DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE|
2123721|ENG|Diseases of the nervous system and sense organs|
2123722|ENG|DISEASES OF THE NERVOUS SYSTEM AND SENSE ORGANS|
2123723|ENG|Diseases of the nervous system|
2123724|ENG|Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue|
2123728|ENG|Diseases of the respiratory system|
2123729|ENG|DISEASES OF THE RESPIRATORY SYSTEM|
2123733|ENG|Diseases of the skin and subcutaneous tissue|
2123734|ENG|DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE|
2123735|ENG|Diseases of the urinary system|
2123752|ENG|Diseases, Otorhinolaryngological|
2123753|ENG|Diseases, Otorhinolaryngologic|
2123758|ENG|Diseases, Pancreatic|
2123762|ENG|Diseases, Parasitic|
2123787|ENG|Diseases, Plant|
2123806|ENG|Diseases, Rectal|
2123808|ENG|Diseases, Respiratory Tract|
2123826|ENG|Diseases, Skin|
2123833|ENG|Diseases, Stomach|
2123834|ENG|Diseases, Stomatognathic|
2123854|ENG|Disease, Stomach|
2123855|ENG|Disease, Stomatognathic|
2123871|ENG|Diseases, Urinary Tract|
2123873|ENG|Diseases, Urological|
2123874|ENG|Diseases, Urologic|
2123890|ENG|Diseases, Viral|
2123894|ENG|Diseases, Virus|
2123909|ENG|disease taxonomy|
2123919|ENG|disease/therapy duration|
2123953|ENG|disease typology|
2123961|ENG|Disease, Urinary Tract|
2123963|ENG|Disease, Urological|
2123964|ENG|Disease, Urologic|
2123985|ENG|Disease, Viral|
2123989|ENG|Disease, Virus|
2124034|ENG|DIS|
2125307|ENG|disopyramide|
2125308|ENG|Disopyramide|
2125309|ENG|DISOPYRAMIDE|
2125407|ENG|Disopyramide (product)|
2125408|ENG|Disopyramide product|
2125418|ENG|Disopyramide (substance)|
2125560|ENG|disorder by body system or organ function|
2125562|ENG|Disorder by Site|
2125595|ENG|Disorder, Child Mental|
2125600|ENG|Disorder circulatory system|
2125602|ENG|disorder classification|
2125631|ENG|Disorder, Congenital|
2125647|ENG|Disorder deglutition|
2125704|ENG|Disorder ear|
2125733|ENG|Disorder endocrine|
2125739|ENG|Disorder|
2125750|ENG|Disorder eye|
2125774|ENG|Disorder gastrointestinal|
2125811|ENG|Disorder hepatic|
2125835|ENG|Disorder, Immune|
2125837|ENG|Disorder immune system (NOS)|
2125853|ENG|Disorder involving the immune mechanism, unspecified|
2125861|ENG|Disorder joint|
2125880|ENG|Disorder liver|
2125978|ENG|Disorder nervous system|
2125979|ENG|Disorder, Nervous System|
2125980|ENG|Disorder, Neurological|
2125982|ENG|Disorder, Neurologic|
2126067|ENG|Disorder of appendix|
2126105|ENG|Disorder of biliary tract|
2126127|ENG|Disorder of body system (disorder)|
2126128|ENG|Disorder of body system|
2126231|ENG|Disorder of circulatory system|
2126270|ENG|Disorder of digestive system specific to fetus OR newborn (disorder)|
2126271|ENG|Disorder of digestive system specific to fetus OR newborn|
2126277|ENG|Disorder of ear and mastoid process|
2126278|ENG|Disorder of ear (disorder)|
2126279|ENG|Disorder of ear|
2126284|ENG|Disorder of ear, unspecified|
2126297|ENG|Disorder of endocrine gland|
2126307|ENG|Disorder of endocrine system (disorder)|
2126308|ENG|Disorder of endocrine system|
2126311|ENG|disorder of environmental origin|
2126321|ENG|Disorder of esophagus|
2126339|ENG|Disorder of eye and adnexa NOS|
2126340|ENG|Disorder of eye and adnexa, unspecified|
2126341|ENG|Disorder of eyeball|
2126342|ENG|Disorder of eye|
2126349|ENG|Disorder of eye proper (disorder)|
2126352|ENG|Disorder of eye, unspecified|
2126400|ENG|Disorder of gallbladder|
2126408|ENG|Disorder of genitourinary system|
2126410|ENG|Disorder of globe|
2126411|ENG|Disorder of globe, unspecified|
2126436|ENG|Disorder of haematopoietic system|
2126457|ENG|Disorder of hematopoietic system|
2126465|ENG|disorder of higher mental process|
2126488|ENG|Disorder of immune system|
2126508|ENG|Disorder of integument (disorder)|
2126509|ENG|Disorder of integument|
2126511|ENG|Disorder of intestine|
2126541|ENG|Disorder of joint|
2126607|ENG|Disorder of liver (disorder)|
2126608|ENG|Disorder of liver|
2126613|ENG|Disorder of lymphatics|
2126617|ENG|Disorder of lymphatic system (disorder)|
2126618|ENG|Disorder of lymphatic system|
2126673|ENG|Disorder of musculoskeletal system|
2126691|ENG|Disorder of nervous system NOS|
2126711|ENG|Disorder of nutrition|
2126716|ENG|Disorder of oesophagus|
2126750|ENG|Disorder of oral cavity|
2126777|ENG|Disorder of pancreas|
2126812|ENG|Disorder of peritoneum|
2126813|ENG|Disorder of peritoneum, unspecified|
2126856|ENG|Disorder of porphyrin and haem metabolism|
2126857|ENG|Disorder of porphyrin and heme metabolism|
2126860|ENG|Disorder of porphyrin metabolism (disorder)|
2126861|ENG|Disorder of porphyrin metabolism|
2126933|ENG|Disorder of reproductive system (disorder)|
2126934|ENG|Disorder of reproductive system|
2126974|ENG|Disorder of skin and subcutaneous tissue|
2126976|ENG|Disorder of skin and subcutaneous tissue, unspecified|
2127004|ENG|Disorder of small intestine|
2127043|ENG|Disorder of stomach|
2127075|ENG|Disorder of teeth and supporting structures, unspecified|
2127100|ENG|Disorder of the circulatory system|
2127101|ENG|Disorder of the dermis and subcutaneous tissue|
2127112|ENG|Disorder of the peripheral nervous system (disorder)|
2127113|ENG|Disorder of the peripheral nervous system|
2127121|ENG|Disorder of the urinary system (disorder)|
2127122|ENG|Disorder of the urinary system|
2127187|ENG|Disorder of urinary system, unspecified|
2127188|ENG|Disorder of urinary tract|
2127313|ENG|Disorder pancreas|
2127434|ENG|Disorder rectal|
2127450|ENG|Disorder, Respiration|
2127457|ENG|Disorder, Rumination|
2127487|ENG|Disorders, Child Mental|
2127517|ENG|Disorders, Congenital|
2127566|ENG|Disorders, Deglutition|
2127579|ENG|Disorders|
2127622|ENG|Disorders, Immune|
2127627|ENG|Disorders involving the immune mechanism|
2127654|ENG|Disorders, Nervous System|
2127655|ENG|Disorders, Neurological|
2127656|ENG|Disorders, Neurologic|
2127732|ENG|Disorders of Environmental Origin|
2127760|ENG|Disorders of gallbladder, biliary tract and pancreas|
2127762|ENG|Disorders of globe|
2127799|ENG|Disorders of lymph node and lymphatics (disorder)|
2127800|ENG|Disorders of lymph node and lymphatics|
2127869|ENG|disorders of porphyrin metabolism|
2127871|ENG|Disorders of porphyrin metabolism|
2127907|ENG|Disorders of teeth and jaw|
2127912|ENG|DISORDERS OF THE EYE AND ADNEXA|
2127916|ENG|Disorders of the globe|
2127919|ENG|Disorders of the peripheral nervous system|
2127920|ENG|DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM|
2128019|ENG|Disorders, Respiration|
2128044|ENG|Disorders, Teeth Grinding|
2128061|ENG|Disorders Usually Diagnosed in Infancy, Childhood or Adolescence|
2128073|ENG|Disorder, Teeth Grinding|
2128100|ENG|Disorder urinary tract|
2128104|ENG|Disorder urogenital|
2128704|ENG|Display, Data|
2128706|ENG|Display, Information|
2128708|ENG|Displays, Data|
2128711|ENG|Displays, Information|
2129473|ENG|Dissemination, Information|
2129482|ENG|dissemination of information|
21320|ENG|GO|
2132235|ENG|Disturbance of mastication|
2132754|ENG|Dithioglycerol|
2133594|ENG|Diverticulitis with diverticulosis NOS|
2133612|ENG|Diverticulosis and diverticulitis|
2133613|ENG|Diverticulosis and Diverticulitis|
2135956|ENG|DMCP|
2136787|ENG|DMPC|
2136951|ENG|DMSA|
2140322|ENG|Documentation|
2140327|ENG|Documentations|
2141249|ENG|Dodecyl Sulfate, Sodium|
214357|ENG|instrumentation|
2145052|ENG|Dolor|
2146378|ENG|Dopamine Agents|
2146396|ENG|dopamine antagonist|
2146397|ENG|Dopamine Antagonists|
2146478|ENG|Dopamine Drugs|
2146479|ENG|dopamine|
2146480|ENG|Dopamine|
2146482|ENG|DOPamine|
2146483|ENG|DOPAMINE|
2146645|ENG|Dopamine preparation|
2146647|ENG|Dopamine (product)|
2146649|ENG|Dopamine product|
2146660|ENG|dopamine receptor antagonist|
2146661|ENG|Dopamine Receptor Antagonists|
2146698|ENG|dopaminergic agents|
2146699|ENG|Dopaminergic Agents|
2146704|ENG|Dopaminergic Antagonists|
2146719|ENG|Dopaminergic Drugs|
2150477|ENG|DOX/DTIC/IFF/mesna|
2151977|ENG|doxylamine|
2151978|ENG|Doxylamine|
2151979|ENG|DOXYLAMINE|
2151999|ENG|Doxylamine (substance)|
2152902|ENG|DPPAO|
2152911|ENG|DPPC Ser-mCnc|
2157862|ENG|Drug Administrations, Sublingual|
2157864|ENG|Drug Administration, Sublingual|
2157894|ENG|drug/agent|
2157899|ENG|drug allergen|
2157900|ENG|Drug allergen|
2157901|ENG|Drug allergen (substance)|
2157902|ENG|Drug Allergies|
2157905|ENG|drug allergy|
2157907|ENG|Drug allergy|
2157908|ENG|Drug Allergy|
2157909|ENG|DRUG ALLERGY|
2157976|ENG|drug classification|
2158227|ENG|Drug effect|
2158244|ENG|Drug|
2158431|ENG|Drug Hypersensitivities|
2158434|ENG|drug hypersensitivity|
2158437|ENG|Drug hypersensitivity|
2158438|ENG|Drug Hypersensitivity|
2158441|ENG|Drug hypersensitivity NOS|
2159072|ENG|Drug intoxication|
2159351|ENG|Drug poisoning|
2159696|ENG|Drugs, Dopamine|
2159697|ENG|Drugs, Dopaminergic|
2159703|ENG|Drugs|
2159904|ENG|Drugs, Protective|
2160050|ENG|drug therapy|
2160076|ENG|Drug Toxicities|
2160079|ENG|drug toxicity|
2160082|ENG|Drug toxicity|
2160083|ENG|Drug Toxicity|
2160084|ENG|DRUG TOXICITY|
2160085|ENG|Drug toxicity (NOS)|
2160086|ENG|Drug toxicity NOS|
2161903|ENG|DT|
2162013|ENG|DTIC/Mesna|
2162179|ENG|DTP|
2163762|ENG|Dulcolax|
2163931|ENG|dumping syndrome|
2163933|ENG|Dumping syndrome|
2163934|ENG|Dumping Syndrome|
2163935|ENG|DUMPING SYNDROME|
2163937|ENG|Dumping Syndromes|
2164928|ENG|Duplicating Process|
2164929|ENG|Duplicating Processes|
2168142|ENG|Dyscrasia blood (NOS)|
2168466|ENG|dysfunction|
2169099|ENG|dyspepsia|
2169100|ENG|Dyspepsia|
2169101|ENG|DYSPEPSIA|
2169105|ENG|Dyspepsias|
2169117|ENG|Dysphagia (disorder)|
2169118|ENG|dysphagia|
2169119|ENG|Dysphagia|
2169120|ENG|DYSPHAGIA|
2169129|ENG|Dysphagia (R13)|
2171623|ENG|Ear conditions|
2171661|ENG|Ear Disease|
2171662|ENG|Ear Diseases|
2171666|ENG|ear disorder|
2171668|ENG|Ear disorder|
2171670|ENG|Ear Disorder|
2171674|ENG|Ear disorder NOS|
2171681|ENG|Ear Disorders|
2172313|ENG|Early satiety|
2174640|ENG|EC|
2176287|ENG|echography|
2177591|ENG|economics|
2177768|ENG|Ecotrin|
2180083|ENG|ED|
2180650|ENG|EDPPC cpd|
2181249|ENG|education|
2181399|ENG|EDUC|
2184037|ENG|EH|
218748|ENG|integumentary disease|
218918|ENG|Intellectual Properties|
218919|ENG|Intellectual Property|
2192303|ENG|(131)I-MAA|
2192525|ENG|(131)I-Macroaggregated Albumin|
2193521|ENG|embryology|
2194254|ENG|EM|
2194811|ENG|Emesis bloody|
2195815|ENG|Empirin|
2198483|ENG|encopresis|
2198484|ENG|Encopresis|
2198485|ENG|ENCOPRESIS|
2198488|ENG|Encopresis NOS|
2198489|ENG|Encopresis of nonorganic origin|
2200109|ENG|Endocrine disease|
2200110|ENG|Endocrine Disease|
2200112|ENG|Endocrine Diseases|
2200130|ENG|endocrine disorder|
2200132|ENG|Endocrine disorder|
2200133|ENG|Endocrine Disorder|
2200134|ENG|ENDOCRINE DISORDER|
2200144|ENG|Endocrine disorder NOS|
2200157|ENG|Endocrine disorders|
2200162|ENG|Endocrine disorder, unspecified|
2200166|ENG|Endocrine disturbance|
2200168|ENG|Endocrine disturbance NOS|
2200328|ENG|ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES, AND IMMUNITY DISORDERS|
2200330|ENG|Endocrine, nutritional and metabolic diseases|
2200336|ENG|Endocrine, nutritional, metabolic and immunity disorders|
2200338|ENG|Endocrine, nutritional, metabolic and immunity disorders (navigational concept)|
2200391|ENG|ENDOCRINE PROBLEM|
2200393|ENG|ENDOCRINE PROBLEM, NOS|
2200452|ENG|Endocrine system disease|
2200453|ENG|Endocrine System Disease|
2200454|ENG|Endocrine System Diseases|
2200530|ENG|Endocrinopathy|
2205331|ENG|EN|
2205636|ENG|1,3,3-trimethyl-4-phenyl-1,2,3,6-tetrahydropyridine|
2208197|ENG|Entericin|
2209224|ENG|Enteropathies, Gluten|
2209225|ENG|Enteropathies, Gluten-Sensitive|
2209256|ENG|enteropathy|
2209257|ENG|Enteropathy|
2209261|ENG|Enteropathy, Gluten|
2209263|ENG|Enteropathy, Gluten-Sensitive|
221393|ENG|interactive multimedia|
2223448|ENG|6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-|
2224614|ENG|6H-Purine-6-thione, 1,7-dihydro- (9CI)|
2224625|ENG|6H-Purine-6-thione, 1,7-dihydro-|
2226859|ENG|6 hydroxydopamine|
2226870|ENG|6 Hydroxydopamine|
2226881|ENG|6-hydroxydopamine|
2226892|ENG|6-Hydroxydopamine|
2229866|ENG|enzyme deficiency|
2229868|ENG|ENZYME DEFICIENCY|
2230243|ENG|enzymes|
2230584|ENG|eosinophilia|
2230585|ENG|Eosinophilia|
2230605|ENG|Eosinophilias|
2230645|ENG|Eosinophilic disorder (disorder)|
2230646|ENG|Eosinophilic disorder|
2230647|ENG|Eosinophilic disorders|
2230743|ENG|Eosinophilic leukocytosis|
2230836|ENG|6 mercaptopurine|
2230847|ENG|6 Mercaptopurine|
2230860|ENG|6-mercaptopurine|
2230871|ENG|6-Mercaptopurine|
2230882|ENG|6 Mercaptopurine Monohydrate|
2230893|ENG|6-Mercaptopurine Monohydrate|
2231543|ENG|EP|
2233657|ENG|epidemiology|
2234958|ENG|6 MP|
2234970|ENG|6-MP|
2234981|ENG|6MP|
2235003|ENG|6MP - Mercaptopurine|
2238169|ENG|6 OHDA|
2238180|ENG|6-OHDA|
2241822|ENG|EPTP|
2241982|ENG|6-Purinethiol|
2243536|ENG|Ercalcidiol|
2244448|ENG|6 Thiohypoxanthine|
2244459|ENG|6-Thiohypoxanthine|
2244537|ENG|6 thiopurine|
2244548|ENG|6 Thiopurine|
2244559|ENG|6-Thiopurine|
2244637|ENG|6-Thioxopurine|
2244986|ENG|Ergothioneine|
2251618|ENG|ES|
2252129|ENG|esophageal cancer|
2252130|ENG|Esophageal cancer|
2252131|ENG|Esophageal Cancer|
2252136|ENG|Esophageal cancer NOS|
2252146|ENG|Esophageal Cancers|
2252220|ENG|Esophageal discomfort|
2252221|ENG|Esophageal Disease|
2252222|ENG|Esophageal disease NOS|
2252223|ENG|Esophageal Diseases|
2252224|ENG|esophageal disorder|
2252225|ENG|Esophageal disorder|
2252227|ENG|Esophageal Disorder|
2252228|ENG|ESOPHAGEAL DISORDER|
2252229|ENG|Esophageal disorder NOS|
2252231|ENG|Esophageal disorders|
2252264|ENG|ESOPHAGEAL|
2252313|ENG|Esophageal hiatal hernia|
2252325|ENG|Esophageal hiatus hernia|
2252377|ENG|Esophageal malignant tumor|
2252434|ENG|Esophageal neoplasms malignant|
2252507|ENG|Esophageal reflux|
2252508|ENG|Esophageal Reflux|
2252509|ENG|ESOPHAGEAL REFLUX|
2252651|ENG|Esophageal, stomach and duodenal diseases (disorder)|
2252652|ENG|Esophageal, stomach and duodenal diseases|
2253160|ENG|esophagus cancer|
2253161|ENG|Esophagus Cancer|
2253165|ENG|Esophagus Cancers|
2253197|ENG|esophagus disorder|
2253198|ENG|Esophagus Disorders|
2253209|ENG|Esophagus|
2257615|ENG|eszopiclone|
2257908|ENG|ET|
2258400|ENG|Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-|
2258449|ENG|Ethanaminium, 2-mercapto-N,N,N-trimethyl-|
2258548|ENG|ethanesulfonic acid, 2,2'-dithiobis-|
2258564|ENG|Ethanesulfonic acid, 2-amino-|
2258570|ENG|Ethanesulfonic acid, 2-mercapto-, monosodium salt|
2258697|ENG|Ethanol, 2-mercapto-|
2259846|ENG|ethics|
2260868|ENG|ethnology|
2263501|ENG|etiology|
226402|ENG|Internal hernia|
2264166|ENG|etoposide/ifosfamide/mesna|
2264167|ENG|Etoposide/Ifosfamide/Mesna|
2264168|ENG|etoposide/ifosfamide/mesna/mitoxantrone|
2264170|ENG|Etoposide/Ifosfamide/Mesna/Mitoxantrone|
2264171|ENG|etoposide/ifosfamide/mesna/topotecan|
2264173|ENG|Etoposide/Ifosfamide/Mesna/Topotecan|
2270950|ENG|Evidence, Levels of|
2272557|ENG|Excessive eating|
2272559|ENG|Excessive eating - polyphagia|
2272560|ENG|Excessive eating - polyphagia (finding)|
227284|ENG|International Classification of Diseases|
227285|ENG|International Classification of Diseases for Oncology (ICD)|
227286|ENG|International Classification of Primary Care, 1993|
227287|ENG|International Classification of Primary Care|
227343|ENG|International Statistical Classification of Diseases and Related Health Problems|
227344|ENG|International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)|
2274193|ENG|7-Mercapto-1,3,4,6-tetrazaindene|
2278595|ENG|Exosurf Neonatal|
2278878|ENG|Expectorant agent|
2278879|ENG|Expectorant agent (product)|
2278880|ENG|Expectorant agent (substance)|
2278896|ENG|expectorant|
2278897|ENG|Expectorant|
2278898|ENG|expectorant/mucolytic|
2278907|ENG|Expectorants|
2280106|ENG|Exposed|
2280109|ENG|Exposed to|
2280170|ENG|exposure|
2280359|ENG|Exposure to (contextual qualifier) (qualifier value)|
2280389|ENG|Exposure to|
2281874|ENG|External causes of morbidity and mortality|
2284930|ENG|Extravasation blood|
2284949|ENG|Extravasation of blood|
2285215|ENG|Extren|
2285884|ENG|Eye Disease|
2285888|ENG|Eye Diseases|
2285895|ENG|eye disorder|
2285897|ENG|Eye disorder|
2285898|ENG|Eye Disorder|
2285899|ENG|EYE DISORDER|
2285906|ENG|Eye disorder NOS|
2285912|ENG|Eye disorders|
2285978|ENG|Eye|
2288024|ENG|Fabrol|
2289939|ENG|Factors influencing health status and contact with health services|
2290770|ENG|Faecal incontinence|
2290771|ENG|Faecal incontinence not due to organic disease|
2290772|ENG|Faecal incontinence (R15)|
2291291|ENG|8 Aminonaphthalene|
2291303|ENG|8-Aminonaphthalene|
2294139|ENG|familial hepatitis|
229441|ENG|intestinal cancer|
229442|ENG|Intestinal cancer|
229443|ENG|Intestinal Cancer|
229445|ENG|Intestinal Cancers|
229508|ENG|Intestinal disease|
229509|ENG|Intestinal Disease|
229511|ENG|Intestinal Diseases|
229513|ENG|intestinal disorder|
229514|ENG|Intestinal Disorder|
2296166|ENG|Family history of digestive disorders|
2296169|ENG|Family history of diseases of the digestive system|
229711|ENG|Intestinal infection|
229716|ENG|Intestinal infections|
229717|ENG|Intestinal infectious disease (disorder)|
229718|ENG|Intestinal infectious disease|
229719|ENG|Intestinal infectious diseases|
229720|ENG|INTESTINAL INFECTIOUS DISEASES|
229768|ENG|intestinal malabsorption|
229843|ENG|Intestinal Neoplasms, Malignant|
229855|ENG|Intestinal obstruction (disorder)|
229861|ENG|intestinal obstruction|
229862|ENG|Intestinal obstruction|
229863|ENG|Intestinal Obstruction|
229864|ENG|INTESTINAL OBSTRUCTION|
229869|ENG|Intestinal obstruction NOS|
229874|ENG|Intestinal Obstructions|
229880|ENG|Intestinal occlusion|
230067|ENG|Intestinal Tumors, Malignant|
230143|ENG|intestine disorder|
230166|ENG|intestine obstruction|
230176|ENG|Intestines Cancer|
230177|ENG|Intestines Cancers|
2302740|ENG|FDA|
230307|ENG|Intolerance, Lactose|
230314|ENG|Intolerance or malabsorption of lactose|
230366|ENG|Intoxication by drug|
2303880|ENG|fecal incontinence|
2303882|ENG|Fecal incontinence|
2303883|ENG|Fecal Incontinence|
2303884|ENG|FECAL INCONTINENCE|
2303885|ENG|Fecal incontinence not due to organic disease|
2303886|ENG|Fecal Incontinences|
2304153|ENG|Feces Incontinence|
2304156|ENG|Feces incontinence of|
230491|ENG|Intra-abdominal hernia (disorder)|
230492|ENG|Intra-abdominal hernia|
2306182|ENG|Felty's syndrome (disorder)|
2306183|ENG|Felty's syndrome|
2306184|ENG|Felty's Syndrome|
2306185|ENG|Feltys Syndrome|
2306186|ENG|FELTYS SYNDROME|
2306187|ENG|Felty Syndrome|
2310081|ENG|1,3-DG-2-P|
2312237|ENG|9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol, (3beta,5Z,7E,22E)-|
2312248|ENG|9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol|
2315144|ENG|Fetor ex ore|
2315145|ENG|Fetor hepaticus|
2315146|ENG|Fetor hepaticus (finding)|
2315148|ENG|Fetor oris|
2323982|ENG|File|
2324004|ENG|Filesna|
2324212|ENG|Filing|
2324218|ENG|Filings|
2325046|ENG|Finding by site|
2325048|ENG|Finding by site (finding)|
2326256|ENG|Finding of hiccoughs|
2332888|ENG|Fistula, Digestive System|
2332899|ENG|fistula|
2332900|ENG|Fistula|
2332901|ENG|FISTULA|
2333029|ENG|Fistula (morphologic abnormality)|
2333038|ENG|Fistula NOS|
2333249|ENG|Fistulas, Digestive System|
2333251|ENG|Fistulas|
2333500|ENG|Fistulous tract|
233503|ENG|Intraperitoneal hernia|
2338845|ENG|Flocofil|
2340015|ENG|Fluatox|
2341650|ENG|Fluimucetin|
2341651|ENG|Fluimucil|
2345777|ENG|Fluprowit|
2347636|ENG|1,3-dipalmitoyl-2-phosphatidylcholine|
2348191|ENG|1,3-dipalmitoyl-glycero-2-phosphocholine|
2348559|ENG|Foetor hepaticus|
2351533|ENG|food borne disease|
2351534|ENG|food borne disorder|
2356382|ENG|forms of communication|
2356383|ENG|Forms of Communication|
2357014|ENG|AA|
2357758|ENG|Foul breath|
2369214|ENG|Abdomen, Acute|
2370036|ENG|abdomen|
2370047|ENG|Abdomen|
2370058|ENG|ABDOMEN|
2370165|ENG|Functional bowel disease|
2370167|ENG|Functional bowel syndrome|
2370206|ENG|Functional digestive disorders, not elsewhere classified|
2370251|ENG|functional encopresis|
2370253|ENG|Functional encopresis|
2371169|ENG|Abdomen mimicking acute|
2371225|ENG|Abdomen, NOS|
237176|ENG|Involuntary stool|
2372047|ENG|Abdomens, Acute|
2372136|ENG|Abdomens|
2372735|ENG|Abdomen (volume)|
2373114|ENG|Abdominal and pelvic pain|
2373125|ENG|Abdominal and pelvic pain (R10)|
2375081|ENG|Abdominal discoloration - around umbilicus|
2375092|ENG|Abdominal discolouration - around umbilicus|
2375103|ENG|Abdominal discomfort|
2375114|ENG|Abdominal discomfort (finding)|
2376003|ENG|Abdominal hernia|
2376014|ENG|Abdominal Hernia|
2376025|ENG|Abdominal hernia NOS|
2376103|ENG|Abdominal Hernias|
2376125|ENG|Abdominal herniation|
2377736|ENG|abdominal pain|
2377759|ENG|Abdominal pain|
2377770|ENG|Abdominal Pain|
2377781|ENG|ABDOMINAL PAIN|
2377803|ENG|Abdominal pain (finding)|
2377836|ENG|Abdominal pain generalised|
2377847|ENG|Abdominal pain generalized|
2377859|ENG|Abdominal pain, generalized|
2377992|ENG|Abdominal pain NOS|
2378003|ENG|ABDOMINAL PAIN NOS|
2378081|ENG|Abdominal Pains|
2378147|ENG|Abdominal pain, unspecified site|
2378169|ENG|Abdominal pain upper|
2378995|ENG|gallbladder cancer|
2378996|ENG|Gallbladder cancer|
2378997|ENG|Gallbladder Cancer|
2379011|ENG|Gallbladder Cancers|
2379033|ENG|Gall bladder carcinoma (adenocarcinoma)|
2379034|ENG|Gallbladder carcinoma|
2379035|ENG|Gallbladder Carcinoma|
2379037|ENG|GALLBLADDER CARCINOMA|
2379077|ENG|Gall Bladder Disease|
2379078|ENG|Gallbladder disease|
2379079|ENG|Gallbladder Disease|
2379083|ENG|Gallbladder disease NOS|
2379084|ENG|Gall Bladder Diseases|
2379085|ENG|Gallbladder Diseases|
2379086|ENG|gallbladder disorder|
2379087|ENG|Gallbladder disorder|
2379088|ENG|Gallbladder Disorder|
2379089|ENG|Gallbladder disorder NOS|
2379090|ENG|Gallbladder disorders|
2379115|ENG|Gall Bladder|
2379739|ENG|Gallstones|
2379836|ENG|Abdominal structure (body structure)|
2379847|ENG|Abdominal structure|
2379981|ENG|Abdominal symptom NOS|
2380003|ENG|Abdominal syndrome acute|
2380612|ENG|gamma Carboxyglutamic Acid|
2380614|ENG|gamma-Carboxyglutamic Acid|
2381691|ENG|Abdominopelvic region|
2381702|ENG|Abdominopelvis|
2382047|ENG|Abdo pain|
2382069|ENG|Abd. pain|
2384569|ENG|AB|
2384944|ENG|Gas|
2385743|ENG|gastric cancer|
2385744|ENG|Gastric cancer|
2385745|ENG|Gastric Cancer|
2385746|ENG|GASTRIC CANCER|
2385756|ENG|Gastric cancer, NOS|
2385787|ENG|Gastric carcinoma|
2385788|ENG|Gastric Carcinoma|
2385789|ENG|GASTRIC CARCINOMA|
2385884|ENG|Gastric Disease|
2385885|ENG|Gastric Diseases|
2385886|ENG|gastric disorder|
2385887|ENG|Gastric disorder|
2387179|ENG|Gastrocardiac syndrome|
2387318|ENG|gastroduodenal ulcer|
2387319|ENG|Gastroduodenal ulcer|
2387320|ENG|Gastroduodenal Ulcer|
2387322|ENG|Gastroduodenal Ulcers|
2387364|ENG|Gastroenteric fistula|
2387367|ENG|Gastroenteritides|
2387387|ENG|Gastroenteritis (disorder)|
2387390|ENG|gastroenteritis|
2387392|ENG|Gastroenteritis|
2387393|ENG|GASTROENTERITIS|
2387407|ENG|Gastroenteritis non-infectious NOS|
2387412|ENG|Gastroenteritis NOS|
2387499|ENG|Gastroenteropathy|
2387500|ENG|Gastroenteropathy NOS|
2387545|ENG|Gastroesophageal reflux disease (disorder)|
2387546|ENG|gastroesophageal reflux disease|
2387547|ENG|Gastro-esophageal reflux disease|
2387549|ENG|Gastroesophageal reflux disease|
2387550|ENG|Gastroesophageal Reflux Disease|
2387551|ENG|GASTROESOPHAGEAL REFLUX DISEASE|
2387563|ENG|gastroesophageal reflux|
2387565|ENG|Gastro Esophageal Reflux|
2387566|ENG|Gastro-esophageal reflux|
2387567|ENG|Gastro-Esophageal Reflux|
2387568|ENG|Gastroesophageal reflux|
2387569|ENG|Gastroesophageal Reflux|
2387571|ENG|GASTROESOPHAGEAL REFLUX|
2387626|ENG|gastrointestinal absorption disorder|
2387673|ENG|Gastrointestinal and digestive disorder|
2387674|ENG|Gastrointestinal and digestive injury (disorder)|
2387675|ENG|Gastrointestinal and digestive injury|
2387685|ENG|Gastrointestinal anomaly|
2387718|ENG|Gastro intestinal bleed|
2387719|ENG|Gastrointestinal bleed|
2387721|ENG|Gastro intestinal bleeding|
2387722|ENG|Gastrointestinal bleeding|
2387723|ENG|Gastrointestinal Bleeding|
2387724|ENG|GASTROINTESTINAL BLEEDING|
2387744|ENG|Gastrointestinal Body System|
2387752|ENG|gastrointestinal cancer|
2387753|ENG|Gastrointestinal Cancer|
2387756|ENG|Gastrointestinal cancer, NOS|
2387757|ENG|Gastrointestinal Cancers|
2387810|ENG|Gastrointestinal Disease|
2387813|ENG|Gastrointestinal Diseases|
2387817|ENG|gastrointestinal disorder diagnosis|
2387818|ENG|gastrointestinal disorder|
2387820|ENG|Gastrointestinal disorder|
2387821|ENG|Gastrointestinal Disorder|
2387823|ENG|Gastro-intestinal disorder NOS|
2387824|ENG|Gastrointestinal disorder NOS|
2387828|ENG|Gastrointestinal disorders|
2387874|ENG|Gastrointestinal fistula (disorder)|
2387875|ENG|Gastrointestinal fistulae|
2387877|ENG|Gastrointestinal fistula|
2387902|ENG|gastrointestinal gas|
2387905|ENG|Gastrointestinal haemorrhage|
2387906|ENG|Gastrointestinal haemorrhage NOS|
2387907|ENG|Gastrointestinal haemorrhages|
2387910|ENG|Gastrointestinal haemorrhage, unspecified|
2387912|ENG|Gastrointestinal hemorrhage (disorder)|
2387913|ENG|gastrointestinal hemorrhage|
2387916|ENG|Gastrointestinal hemorrhage|
2387917|ENG|Gastrointestinal Hemorrhage|
2387918|ENG|GASTROINTESTINAL HEMORRHAGE|
2387919|ENG|Gastrointestinal hemorrhage NOS|
2387921|ENG|Gastrointestinal hemorrhages|
2387922|ENG|Gastrointestinal Hemorrhages|
2387927|ENG|Gastrointestinal hemorrhage, unspecified|
2387968|ENG|gastrointestinal infection|
2387972|ENG|Gastrointestinal infection|
2387973|ENG|Gastrointestinal Infection|
2387975|ENG|Gastrointestinal infection NOS|
2387977|ENG|Gastrointestinal infections|
2388013|ENG|Gastrointestinal malformation NOS|
2388061|ENG|Gastrointestinal neoplasm malignant|
2388091|ENG|Gastrointestinal Organ System|
2388097|ENG|Gastrointestinal pain|
2388099|ENG|Gastrointestinal pain NOS|
2388159|ENG|Gastrointestinal signs and symptoms NEC|
2388248|ENG|gastrointestinal system|
2388249|ENG|Gastrointestinal system|
2388250|ENG|Gastrointestinal System|
2388251|ENG|GASTROINTESTINAL SYSTEM|
2388252|ENG|Gastrointestinal System Finding|
2388286|ENG|Gastrointestinal tract anomaly NOS|
2388290|ENG|Gastro-intestinal tract bleed|
2388292|ENG|Gastrointestinal tract bleed NOS|
2388294|ENG|Gastrointestinal Tract Cancer|
2388295|ENG|Gastrointestinal tract cancer NOS|
2388296|ENG|Gastrointestinal Tract Cancers|
2388706|ENG|Gastro-oesophageal reflux disease|
2388707|ENG|Gastrooesophageal reflux disease|
2388715|ENG|Gastro oesophageal Reflux|
2388716|ENG|Gastro-oesophageal reflux|
2388717|ENG|Gastro-oesophageal Reflux|
2388718|ENG|Gastrooesophageal reflux|
2388746|ENG|Gastropathy|
2391150|ENG|GD|
2391548|ENG|GDU|
2391690|ENG|GE|
2391744|ENG|GE - Gastroenteritis|
239319|ENG|IO - Intestinal obstruction|
2393810|ENG|Gene Ontology|
2393925|ENG|General abdominal pain-symptom|
2393936|ENG|General adjectival modifier|
2393937|ENG|General adjectival modifier (qualifier value)|
2394109|ENG|general concepts of health and disease|
2394163|ENG|General drug type|
2394164|ENG|General drug type (product)|
2394334|ENG|Generalised abdominal pain|
2394453|ENG|Generalised metabolic disorder|
2394564|ENG|Generalized abdominal pain|
2394565|ENG|Generalized abdominal pain (finding)|
2394833|ENG|Generalized metabolic disorder (disorder)|
2394834|ENG|Generalized metabolic disorder|
2396194|ENG|Genetic Condition|
2396252|ENG|Genetic disease|
2396267|ENG|genetic disorder|
2396269|ENG|Genetic Disorder|
2396278|ENG|Genetic Disorders|
2396502|ENG|genetics|
2397013|ENG|genital disorder|
2397017|ENG|Genital Disorders|
2397497|ENG|genitourinary disorder|
2402270|ENG|GERD|
2402284|ENG|GER|
2405639|ENG|GI bleed|
2405640|ENG|GI bleeding|
2405641|ENG|GI Bleeding|
2405920|ENG|GI - Gastrointestinal bleed|
2405921|ENG|GI - Gastrointestinal haemorrhage|
2405922|ENG|GI - Gastrointestinal hemorrhage|
2405943|ENG|GI haemorrhage|
2405944|ENG|GI hemorrhage|
2405945|ENG|GI HEMORRHAGE|
2405947|ENG|GIH - Gastrointestinal haemorrhage|
2405948|ENG|GIH - Gastrointestinal hemorrhage|
2405958|ENG|GI infection|
2406229|ENG|GI malformation|
2406275|ENG|GI neoplasm malignant|
2406751|ENG|Gingivostomatitis (disorder)|
2406753|ENG|Gingivostomatitis|
2406754|ENG|GINGIVOSTOMATITIS|
2407319|ENG|GI pain|
2407625|ENG|HEM|
2407708|ENG|IFF/MSA/TOPO/VP-16|
2407709|ENG|IFF/MSA/VP-16|
2408964|ENG|VIT-B6|
2409205|ENG|BCNU/CTX/MSA/VP-16|
2409517|ENG|CBDCA/G-CSF/IFF/MSA|
2409521|ENG|CBDCA/IFF/MSA|
2409617|ENG|CDDP/IFF/MSA/MITO|
2410186|ENG|DHAD/IFF/MSA|
2410188|ENG|DHAD/IFF/MSA/VP-16|
2410273|ENG|DOX/DTIC/IFF/MSA|
241307|ENG|IP|
242529|ENG|IR|
243617|ENG|iron accumulation disorders|
244895|ENG|iron storage disease|
244896|ENG|Iron storage disease|
244897|ENG|iron storage disorder|
24546|ENG|GORD - Gastro-esophageal reflux disease|
24547|ENG|GORD - Gastro-oesophageal reflux disease|
245830|ENG|Irritable bowel|
245833|ENG|irritable bowel syndrome|
245835|ENG|Irritable bowel syndrome|
245836|ENG|Irritable Bowel Syndrome|
245837|ENG|IRRITABLE BOWEL SYNDROME|
245839|ENG|Irritable Bowel Syndromes|
245855|ENG|irritable colon|
245856|ENG|Irritable colon|
245857|ENG|Irritable Colon|
245858|ENG|Irritable colon syndrome|
245859|ENG|Irritable Colon Syndrome|
2458900|ENG|MDBCAC|
2459120|ENG|XZ-450|
2459374|ENG|1,7-Dihydro-6H-purine-6-thione Monohydrate|
2459614|ENG|beta-Pyridyl-alpha-N-methylpyrrolidine|
2459638|ENG|1-Methyl-2-(3-pyridyl)pyrrolidine|
2459657|ENG|BioCarta|
2460231|ENG|2,4,5-Trihydroxyphenethylamine|
2460477|ENG|2-Mercaptoethanesulfonic Acid Sodium Salt|
2460602|ENG|(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentade|
2461204|ENG|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone|
2461797|ENG|Digestive System Disorder|
2461838|ENG|Disease, Disorder or Finding|
2463206|ENG|Gluten-Induced Enteropathy|
2463231|ENG|GO Ontology|
2463427|ENG|Hematologic and Lymphocytic Disorder|
2463493|ENG|HI|
2463863|ENG|INJ|
2464073|ENG|JAX|
2464115|ENG|KEGG|
2464118|ENG|KEGG Pathway Database|
2464737|ENG|Medical Dictionary for Regulatory Activities|
2464751|ENG|ME|
2465202|ENG|National Cancer Institute Thesaurus|
2465226|ENG|NCI Developmental Therapeutics Program|
2465227|ENG|NCI|
2465484|ENG|N-methyl-11-aza-10-deoxy-10-dihydroerythromycin A|
2465611|ENG|Non Tropical Sprue|
2465786|ENG|Oral Tablet Dosage Form|
2465787|ENG|Oral Tablet Dose Form|
2467048|ENG|(S)-3-(1-Methyl-2-pyrrolidinyl)pyridine|
2468106|ENG|TO|
2468407|ENG|U.S. Centers for Disease Control and Prevention|
2468408|ENG|US Department of Veterans Affairs National Drug Formulary Reference Terminology|
2468417|ENG|US Veterans' Administration National Drug Formulary Reference Terminology|
2468419|ENG|UT|
2468703|ENG|ICDO|
2468709|ENG|International Classification of Disease for Oncology (ICD)|
2468718|ENG|BioC|
247006|ENG|IS|
2470454|ENG|CBO|
2471021|ENG|Clinical Bioinformatics Ontology|
247324|ENG|Islands of Langerhans Transplantation|
247330|ENG|Islands of Pancreas Transplantation|
24738|ENG|GOR - Gastro-esophageal reflux|
24740|ENG|GOR - Gastro-oesophageal reflux|
247464|ENG|Islet Cell Transplantation|
247465|ENG|Islet cell transplant|
247466|ENG|Islet cell transplant (procedure)|
247506|ENG|islets of Langerhans transplantation|
247507|ENG|Islets of Langerhans Transplantation|
247511|ENG|Islets Transplantation, Pancreatic|
247513|ENG|Islet Transplantation|
247514|ENG|Islet Transplantations|
2475383|ENG|Tropimil|
2475491|ENG|UL|
247555|ENG|Ismipur|
2475804|ENG|Atazanavir Sulfate|
2475846|ENG|BAL in Oil|
2476210|ENG|2,3-Dimercapto-1-propanol|
2476394|ENG|2-Mercaptoethanesulfonate, Sodium Salt|
2476513|ENG|Colfosceril Palmitate|
2477843|ENG|Grading System|
2478558|ENG|l-Picamide|
2478795|ENG|1,2-Dipalmitoyl-sn-glycero-3-phosphocholine|
2478811|ENG|1,2-Dithioglycerol|
2479415|ENG|N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide|
2479454|ENG|Adverse Event Classification|
2480726|ENG|Published|
2480755|ENG|(R)-(4-Oxido-10-oxo-7-palmitoyl-3,5,9-trioxa-4-phosphapentacosyl)trimethylammonium 4-Oxide|
2480951|ENG|Ro 1-7683|
2481023|ENG|Schedule of Controlled Substances|
2481180|ENG|SOP|
2481296|ENG|Structured Product Labeling and Drug Enforcement Administration Schedule of Controlled Substances|
2481304|ENG|Sublingual Route of Administration|
2481989|ENG|755|
2482460|ENG|19767-45-4|
2482520|ENG|24850|
2482526|ENG|25232|
2482606|ENG|113891|
2482734|ENG|406186|
2482816|ENG|50-44-2|
2482821|ENG|50-78-2|
2482835|ENG|1226|
2482962|ENG|6112-76-1 (monohydrate)|
2483032|ENG|TOAST Classification|
2483033|ENG|TOAST|
2483037|ENG|Trial of ORG 10172 in Acute Stroke Treatment Classification|
2483153|ENG|CDISC|
2483166|ENG|Clinical Data Interchange Standards Consortium|
2483206|ENG|DICOM|
2483309|ENG|Ischemic Stroke Subtype Classification|
2483839|ENG|MDBCAC2005_12|
2483869|ENG|Standard Toxicity Grade|
2484040|ENG|Systematized Nomenclature of Medicine Clinical Terms|
2484175|ENG|Thesaurus of Adverse Reaction Term Coding Symbols|
2484225|ENG|Tissue Degeneration|
2484342|ENG|Transplantation of Liver|
2485559|ENG|Coding Symbols for a Thesaurus of Adverse Reaction Terms|
2485585|ENG|Common Toxicity Criteria for Adverse Events|
2485699|ENG|COSTART|
2485744|ENG|CTCAE Grades|
2486207|ENG|ENDOCRINE DISORDERS|
2486663|ENG|GASTROINTESTINAL DISORDERS|
2487068|ENG|ICD|
2487144|ENG|Immuno-Deficiency|
2487210|ENG|Infection, Viral|
2487668|ENG|Logical Observation Identifiers Names and Codes|
2489063|ENG|Radiation Sickness Syndrome|
2491959|ENG|NCI Metathesaurus|
2491960|ENG|NCIMTH|
249546|ENG|ISOL|
250382|ENG|Acetic Acid|
250525|ENG|Isonicotinic Acids|
252160|ENG|Acetic Acids|
254649|ENG|ITP regimen|
25501|ENG|Gowers' chorea|
255038|ENG|IVADIC regimen|
257598|ENG|Jaundiced|
257616|ENG|jaundice|
257617|ENG|Jaundice|
257618|ENG|JAUNDICE|
257669|ENG|Jaundice (finding)|
257708|ENG|Jaundice NOS|
258351|ENG|Jejunal syndrome|
260057|ENG|Joint, Charcot's|
260174|ENG|Joint disease|
260175|ENG|Joint Disease|
260178|ENG|joint diseases|
260179|ENG|Joint Diseases|
260198|ENG|joint disorder|
260200|ENG|Joint disorder|
260201|ENG|Joint Disorder|
260203|ENG|Joint disorder NOS|
260230|ENG|Joint disorders|
260235|ENG|Joint disorder, unspecified|
260236|ENG|Joint dysfunction|
260280|ENG|Joint finding|
260281|ENG|Joint finding (finding)|
260447|ENG|Joint observation|
267581|ENG|acetylcoenzyme M|
269648|ENG|acetylcysteine|
269659|ENG|Acetyl cysteine|
269671|ENG|Acetylcysteine|
269682|ENG|ACETYLCYSTEINE|
269949|ENG|Acetylcysteine Inpharzam Brand|
270338|ENG|Acetylcysteine (product)|
270371|ENG|Acetylcysteine Roberts Brand|
270449|ENG|Acetylcysteine (substance)|
270493|ENG|Acetylcysteine Thiemann Brand|
270593|ENG|Acetylcysteine UPSA Brand|
270626|ENG|Acetylcysteine Zambon Brand|
270648|ENG|Acetylcysteine Zyma Brand|
272937|ENG|Acetylin|
275537|ENG|acetylsalicylic acid|
275548|ENG|Acetylsalicylic acid|
275560|ENG|Acetylsalicylic Acid|
275614|ENG|Kinnier Wilson Disease|
275616|ENG|Kinnier-Wilson disease|
275617|ENG|Kinnier-Wilson Disease|
275618|ENG|Kinnier-Wilson Diseases|
278588|ENG|Knowledge|
27883|ENG|Abnormalities, Digestive System|
28405|ENG|Abnormality, Digestive System|
287636|ENG|Acid, 3-Mercaptopropanoic|
287647|ENG|Acid, 3-Mercaptopropionic|
287926|ENG|Acid, Acetylsalicylic|
290865|ENG|Lactose intolerance (disorder)|
290866|ENG|lactose intolerance|
290868|ENG|Lactose intolerance|
290869|ENG|Lactose Intolerance|
290871|ENG|LACTOSE INTOLERANCE|
290876|ENG|Lactose intolerance, unspecified|
290884|ENG|Lactose malabsorption|
290885|ENG|Lactose Malabsorption|
292298|ENG|L-Alpha-acetamido-beta-mercaptopropionic Acid|
296148|ENG|Acid, Mercapturic|
297116|ENG|L-arginine mono(2-mercaptoethanesulfonate)|
300537|ENG|Late onset immunoglobulin deficiency|
301615|ENG|Acid reflux|
301626|ENG|Acid Reflux|
301848|ENG|Acids, Acetic|
303092|ENG|Acids, Isonicotinic|
303293|ENG|Acids, Nicotinic|
303782|ENG|Acids, Picolinic|
303937|ENG|Acids, Quinolinic|
304902|ENG|Lauryl Sulfate, Sodium|
306182|ENG|L Cysteine|
306183|ENG|L-Cysteine|
306204|ENG|L-Cysteine, N-acetyl-|
306528|ENG|LD - Liver disease|
308843|ENG|lecithin|
308844|ENG|Lecithin|
308845|ENG|LECITHIN|
309024|ENG|Lecithin product|
309025|ENG|Lecithin product (product)|
309067|ENG|Lecithins|
319510|ENG|Lenticular Degeneration, Progressive|
327322|ENG|Leukerin|
328115|ENG|Acquired Agammaglobulinemia|
328171|ENG|Leukoplakia and other disturbances of oral epithelium, including tongue|
328240|ENG|Leukoplakia of oral mucosa, incl tongue|
328241|ENG|Leukoplakia of oral mucosa, including tongue|
328817|ENG|Leupurin|
329323|ENG|Level of Evidence|
329513|ENG|Levels of Evidence|
333466|ENG|Library Science|
333467|ENG|Library Sciences|
334783|ENG|Acquired hypogammaglobulinaemia|
334794|ENG|Acquired hypogammaglobulinemia|
34037|ENG|Grafting, Islets of Langerhans|
34040|ENG|Grafting, Liver|
34168|ENG|Grafting, Pancreas|
34183|ENG|Graftings, Liver|
34186|ENG|Graftings, Pancreas|
344526|ENG|Acridinium, 3,6-bis(dimethylamino)-10-(4-hydroxy-10-oxo-7-((1-oxohexadecyl)oxy)-3,5,9-trioxa-4-phosphapentacosan-1-yl)-, endo-(+-)-|
346300|ENG|List of epidemiology terms submitted by McMaster University, 1992|
346301|ENG|List of epidemiology terms submitted by McMaster University|
348285|ENG|liver cancer|
348286|ENG|Liver cancer|
348287|ENG|Liver Cancer|
348290|ENG|Liver, cancer of|
348314|ENG|Liver Cancers|
348373|ENG|Liver Cirrhoses|
348378|ENG|liver cirrhosis|
348380|ENG|Liver cirrhosis|
348381|ENG|Liver Cirrhosis|
348525|ENG|Liver disease|
348527|ENG|Liver Disease|
348528|ENG|LIVER DISEASE|
348545|ENG|Liver Diseases|
348556|ENG|Liver disease, unspecified|
348563|ENG|liver disorder|
348564|ENG|Liver disorder|
348565|ENG|Liver Disorder|
348578|ENG|Liver disorder NOS|
348870|ENG|Liver Grafting|
348872|ENG|Liver Graftings|
349322|ENG|liver transplantation|
349323|ENG|Liver transplantation|
349324|ENG|Liver Transplantation|
349325|ENG|Liver Transplantations|
349330|ENG|Liver transplant|
349331|ENG|LIVER TRANSPLANT|
349359|ENG|liver tumor or cancer|
350709|ENG|LM - Lactose malabsorption|
350968|ENG|LNC|
354742|ENG|Logical Observation Identifier Names and Codes|
354833|ENG|LOINC class types|
354834|ENG|LOINC|
354835|ENG|LOINC Root|
3567277|ENG|ENTEROCOLITIS, PSEUDOMEMBRANOUS, ACUTE|
3567807|ENG|enzymology|
3568039|ENG|epidemiologic|
3568747|ENG|abnormalities|
3570465|ENG|Eszopiclone|
3570469|ENG|Eszopiclone (product)|
3570470|ENG|Eszopiclone (substance)|
3570657|ENG|ethics qualifier|
3570931|ENG|ethnologic|
3571068|ENG|Etiology aspects|
3572142|ENG|EXTRAVASATION BLOOD|
3572344|ENG|EYE DISORDER (NOS)|
3572848|ENG|FAECAL INCONTINENCE|
3574440|ENG|FECES INCONTINENCE OF|
3574462|ENG|FECTOR HEPATICUS|
3574591|ENG|FELTY SYNDROME|
3575702|ENG|FETOR HEPATICUS|
3577108|ENG|Florisan N|
3579561|ENG|function|
3580152|ENG|GALLBLADDER CANCER, CARCINOMA|
3580153|ENG|GALLBLADDER, CARCINOMA|
3580154|ENG|GALL BLADDER DISORDER|
3580554|ENG|GASTRIC CANCER, CARCINOMA|
3580624|ENG|GASTROINTESTINAL ANOMALY|
3580631|ENG|GASTROINTESTINAL DISORDER|
3580632|ENG|GASTRO-INTESTINAL DISORDER NOS|
3580633|ENG|GASTROINTESTINAL DISORDER (NOS)|
3580634|ENG|GASTROINTESTINAL DISORDERS: GENERAL|
3580648|ENG|GASTROINTESTINAL TRACT BLEED (NOS)|
3580649|ENG|Gastrointestinal tract congenital anomaly|
3581111|ENG|Gene_Ontology|
3581180|ENG|genetic aspects|
3581260|ENG|GENITOURINARY DISORDERS|
3581839|ENG|GERD - Gastro-esophageal reflux disease|
3581840|ENG|GE REFLUX|
3582020|ENG|GI HAEMORRHAGE|
3582041|ENG|GI MALFORMATION|
3582055|ENG|GI NEOPLASM MALIGNANT|
3582100|ENG|GI PAIN|
3582296|ENG|GlaxoSmithKline Brand of 6 Mercaptopurine|
3582297|ENG|GlaxoSmithKline Brand of 6-Mercaptopurine|
3582337|ENG|Glaxo Wellcome Brand of 6 Mercaptopurine|
3582338|ENG|Glaxo Wellcome Brand of 6-Mercaptopurine|
3583357|ENG|GLUTEN INTOLERANCE|
3583870|ENG|GNASHING TOOTH|
3584865|ENG|GRINDING TOOTH|
3585086|ENG|Growth & development aspects|
3585088|ENG|growth & development|
3588555|ENG|HAEMORRHAGE NOS|
3590244|ENG|HEART BURN|
3590760|ENG|HEMATOLOGIC DISORDERS|
3591174|ENG|HEMORRHAGE GASTROINTESTINAL|
3591192|ENG|HEMORRHAGE (NOS)|
3591379|ENG|HEPATIC CIRRHOSIS|
3591382|ENG|HEPATIC DISEASE (NOS)|
3591383|ENG|HEPATIC DISORDER (NOS)|
3591406|ENG|HEPATIC NEOPLASM MALIGNANT|
3591574|ENG|HEPATITIS, INFECTIOUS|
3591583|ENG|HEPATITIS NONSPECIFIC|
3591589|ENG|HEPATITIS, SERUM|
3591611|ENG|hepatocerebral degeneration|
3591879|ENG|HERNIA HIATAL|
3591880|ENG|HERNIA, HIATUS|
3591903|ENG|Herniated structure|
3591904|ENG|Herniated structure (morphologic abnormality)|
3592360|ENG|HIATUS HERNIA|
3592377|ENG|HICCOUGHS|
3592378|ENG|HICCUP|
3592379|ENG|HICCUPS|
3592930|ENG|historical aspects|
3592931|ENG|Historical aspects qualifier|
3593119|ENG|HL7 Version 3.0|
3596978|ENG|HYPERPHAGIA|
3598535|ENG|IMMUNE DISORDER (NOS)|
3598590|ENG|IMMUNE SYSTEM DISORDER|
3598591|ENG|IMMUNE SYSTEM DISORDER (NOS)|
3598653|ENG|Immunoglobulin deficiency|
3598795|ENG|immunology aspects|
3599007|ENG|In Cerebrospinal Fluid|
3599142|ENG|INCONTINENCE FECAL|
3599660|ENG|infectivity|
3600410|ENG|injuries|
3600411|ENG|injurious effects|
3602649|ENG|INTESTINE, OBSTRUCTION|
3603032|ENG|In Urine|
3603806|ENG|IRON STORAGE DISEASE|
3603934|ENG|IRRITABLE BOWEL DISEASE|
3603936|ENG|IRRITABLE COLON SYNDROME|
3604051|ENG|ISO3166-2|
3604189|ENG|isolation & purification|
36053|ENG|Granuloma and granuloma-like lesions of oral mucosa|
3605346|ENG|JOINT ABNORMALITY|
3605359|ENG|JOINT DISEASE, NEUROPATHIC|
3605361|ENG|JOINT DISORDER|
3605364|ENG|Joint Disorders|
3605420|ENG|Jones Brand of Methimazole|
3606075|ENG|Kendrick Brand of Mesna|
360862|ENG|Lower gastrointestinal disorders|
3609209|ENG|legislation & jurisprudence|
3609355|ENG|LENTICULAR DEGENERATION, PROGRESSIVE|
3611796|ENG|administration & dosage|
3611816|ENG|LIVER CIRRHOSIS|
3611829|ENG|Liver diseases|
3611830|ENG|LIVER DISORDER|
3613078|ENG|Lunesta|
3613410|ENG|LYMPH NODES ENLARGED|
3614576|ENG|Malignant neoplasm of gastrointestinal tract|
3615074|ENG|MAN|
3615221|ENG|adverse effects|
3616063|ENG|MDNS|
3616215|ENG|mechanism of action qualifier|
3616491|ENG|Medical Subject Heading|
3616975|ENG|MELAENA|
3617080|ENG|Melena due to gastrointestinal hemorrhage (disorder)|
3617081|ENG|Melena due to gastrointestinal hemorrhage|
3618092|ENG|MeSH Headings|
3618097|ENG|Mesna 100 MG/ML [Mesnex]|
3618105|ENG|Mesna 400 MG [Mesnex]|
3618106|ENG|MESNA cell|
3618107|ENG|MESNA-cell|
3618109|ENG|Mesna Injectable Solution [Mesnex]|
3618110|ENG|Mesna Kendrick Brand|
3618111|ENG|Mesna Oral Tablet [Mesnex]|
3618112|ENG|Mesna Sanfer Brand|
3618208|ENG|Metabolic and Nutritional Disorders|
3618210|ENG|metabolic aspects|
3618220|ENG|METABOLIC DISORDERS|
3618221|ENG|METABOLIC DISORDERS: GENERAL|
3618335|ENG|metastatic qualifier|
3618677|ENG|methods|
3619617|ENG|Métopirone|
3619814|ENG|Metyrapone Alliance Brand|
3619815|ENG|Metyrapone Novartis Brand|
3620172|ENG|Microbiological|
3620763|ENG|MILK SUGAR INTOLERANCE|
3622057|ENG|mode of action|
3626350|ENG|Musculoskeletal and connective tissue disorder (disorder)|
3626351|ENG|Musculoskeletal and connective tissue disorder|
3626459|ENG|MVX|
3627514|ENG|NAICS|
3628180|ENG|National Drug File|
3628358|ENG|NAUSEA AND VOMITING|
3629635|ENG|NEOPLASM (NOS)|
3629636|ENG|NEOPLASM NOS|
3629911|ENG|nerve supply|
3629918|ENG|NERVOUS DISORDERS|
3629921|ENG|NERVOUS SYSTEM DISORDER|
3630092|ENG|Neurogenic arthropathy|
3630134|ENG|NEUROLOGIC DISORDER NOS|
3630223|ENG|NEUROPATHIC ARTHROPATHY|
3632611|ENG|North American Industry Classification System|
3632906|ENG|Novartis Brand of Metyrapone|
3633910|ENG|nursing therapy|
3633936|ENG|nutritional management|
3634309|ENG|OBSTRUCTION BOWEL|
3634314|ENG|OBSTRUCTION INTESTINAL|
3634659|ENG|ODOR BREATH|
3635625|ENG|operations|
3635630|ENG|operative procedures|
3635631|ENG|operative therapy|
3635673|ENG|OPHTHALMIC DISORDERS|
3636276|ENG|organization & administration|
3636282|ENG|Organization and administration aspects|
3636394|ENG|Oropharyngeal disorders|
3638712|ENG|PAIN ABDOMINAL|
3638808|ENG|PAIN WITH SWALLOWING|
3639118|ENG|PANCREAS DISORDER|
3639134|ENG|PANCREAS NEOPLASM MALIGNANT|
3639872|ENG|parasitology|
3640005|ENG|all|
3640589|ENG|Pathogenicity Aspects|
3640590|ENG|pathogenicity|
3640591|ENG|Pathological aspects|
3640609|ENG|pathologic fistula|
3642673|ENG|Peptic ulcer; site unspecified|
3642674|ENG|PEPTIC ULCER SYNDROME|
3643317|ENG|Perioperative Nursing Data Set|
3643416|ENG|PERIUMBILICAL PURPURA|
3643486|ENG|Allergic reaction to drug (disorder)|
3643601|ENG|Allergy to drug|
3643662|ENG|Alliance Brand of Metyrapone|
3644052|ENG|pharmacologic effects|
3644058|ENG|pharmacologic therapy|
3646421|ENG|physiological aspects|
3646447|ENG|physiopathological|
3646448|ENG|physiopathology|
3648254|ENG|PNDS|
3648532|ENG|Poisoning aspects|
3648620|ENG|Polaronil|
3649749|ENG|POSTCHOLECYSTECTOMY SYNDROME|
365051|ENG|LTx - Liver transplant|
3653205|ENG|prevention & control|
3653224|ENG|preventive measures|
3653233|ENG|preventive therapy|
3653697|ENG|procedures|
3656748|ENG|psychology qualifier|
3657543|ENG|Puri Nethol|
3658008|ENG|PYROSIS|
3658883|ENG|radioisotope scanning|
3658922|ENG|radiotherapeutic|
3660078|ENG|RECTAL DISORDER|
3661041|ENG|Rehabilitation aspects|
3661985|ENG|Residual codes; unclassified; all E codes|
3661986|ENG|Residual codes; unclassified|
3662120|ENG|RESPIRATORY DISORDER (NOS)|
3662228|ENG|RESPIRATORY SYSTEM DISORDER OF|
3664482|ENG|roentgenographic|
3670089|ENG|Sanfer Brand of Mesna|
3670117|ENG|Sanofi Brand of Succimer|
3671445|ENG|secondary|
3672011|ENG|SENSORY ABERRATIONS|
3672016|ENG|SENSORY DISORDER|
3674450|ENG|SINGULTUS|
3674639|ENG|Skeletal|
3674794|ENG|SKIN DISORDER (NOS)|
3674795|ENG|SKIN DISORDERS|
3675485|ENG|SMELLY BREATH|
3675772|ENG|analogs & derivatives|
3675783|ENG|analysis aspect|
3675784|ENG|analysis|
3676841|ENG|Sodium lauryl sulfate|
3676842|ENG|Sodium lauryl sulfate (substance)|
3678185|ENG|Specimen Type - Fistula|
3678215|ENG|anatomy & histology|
3679602|ENG|standards characteristics|
3679603|ENG|standards|
3679822|ENG|statistics & numerical data|
3680290|ENG|STOMACH, CARCINOMA|
3680317|ENG|STOMATITIS APHHNOUS|
3680318|ENG|STOMATITIS APHTHOUS|
3680319|ENG|STOMATITIS, APHTHOUS|
3680335|ENG|STOOL BLACK|
3680342|ENG|STOOL COLOR BLACK|
3680362|ENG|STOOL TARRY|
3681161|ENG|subcellular structure|
3681241|ENG|Subject Heading, Medical|
3681242|ENG|Subject Headings, Medical|
3681269|ENG|submicroscopic anatomy|
3682469|ENG|supply & distribution|
3682579|ENG|Surgeries, Bariatric|
3682581|ENG|Surgery, Bariatric|
3682593|ENG|Surgical aspects|
3682818|ENG|SWALLOWING DIFFICULT|
3682819|ENG|SWALLOWING DIFFICULTY|
3682820|ENG|SWALLOWING DISORDER|
3682822|ENG|SWALLOWING PAINFUL|
3682964|ENG|Symptoms; signs; and ill-defined conditions and factors influencing health status|
3682965|ENG|Symptoms; signs; and ill-defined conditions|
3683103|ENG|SYNDROME ABDOMINAL ACUTE|
3683549|ENG|systematic|
3683555|ENG|systematics|
3684205|ENG|Taxonomic|
3684212|ENG|Taylor Brand of Dimercaprol|
3684723|ENG|techniques|
3684814|ENG|TEETH GRATING|
3684816|ENG|TEETH GRINDING|
3684817|ENG|TEETH-GRINDING|
3685139|ENG|teratologic|
3686537|ENG|therapeutic aspects|
3686585|ENG|therapeutic use|
3689275|ENG|Toxicity aspects|
3690334|ENG|transmission|
3690375|ENG|anomalies|
3690465|ENG|ANOMALY CONGENITAL GASTROINTESTINAL (NOS)|
3690533|ENG|trauma qualifier|
3690540|ENG|Traumatic injury (disorder)|
3690541|ENG|TRAUMATIC INJURY|
3690616|ENG|treatment|
3690675|ENG|trends|
3690676|ENG|trends qualifier|
3691234|ENG|antagonists & inhibitors|
3691875|ENG|TROISIER-HANOT-CHAUFFARD SYNDROME|
3693301|ENG|UCB Brand of Mesna|
3693332|ENG|UCUM|
3693460|ENG|ULCER APHTHOUS ORAL|
3693493|ENG|ULCER GASTRODUODENAL|
3693507|ENG|ULCER PEPTIC|
3693520|ENG|ULCER SYNDROME PEPTIC|
3693597|ENG|ultrastructure|
3693598|ENG|Ultrastructure|
3693811|ENG|undesirable effects|
3694814|ENG|URINARY TRACT DISORDER|
3694815|ENG|URINARY TRACT DISORDER OF|
3694816|ENG|Urinary Tract Disorders|
3695212|ENG|UROGENITAL DISORDER|
3695387|ENG|use|
3695448|ENG|USP Model Guidelines|
3695548|ENG|utilization|
3695549|ENG|utilization qualifier|
3696392|ENG|vasculature|
3697130|ENG|veterinary|
3700985|ENG|viruses|
370203|ENG|LUQ RUQ ABDOMINAL PAIN|
3702856|ENG|WESTPHAL-STRUEMPELL PSEUDOSCLEROSIS|
3703267|ENG|workers|
3703271|ENG|workforce|
3704084|ENG|X-ray image|
3704548|ENG|YELLOW SKIN|
3706738|ENG|APHTHOUS STOMATITIS|
3707966|ENG|ARTHRITIS, MULTIPLE JOINT INVOLVEMENT|
3708023|ENG|ARTHROPATHY NEUROGENIC|
3708024|ENG|ARTHROPATHY, NEUROPATHIC|
3708025|ENG|ARTHROPATHY (NOS)|
3708067|ENG|ARTHROSIS|
3709117|ENG|aspects of adverse effects|
3709120|ENG|Aspects of mortality statistics|
3709121|ENG|aspects of radiation effects|
3709122|ENG|Aspects of radionuclide imaging|
3709963|ENG|ASTA Medica Brand of Mesna|
3712136|ENG|Azithromycin 250 MG [Zithromax]|
3712708|ENG|BAD BREATH|
3713110|ENG|Bariatric Surgeries|
3716489|ENG|bioformation|
3716697|ENG|BI RG 587|
3716698|ENG|BIRG587|
3716702|ENG|BIRTH DISORDER (NOS)|
3717116|ENG|BLACK STOOL|
3717260|ENG|BLEEDING GASTROINTESTINAL|
3717567|ENG|BLOOD LOSS OF (NOS)|
3717656|ENG|Blood supply aspects|
3718531|ENG|BOWEL INCONTINENA|
3718795|ENG|BRASH|
3719075|ENG|BREATH ODOR|
3719274|ENG|Bristol Myers Squibb Brand of Mesna|
3719275|ENG|Bristol-Myers Squibb Brand of Mesna|
3723321|ENG|CANKER SORES ORAL|
3724865|ENG|CARCINOMA GASTRIC|
3724897|ENG|CARCINOMA STOMACH|
3725017|ENG|CARDIOESOPHAGEAL RELAXATION, GASTROESOPHAGEAL REFLUX|
3726402|ENG|causality|
3728057|ENG|cell pharm Brand of Mesna|
3728220|ENG|cellular aspects|
3728221|ENG|Cellular aspects of|
3728611|ENG|cerebral pseudosclerosis|
3729396|ENG|chemical aspects|
3729405|ENG|chemically induced|
3734205|ENG|CIRRHOSIS OF LIVER|
3734329|ENG|cisplatin/ifosfamide/mesna/mitomycin protocol|
3735175|ENG|Clinical Classifications Software, 2005|
3735724|ENG|CLOSTRIDIUM DIFFICILE COLITIS|
3736804|ENG|CodeSystem|
3737083|ENG|COLITIS MUCOUS|
3737084|ENG|COLITIS, MUCOUS|
3737259|ENG|COLON SPASTIC|
3737260|ENG|COLON, SPASTIC|
3737470|ENG|COMMON VARIABLE IMMUNODEFICIENCY|
3737471|ENG|COMMON VARIED IMMUNODEFICIENCY|
3737814|ENG|Complication Aspects|
3737833|ENG|complications|
3737837|ENG|Complications of pregnancy; childbirth; and the puerperium|
3738112|ENG|congenital|
3738262|ENG|connatal|
3738557|ENG|contraindications|
373867|ENG|lymphadenopathy|
373868|ENG|Lymphadenopathy|
373869|ENG|LYMPHADENOPATHY|
3739229|ENG|COSTART, 1995|
3739230|ENG|COSTART: coding symbols for thesaurus of adverse reaction terms|
3739380|ENG|counterindications|
374060|ENG|Lymphangiopathies|
374061|ENG|Lymphangiopathy|
374062|ENG|Lymphangiopathy NOS|
3740652|ENG|CST|
3740932|ENG|CULLEN SIGN|
3741106|ENG|CVID|
374153|ENG|Lymphatic Disease|
374154|ENG|Lymphatic Diseases|
374155|ENG|lymphatic disorder|
374156|ENG|Lymphatic disorder|
374157|ENG|Lymphatic Disorders|
3742009|ENG|CYSTITIS (NOS)|
3742434|ENG|dacarbazine/doxorubicin/ifosfamide/mesna protocol|
3743460|ENG|deficiency|
3743546|ENG|DEGLUTITION DISORDER|
3745193|ENG|Dermatopathy|
3747914|ENG|DIABETES, BRONZE|
3748983|ENG|dietary management|
3749217|ENG|Digestive System Disorders|
3751261|ENG|DISCOMFORT ABDOMINAL|
3751332|ENG|DISEASE GALLBLADDER|
3751339|ENG|DISEASE HEPATOCELLULAR|
3751341|ENG|disease management|
3751344|ENG|Disease of blood AND/OR blood-forming organ|
3751345|ENG|Disease of blood AND/OR blood-forming organ (navigational concept)|
3751360|ENG|Diseases of mouth; excluding dental|
3751361|ENG|DISEASES OF OESOPHAGUS|
3751370|ENG|disease transmission qualifier|
3751445|ENG|DISORDER BIRTH|
3751446|ENG|DISORDER BLOOD (NOS)|
3751451|ENG|Disorder by body site (disorder)|
3751452|ENG|Disorder by body site|
3751464|ENG|DISORDER CIRCULATORY SYSTEM|
3751470|ENG|DISORDER DEGLUTITION|
3751479|ENG|DISORDER ENDOCRINE|
3751482|ENG|DISORDER EYE|
3751485|ENG|DISORDER GASTROINTESTINAL|
3751487|ENG|DISORDER HEMATOLOGIC|
3751488|ENG|DISORDER IMMUNE SYSTEM (NOS)|
3751489|ENG|DISORDER JOINT|
3751492|ENG|DISORDER LIVER|
3751499|ENG|DISORDER NERVOUS SYSTEM|
3751500|ENG|Disorder of abdomen (disorder)|
3751501|ENG|Disorder of abdomen|
3751516|ENG|Disorder of appendix (disorder)|
3751530|ENG|Disorder of biliary tract (disorder)|
3751557|ENG|Disorder of colon (disorder)|
3751558|ENG|Disorder of colon|
3751567|ENG|Disorder of digestive organ (disorder)|
3751568|ENG|Disorder of digestive organ|
3751569|ENG|Disorder of digestive system (disorder)|
3751570|ENG|Disorder of digestive system|
3751571|ENG|Disorder of digestive tract (disorder)|
3751572|ENG|Disorder of digestive tract|
3751580|ENG|Disorder of esophagus (disorder)|
3751601|ENG|Disorder of gallbladder (disorder)|
3751602|ENG|Disorder of gastrointestinal tract (disorder)|
3751603|ENG|Disorder of gastrointestinal tract|
3751627|ENG|Disorder of hematopoietic system (navigational concept)|
3751634|ENG|Disorder of immune function (disorder)|
3751635|ENG|Disorder of immune function|
3751638|ENG|Disorder of immune system (navigational concept)|
3751643|ENG|Disorder of intestine (disorder)|
3751668|ENG|Disorder of lymphoid system (disorder)|
3751669|ENG|Disorder of lymphoid system|
3751678|ENG|Disorder of mouth (disorder)|
3751681|ENG|Disorder of musculoskeletal system (disorder)|
3751689|ENG|Disorder of nervous system (disorder)|
3751690|ENG|Disorder of nervous system|
3751698|ENG|Disorder of oropharynx (disorder)|
3751699|ENG|Disorder of oropharynx|
3751704|ENG|Disorder of pancreas (disorder)|
3751716|ENG|Disorder of peritoneum (disorder)|
3751728|ENG|Disorder of rectum (disorder)|
3751729|ENG|Disorder of rectum|
3751730|ENG|Disorder of respiratory system (disorder)|
3751731|ENG|Disorder of respiratory system|
3751746|ENG|Disorder of skin AND/OR subcutaneous tissue (disorder)|
3751747|ENG|Disorder of skin AND/OR subcutaneous tissue|
3751757|ENG|Disorder of skin (disorder)|
3751758|ENG|Disorder of skin|
3751762|ENG|Disorder of small intestine (disorder)|
3751770|ENG|Disorder of stomach (disorder)|
3751773|ENG|Disorder of teeth AND/OR supporting structures (disorder)|
3751774|ENG|Disorder of teeth AND/OR supporting structures|
3751779|ENG|Disorder of the genitourinary system (disorder)|
3751833|ENG|DISORDER PANCREAS|
3751849|ENG|DISORDER RECTAL|
3751851|ENG|DISORDER RESPIRATORY SYSTEM|
3751859|ENG|DISORDER SKIN (NOS)|
3751881|ENG|DISORDER URINARY TRACT|
3751882|ENG|DISORDER UROGENITAL|
3752873|ENG|Dopamine agent|
3752917|ENG|Dopamine (substance)|
3753394|ENG|Doxylamine (product)|
3754061|ENG|Drug allergy (disorder)|
3754099|ENG|drug effects|
3754181|ENG|Drug or medicament|
3754182|ENG|Drug or medicament (substance)|
3754390|ENG|Dulco Lax|
3754391|ENG|Dulco-Lax|
3754392|ENG|Dulco lax perles|
3754393|ENG|Dulco-lax perles|
3754394|ENG|Dulcolax perles|
3754551|ENG|Durolax|
3754609|ENG|DXplain, 1994|
3754817|ENG|DYSCRASIA BLOOD (NOS)|
3755075|ENG|EAR DISORDER|
3755076|ENG|EAR DISORDER (NOS)|
3755077|ENG|EAR DISORDER NOS|
3755078|ENG|EAR DISORDERS|
3755120|ENG|EARLY SATIETY|
3755326|ENG|echotomography|
3755387|ENG|Economic|
3755575|ENG|Educational aspects|
3755692|ENG|effect of drugs|
3756384|ENG|Eli Lilly Brand of Methimazole|
3756518|ENG|ABDOMEN MIMICKING ACUTE|
3756559|ENG|embryologic|
3756609|ENG|ABDOMINAL DISCOMFORT|
3756610|ENG|ABDOMINAL DISORDERS|
3756652|ENG|EMESIS BLOODY|
3756720|ENG|employees|
3756751|ENG|ABDOMINAL PAIN UPPER|
3756752|ENG|ABDOMINAL PAIN, UPPER|
3756908|ENG|ABDOMINAL SYNDROME ACUTE|
3757293|ENG|ENDOCRINE DISORDER (NOS)|
3757294|ENG|ENDOCRINE DISORDER NOS|
3757300|ENG|Endocrine; nutritional; and metabolic diseases and immunity disorders|
3757646|ENG|VOMITING BLOOD|
3757880|ENG|neurohepatic degeneration|
3757976|ENG|BLOOD DYSCRASIA|
3757998|ENG|Sodium lauryl sulphate|
3758060|ENG|PAIN CHEST|
3758073|ENG|PANCREATIC DISORDER|
3758098|ENG|BOWEL OBSTRUCTION|
3758214|ENG|PERISTALSIS VISIBLE|
3758446|ENG|CIRRHOSIS LIVER|
3758502|ENG|causes|
3758525|ENG|CIRCULATORY SYSTEM DISORDER (NOS)|
3758551|ENG|Eye Disorders|
3758643|ENG|radiation effects|
3758747|ENG|Disorder of the genitourinary system|
3758838|ENG|RESPIRATORY DISORDER|
3758899|ENG|DISORDER EAR|
3758901|ENG|DISORDER HEPATIC|
3759045|ENG|DRUG INTOXICATION|
3759046|ENG|DRUG TOXICITY (NOS)|
3759088|ENG|HAEMATEMESIS|
3759242|ENG|Hepatitis B infection|
3759246|ENG|HEPATOLENTICULAR DEGENERATION|
3759402|ENG|ICTERUS|
3759423|ENG|INFECTION VIRAL|
3759506|ENG|HERNIA, INTERNAL|
3759539|ENG|In Blood|
3759578|ENG|IRRITABLE COLON|
3759658|ENG|invasive procedures|
3759762|ENG|SYNDROME PEPTIC ULCER|
3760243|ENG|Unified Code for Units of Measure|
3762299|ENG|HL7V3.0|
3762301|ENG|VANDF|
3762302|ENG|USPMG|
3762303|ENG|DXP|
3762307|ENG|Veterans Health Administration National Drug File|
3762308|ENG|DXplain|
3762310|ENG|HL7 Vocabulary Version 3.0|
3762739|ENG|SDS|
3767319|ENG|Gastrointestinal System Cancer|
3768408|ENG|Registry Nomenclature Information System|
3768423|ENG|RENI|
3768871|ENG|Circulatory system disorder (NOS)|
3769222|ENG|Abdominal symptom|
3769397|ENG|Cystitis (NOS)|
3769670|ENG|Diseases of blood and blood-forming organs, unspecified|
3769677|ENG|Disorder birth|
3769678|ENG|Disorder blood (NOS)|
3769682|ENG|Disorder hematologic|
3769691|ENG|Disorder respiratory system|
3769824|ENG|Ear disorder (NOS)|
3769902|ENG|Endocrine disorder (NOS)|
3770008|ENG|Esophageal food impaction|
3770101|ENG|Eye disorder (NOS)|
3770174|ENG|Fector hepaticus|
3770404|ENG|Gastroenteritis noninfectious|
3770414|ENG|Gastrointestinal disorder (NOS)|
3770422|ENG|Gastrointestinal malformation|
3770428|ENG|Gastrointestinal tract bleed (NOS)|
3770662|ENG|Hematologic disorder|
3770666|ENG|Hem|
3770691|ENG|Hemorrhage term|
3770696|ENG|Hep A|
3770707|ENG|Hepatic disorder (NOS)|
3770722|ENG|Hepatic pathology|
3770740|ENG|Hep B|
3770749|ENG|Hereditary disorder|
3770811|ENG|Anal cancer|
3770948|ENG|Hypophagia|
3771318|ENG|Intestinal congestion|
3771709|ENG|Anomaly congenital gastrointestinal (NOS)|
3772229|ENG|Neoplasm (NOS)|
3772267|ENG|Neurodevelopmental disorder|
3772274|ENG|Neurologic disorder NOS|
3772408|ENG|Oesophageal disorder|
3772410|ENG|Oesophageal food impaction|
3772443|ENG|Appendix disorder|
3772647|ENG|Oral intake reduced|
3773305|ENG|Pelvic discomfort|
3773581|ENG|Porphyrin metabolism disorder|
3773588|ENG|Portal venous gas|
3773702|ENG|Primary immunodeficiency syndrome|
3773727|ENG|Abdo. discomfort|
3773986|ENG|Reproductive tract disorder|
3773993|ENG|Respiratory disorder (NOS)|
3773999|ENG|Respiratory system disorder of|
3774496|ENG|Stomatitis aphhnous|
3775361|ENG|Bile ducts, cancer of|
3775492|ENG|Biliary tract disorder|
3775688|ENG|Birth disorder (NOS)|
3775689|ENG|Birth disorder NOS|
3775698|ENG|Bladder inflammation|
3775751|ENG|Abdominal catastrophe|
3775867|ENG|Bowel incontinena|
3776037|ENG|Ca esophagus|
3776088|ENG|Disorder skin (NOS)|
3776109|ENG|Hepatic disease (NOS)|
3776148|ENG|Peritoneal disorder|
3776165|ENG|Skin disorder (NOS)|
37839|ENG|Abnormal sinus tract|
381189|ENG|M-3-PTP|
382509|ENG|Mack Brand of Azithromycin Dihydrate|
384972|ENG|MA|
3877290|ENG|Incontinence (excl P12)|
3877664|ENG|innervation aspect|
3880768|ENG|manifestations of immunopathology|
3883818|ENG|NBDPC cpd|
3886099|ENG|palmitoyl-2-(N-4-nitrobenz-2-oxa-1,3-diazol)aminocaproyl-sn-glycero-3-phosphocholine|
3898300|ENG|veterinary aspects|
390347|ENG|MAID|
390366|ENG|MAID protocol|
3911910|ENG|Secreted|
3911911|ENG|Secreting|
3911912|ENG|Secretory|
3912210|ENG|Communicative|
3913164|ENG|Urinary System Disorder|
3913553|ENG|SIC|
3913670|ENG|Standard Industrial Classification|
3914159|ENG|Clinical Finding|
391779|ENG|Malabsorption conditions|
391796|ENG|malabsorption|
391797|ENG|Malabsorption|
391812|ENG|Malabsorption, Lactose|
391822|ENG|Malabsorption syndrome (disorder)|
391823|ENG|malabsorption syndrome|
391825|ENG|Malabsorption syndrome|
391827|ENG|Malabsorption Syndrome|
391830|ENG|Malabsorption syndrome NOS|
391832|ENG|Malabsorption syndromes|
391833|ENG|Malabsorption Syndromes|
3918420|ENG|Dimyristoyl Lecithin|
3919051|ENG|NICOTINYL ALCOHOL|
3919505|ENG|Digestive|
3919717|ENG|LA Classification System|
3919737|ENG|Los Angeles Classification System for endoscopic assessment of reflux esophagitis|
3919738|ENG|Los Angeles Classification System|
3922314|ENG|5065|
3922326|ENG|52-86-8|
3922341|ENG|54-11-5|
3922424|ENG|616-91-1|
3922850|ENG|111180|
3922993|ENG|170973|
3923253|ENG|R-ICE Regimen|
3923266|ENG|RICE Regimen|
3923505|ENG|TIC Regimen|
3923506|ENG|TIP Regimen|
3923513|ENG|Taxol-Ifosfamide-Platinol Regimen|
3923545|ENG|VeIP Regimen|
3923548|ENG|Velban-Ifosfamide-Platinol Regimen|
3923703|ENG|CALGB 9251 Regimen|
3923727|ENG|CODOX-M/IVAC Regimen|
3923733|ENG|2-Methyl-1,2-di-3-pyridinyl-1-propanone|
3923893|ENG|Cyclophosphamide-Oncovin-Doxorubicin-Methotrexate/Ifosfamide, VePesid, AraC Regimen|
3924007|ENG|FDA Established Names and Unique Ingredient Identifier Codes Terminology|
3924008|ENG|FDA UNII Code Terminology|
3924097|ENG|AIM Regimen|
3924238|ENG|MAID Regimen|
3924243|ENG|MINE Regimen|
3924284|ENG|Mesna-Adriamycin-Ifosfamide-DTIC Regimen|
3924285|ENG|Mesna-Adriamycin-Ifosfamide-Dacarbazine Regimen|
3924286|ENG|Mesna-Ifosfamide-Novantrone-Etoposide Regimen|
3924312|ENG|Miller and Payne Classification|
3924358|ENG|Adriamycin-Ifosfamide-Mesna Regimen|
3924367|ENG|Neurosensory Disorder|
3934448|ENG|Digestive symptom (finding)|
3934449|ENG|Digestive symptom|
3934451|ENG|Digestive system symptom|
3934515|ENG|Disease due to virus|
3940542|ENG|Nicotinyl alcohol (substance)|
3942275|ENG|On examination - hernia-cough impulse shown (disorder)|
394352|ENG|Malignant Esophageal Neoplasm|
394355|ENG|Malignant Esophageal Tumor|
394356|ENG|Malignant Esophagus Tumor|
3944493|ENG|Porphyria (disorder)|
394483|ENG|Malignant Gastrointestinal Neoplasm|
3945418|ENG|Sinus (morphologic abnormality)|
3946433|ENG|Taurine (product)|
394724|ENG|Malignant hepatic neoplasm|
394923|ENG|Malignant Intestinal Neoplasm|
394924|ENG|Malignant intestinal neoplasms|
394925|ENG|Malignant Intestinal Neoplasms|
394927|ENG|Malignant Intestinal Tumor|
394928|ENG|Malignant Intestinal Tumors|
394929|ENG|Malignant Intestine Neoplasm|
394930|ENG|Malignant Intestine Tumor|
395006|ENG|Malignant liver tumor|
395010|ENG|Malignant liver tumour|
3951641|ENG|Betahistine (substance)|
3957975|ENG|CRISP Thesaurus, 2006|
39611|ENG|Grinding Disorders, Teeth|
39612|ENG|Grinding Disorder, Teeth|
39614|ENG|Grinding of teeth|
39620|ENG|Grinding teeth|
39621|ENG|Grinding teeth (finding)|
39622|ENG|Grinding tooth|
396927|ENG|Malignant neoplasm of esophagus|
396928|ENG|Malignant Neoplasm of Esophagus|
396930|ENG|Malignant neoplasm of esophagus NOS|
396931|ENG|Malignant neoplasm of esophagus, unspecified|
397100|ENG|Malignant neoplasm of gastrointestinal tract NOS|
397240|ENG|Malignant neoplasm of intestinal tract, part unspecified|
397241|ENG|Malignant neoplasm of intestine|
397242|ENG|Malignant Neoplasm of Intestine|
397243|ENG|Malignant neoplasm of intestine NOS|
397476|ENG|Malignant neoplasm of liver (disorder)|
397477|ENG|Malignant neoplasm of liver|
397478|ENG|Malignant neoplasm of liver, not specified as primary or secondary|
397780|ENG|Malignant neoplasm of oesophagus (C15)|
397783|ENG|Malignant neoplasm of oesophagus|
397784|ENG|Malignant neoplasm of oesophagus NOS|
397785|ENG|Malignant neoplasm of oesophagus, unspecified|
398099|ENG|Malignant neoplasm of pancreas (C25)|
398100|ENG|Malignant neoplasm of pancreas|
398101|ENG|Malignant Neoplasm of Pancreas|
398107|ENG|Malignant neoplasm of pancreas, part unspecified|
398110|ENG|Malignant neoplasm of pancreas, unspecified|
3982063|ENG|IBS (irritable bowel syndrome)|
398714|ENG|Activities, Research|
398841|ENG|Malignant Neoplasm of the Esophagus|
398871|ENG|Malignant Neoplasm of the Intestine|
398916|ENG|Malignant Neoplasm of the Pancreas|
399416|ENG|Malignant neoplasm pancreas|
399657|ENG|Malignant Pancreatic Neoplasm|
399880|ENG|Activity, Research|
400957|ENG|Malignant tumor of esophagus (disorder)|
400959|ENG|Malignant tumor of esophagus|
400960|ENG|Malignant Tumor of Esophagus|
401088|ENG|Malignant tumor of intestine (disorder)|
401089|ENG|Malignant tumor of intestine|
401090|ENG|Malignant Tumor of Intestine|
401155|ENG|Malignant tumor of liver|
4011950|ENG|RxNorm|
401301|ENG|Malignant tumor of pancreas (disorder)|
401302|ENG|Malignant tumor of pancreas|
401600|ENG|Malignant Tumor of the Esophagus|
401630|ENG|Malignant Tumor of the Intestine|
402212|ENG|Malignant tumour of intestine|
402243|ENG|Malignant tumour of liver|
402292|ENG|Malignant tumour of oesophagus|
402313|ENG|Malignant tumour of pancreas|
4032936|ENG|bariatric surgery|
4035030|ENG|deficiency aspects|
403571|ENG|Acute abdomen (disorder)|
403582|ENG|acute abdomen|
403604|ENG|Acute abdomen|
403615|ENG|Acute Abdomen|
403626|ENG|Acute Abdomens|
403671|ENG|Acute abdominal pain syndrome|
4047921|ENG|weight loss surgery|
405135|ENG|Management, Information|
4051783|ENG|Disease or Disorder|
4051957|ENG|FMA|
4052004|ENG|MESH|
4052006|ENG|MGED Ontology|
4052007|ENG|MGED131|
4052012|ENG|MGEDOntology|
4052013|ENG|MGED|
4052026|ENG|NCBI_taxonomy|
4052027|ENG|NCI_Thesaurus|
4052117|ENG|The MGED Ontology|
406988|ENG|Manifestation, Oral|
406998|ENG|Manifestations, Oral|
408563|ENG|manpower|
411159|ENG|Acute digestive system disorder (disorder)|
411170|ENG|Acute digestive system disorder|
412432|ENG|marine toxin|
412433|ENG|Marine toxin|
412434|ENG|marine toxins|
412435|ENG|Marine Toxins|
412436|ENG|Marine toxin (substance)|
4129499|ENG|SublingualRoute|
4140666|ENG|CDISC Organization|
4140977|ENG|Dopamine Antagonist|
4141043|ENG|ESZOPICLONE|
4142958|ENG|McGrath Regimen|
41431|ENG|GROWTH|
4143668|ENG|Benzimidazole Methylpyridine Sulfoxides|
4144660|ENG|Dental Diseases|
4144713|ENG|Disease, Dental|
4144718|ENG|Diseases, Dental|
4145158|ENG|Female Urogenital Diseases and Pregnancy Complications|
4145412|ENG|Genitourinary Disease, Male|
4145414|ENG|Genitourinary Diseases, Male|
4146388|ENG|2 Pyridinylmethylsulfinylbenzimidazoles|
4147085|ENG|Male Genitourinary Diseases|
4147086|ENG|Male Genitourinary Disease|
4147087|ENG|Male Urogenital Diseases|
4147088|ENG|Male Urogenital Disease|
4147293|ENG|Methylpyridine Sulfoxides, Benzimidazole|
4148707|ENG|2-Pyridinylmethylsulfinylbenzimidazoles|
4149695|ENG|Sulfoxides, Benzimidazole Methylpyridine|
4150303|ENG|Urogenital Disease, Male|
4150305|ENG|Urogenital Diseases, Male|
415296|ENG|Mastication disorder|
4153499|ENG|Dental Disease|
4153656|ENG|Pyrido(4,3-b)Indoles|
4155257|ENG|Digestive system allergy|
4155954|ENG|Encopresis (finding)|
4157243|ENG|Functional encopresis (finding)|
4160420|ENG|Allergic disorder of digestive system (disorder)|
4160421|ENG|Allergic disorder of digestive system|
4162406|ENG|Oral tablet|
4166367|ENG|1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism|
4166557|ENG|World Health Organisation (WHO) tumour classification|
4166607|ENG|World Health Organization (WHO) tumor classification|
4172107|ENG|Class (taxonomic)|
4174468|ENG|Drug allergy NOS|
4175829|ENG|File (record)|
4176730|ENG|Gastrointestinal mucositis (ulcerative)|
4190327|ENG|Ulcerative stomatitis NOS|
4192374|ENG|contraindications aspect|
4192636|ENG|instrumentation aspects|
4192893|ENG|Authorized Osteopathic Thesaurus, 2003|
419484|ENG|MBzTP|
4196065|ENG|{Copies}|
4196173|ENG|Copies|
4196174|ENG|Copy|
4196633|ENG|Stomach (gastric) cancer|
4196758|ENG|hereditary neoplastic syndrome|
4197148|ENG|Phospholipid with Choline|
4197423|ENG|Vitamin B-6|
4197484|ENG|copies|
4198311|ENG|International Conference on Harmonization|
4198449|ENG|NCI-HL7|
4202347|ENG|AzaSite|
4202711|ENG|Genomic Data and Sample Coding Category|
4203351|ENG|DICOM Terminology|
420386|ENG|McMaster University Epidemiology Terms, 1992|
420387|ENG|McMaster University Epidemiology Terms|
420394|ENG|MCM|
420493|ENG|McN-JR-1625|
420839|ENG|MCTP|
421778|ENG|MD - Metabolic disorders|
421870|ENG|MDR|
422082|ENG|Me-4-(FMePh)THP|
42267|ENG|GSE - Gluten-sensitive enteropathy|
423273|ENG|Measurin|
4238925|ENG|Pathological Conditions, Signs & Symptoms|
4241514|ENG|diagnosis aspect|
4241789|ENG|Authorized Osteopathic Thesaurus|
4242614|ENG|AOT|
4243633|ENG|System of Measurement|
4243702|ENG|Unit of Measure Coding Scheme|
4243703|ENG|Unit of Measure System|
4243840|ENG|Code System|
4244084|ENG|Measurement System|
424435|ENG|mechanism of action|
4245775|ENG|Hepatitis A Infection|
4246924|ENG|BILIARY TRACT DIS|
4247017|ENG|BIOSYN|
4247025|ENG|BIPYRIDINE 02 02|
4247096|ENG|BLOOD DIS|
4247109|ENG|BLOOD SUPPLY|
4247641|ENG|CARBOXYGLUTAMIC ACID 01|
4248055|ENG|CELIAC DIS|
4248239|ENG|CHEM IND|
4248255|ENG|CHEM SYN|
4248291|ENG|CHILD DEVELOPMENT DIS|
4248812|ENG|COLONIC DIS|
4248863|ENG|COMMON VARIABLE IMMUNODEFIC|
4248967|ENG|COMPL|
4248994|ENG|COMPUTING METHODOL|
4249086|ENG|CONGENITAL DIS|
4249087|ENG|CONGENITAL HEREDITARY NEONATAL DIS ABNORM|
4249088|ENG|CONGEN|
4249139|ENG|CONTRA|
4249549|ENG|CYTOL|
4249925|ENG|DEFIC SYNDROME IMMUNOL|
4249928|ENG|DEFIC SYNDROMES IMMUNOL|
4249942|ENG|DEFIC|
4249955|ENG|DEGLUTITION DIS|
4250413|ENG|DEVELOPMENT DIS CHILD|
4250441|ENG|DF|
4250452|ENG|DH|
4250589|ENG|DIET THER|
4250627|ENG|DIGESTIVE SYSTEM ABNORM|
4250632|ENG|DIGESTIVE SYSTEM DIS|
4250635|ENG|DIGESTIVE SYSTEM NEOPL|
4250692|ENG|DIPALMITOYLPHOSPHATIDYLCHOLINE 0102|
4250700|ENG|DIPYRIDYL 02 02|
4250701|ENG|DIPYRIDYL|
4250713|ENG|DIS CONGENITAL|
4250717|ENG|DIS ENDOCRINE SYSTEM|
4250721|ENG|DIS IMMUNE SYSTEM|
4250725|ENG|DIS METAB|
4250731|ENG|DIS OCCUP|
4250858|ENG|DOPAMINE ANTAG|
4250867|ENG|DOPAMINE RECEPT ANTAG|
4250878|ENG|DOPAMINERGIC ANTAG|
4250923|ENG|DPPC|
4250954|ENG|DRUG ADMIN SUBLINGUAL|
4250965|ENG|DRUG EFF|
4250984|ENG|DRUG THER|
4250985|ENG|DRUG TOX|
4251158|ENG|EAR DIS|
4251258|ENG|ECON|
4251468|ENG|EMBRYOL|
4251665|ENG|ENDOCRINE DIS|
4251670|ENG|ENDOCRINE SYSTEM DIS|
4251812|ENG|ENZYMOL|
4251885|ENG|EPIDEMIOL|
4251995|ENG|ESOPHAGEAL DIS|
4252045|ENG|ETHICS|
4252048|ENG|ETHNOL|
4252059|ENG|ETIOL|
4252227|ENG|EYE DIS|
4252458|ENG|FEMALE UROGENITAL DIS PREGNANCY COMPL|
4252936|ENG|GALL BLADDER DIS|
4252937|ENG|GALLBLADDER DIS|
4252989|ENG|GASTRIC DIS|
4252998|ENG|GASTROESOPHAGEAL REFLUX DIS|
4252999|ENG|GASTROINTESTINAL DIS|
4253234|ENG|GENET|
4253556|ENG|GROWTH A|
425379|ENG|MedDRA|
4253975|ENG|HEMATOL DIS|
4253994|ENG|HEMIC LYMPHATIC DIS|
4254035|ENG|HEPATIC TRANSPL|
4254042|ENG|HEPATITIS INFECT|
4254060|ENG|HEPATONEUROLOGIC WILSON DIS|
4254077|ENG|HEREDITARY DIS|
4254084|ENG|HEREDITARY NEOPL SYNDROMES|
425474|ENG|Media, Communications|
425486|ENG|Media|
4255034|ENG|HYDROXYDOPAMINE 06|
4255039|ENG|HYDROXYERGOCALCIFEROL 025|
4255066|ENG|HYDROXYVITAMIN D 02 25|
4255402|ENG|IMMUNE SYSTEM DIS|
4255412|ENG|IMMUNODEFIC COMMON VARIABLE|
4255447|ENG|IMMUNOL DEFIC SYNDROMES|
4255448|ENG|IMMUNOL DEFIC SYNDROME|
4255451|ENG|IMMUNOL DIS|
4255483|ENG|IMMUNOLOGICAL DIS|
4255485|ENG|IMMUNOL|
4255777|ENG|INFECT HEPATITIS|
4255939|ENG|INFORMATION SERV|
4255940|ENG|INFORMATION STORAGE RETRIEVAL|
4256085|ENG|INJ WOUNDS|
4256111|ENG|INJURIES WOUNDS|
4256114|ENG|INNERV|
4256155|ENG|INSTRUM|
4256350|ENG|INTERNATIONAL CLASS DIS|
4256352|ENG|INTERNATIONAL STATIS CLASS DIS RELAT HEALTH PROBLEMS|
4256378|ENG|INTESTINAL DIS|
4256506|ENG|ISLANDS OF LANGERHANS TRANSPL|
4256507|ENG|ISLANDS OF PANCREAS TRANSPL|
4256508|ENG|ISLET TRANSPL|
4256509|ENG|ISLETS TRANSPL|
4256516|ENG|ISOLATION A|
4256628|ENG|JOINT DIS|
4256799|ENG|KINNIER WILSON DIS|
4257062|ENG|LEGISLATION AB|
4257064|ENG|LEGIS|
4257248|ENG|LIVER DIS|
4257251|ENG|LIVER TRANSPL|
4257252|ENG|LJ|
4257386|ENG|LYMPHATIC DIS|
4257624|ENG|MALE GENITOURINARY DIS|
4257625|ENG|MALE UROGENITAL DIS|
4258203|ENG|MERCAPTO CPDS|
4258204|ENG|MERCAPTOETHANESULFONATE 002|
4258205|ENG|MERCAPTOPROPANOIC ACID 03|
4258206|ENG|MERCAPTOPROPIONIC ACID 03|
4258207|ENG|MERCAPTOPURINE A 06|
4258256|ENG|METAB DIS|
4258271|ENG|METAB|
4258285|ENG|METHODOL COMPUTING|
4258294|ENG|METHODS|
4258329|ENG|METHYLPHENYLPYRIDINIUM 01 04|
4258330|ENG|METHYLPHENYLTETRAHYDROPYRIDINE 01 04 01 02 03 06|
4258371|ENG|MICROBIOL|
4258561|ENG|MOL SEQ DATA|
4258568|ENG|MOLEC SEQ DATA|
4258611|ENG|MORTAL|
4258637|ENG|MOUTH DIS|
4258639|ENG|MOUTH REHABIL|
4258640|ENG|MOUTH TOOTH DIS|
4258673|ENG|MPTP IND PARKINSONISM|
4258674|ENG|MPTP NEUROTOX SYNDROME|
4258675|ENG|MPTP POIS|
4258809|ENG|MUSCULOSKELETAL DIS|
4258973|ENG|(+)-(5S)-6(chloropyridine-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)-pyrazin-5-yl-4-methyl-piperazine-1-carboxylate|
4259034|ENG|N METHYL 4 PHENYLPYRIDINIUM|
4259305|ENG|NAPHTHYLAMINE 01|
4259446|ENG|NEOPL DIGESTIVE SYSTEM|
4259603|ENG|NEOPL SYNDROMES HEREDITARY|
4259641|ENG|NEOPL|
4259689|ENG|NERVOUS SYSTEM DIS|
4259781|ENG|NEUROLOG DIS|
4259787|ENG|NEUROLOGICAL DIS|
4259835|ENG|NEUROTOX SYNDROME MPTP|
4260224|ENG|NURS|
4260228|ENG|NUTRITION DIS|
4260232|ENG|NUTRITIONAL DIS|
4260233|ENG|NUTRITIONAL METAB DIS|
4260370|ENG|OCCUP DIS|
4260431|ENG|OG|
4260435|ENG|OHDA 06|
4260602|ENG|ORGANIZATION ANDD|
4260617|ENG|ORGAN|
4260622|ENG|ORL DIS|
4260671|ENG|OTORHINOLARYNGOL DIS|
4260928|ENG|PANCREAS TRANSPL|
4260929|ENG|PANCREATIC DIS|
4260931|ENG|PANCREATIC ISLETS TRANSPL|
4260992|ENG|PARASITIC DIS|
4261001|ENG|PARASITOL|
4261075|ENG|PATHOL CONDITIONS SIGNS SYMPTOMS|
4261097|ENG|PATHOL|
4261287|ENG|PERIPHERAL NERVE DIS|
4261292|ENG|PERIPHERAL NERVOUS SYSTEM DIS|
4261300|ENG|PERITONEAL DIS|
4261456|ENG|PHARM PREPARATIONS|
4261478|ENG|PHARMACOKIN|
4261480|ENG|PHARMACOL|
4261663|ENG|PHYSIOL|
4261664|ENG|PHYSIOPATHOL|
4261746|ENG|PLANT DIS|
4261828|ENG|PNS DIS|
4261832|ENG|PNS PERIPHERAL NERVOUS SYSTEM DIS|
4261842|ENG|POIS 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE|
4261874|ENG|POIS|
4262244|ENG|PREPARATIONS PHARM|
4262268|ENG|PREVENTION A|
4262702|ENG|PSYCHOL|
4262991|ENG|PYRIDINIUM CPDS|
4262992|ENG|PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 02|
4263216|ENG|RAD EFF|
4263290|ENG|RADIOGR|
4263330|ENG|RADIONUCLIDE|
4263350|ENG|RADIOTHER|
4264261|ENG|RECTAL DIS|
4264361|ENG|REHABIL|
4264498|ENG|RESPIRATION DIS|
4264519|ENG|RESPIRATORY TRACT DIS|
4264650|ENG|RISA|
4264761|ENG|RUMINATION DIS|
4265089|ENG|SECOND|
4265098|ENG|SECRET|
4265167|ENG|SENSORY DIS|
4265190|ENG|SEQ DATA MOL|
4265334|ENG|SERV INFORMATION|
4265482|ENG|SIGNS SYMPTOMS|
4265541|ENG|SKIN CONNECTIVE TISSUE DIS|
4265556|ENG|SKIN DIS|
4266012|ENG|STATIST|
4266073|ENG|STOMACH DIS|
4266075|ENG|STOMATOGNATHIC DIS|
4266172|ENG|SUBLINGUAL ADMIN|
4266173|ENG|SUBLINGUAL DRUG ADMIN|
4266216|ENG|SULFHYDRYL CPDS|
4266245|ENG|SUPPLY|
4266496|ENG|SWALLOWING DIS|
4266519|ENG|SYMPTOMS GENERAL PATHOL|
4266566|ENG|SYSTEMS ANAL|
4267082|ENG|TEETH GRINDING DIS|
4267309|ENG|THER USE|
4267322|ENG|THER|
4267576|ENG|TOX DRUG|
4267727|ENG|TRANSM|
4267745|ENG|TRANSPL HEPATIC|
4267750|ENG|TRANSPL ISLANDS OF LANGERHANS|
4267751|ENG|TRANSPL ISLANDS OF PANCREAS|
4267752|ENG|TRANSPL ISLETS OF LANGERHANS|
4267753|ENG|TRANSPL ISLET|
4267757|ENG|TRANSPL LIVER|
4267762|ENG|TRANSPL PANCREAS|
4267763|ENG|TRANSPL PANCREATIC ISLETS|
4267774|ENG|TRANSPL|
4268156|ENG|ULTRASONOGR|
4268158|ENG|ULTRASTRUCT|
4268247|ENG|URINARY TRACT DIS|
4268264|ENG|UROL DIS|
4268287|ENG|UTIL|
4268518|ENG|VET|
4268543|ENG|VIRAL DIS|
4268560|ENG|VIROL|
4268566|ENG|VIRUS DIS|
4268601|ENG|VITAMIN B A 06|
4268771|ENG|WILSON DIS|
4268772|ENG|WILSONS DIS|
4268800|ENG|WOUNDS AND INJ|
4268801|ENG|WOUNDS INJURIES|
4268802|ENG|WOUNDS INJ|
4272750|ENG|ABNORM DIGESTIVE SYSTEM|
4272772|ENG|ABNORM|
4273059|ENG|ADMIN SUBLINGUAL|
4273067|ENG|ADMINISTRATION A|
4273070|ENG|ADMIN|
4273157|ENG|ADV EFF|
4273207|ENG|AGON|
4273219|ENG|AH|
4273484|ENG|AMINONAPHTHALENE 01|
4273580|ENG|ANAL SYSTEMS|
4273586|ENG|ANALOGS|
4273599|ENG|ANATOMY A|
4273719|ENG|ANTAG DOPAMINE RECEPT|
4273720|ENG|ANTAG DOPAMINERGIC|
4273721|ENG|ANTAG DOPAMINE|
4273730|ENG|ANTAG|
4274153|ENG|PATHOGEN|
4274156|ENG|STAND|
4274157|ENG|TRENDS|
4274187|ENG|NITROSOTHIOLS S|
4274700|ENG|Clostridium difficile colitis (disorder)|
4281746|ENG|Structure of digestive system (body structure)|
4281747|ENG|Structure of digestive system|
428775|ENG|Medical Dictionary for Regulatory Activities Terminology (MedDRA)|
428998|ENG|Medical Information Systems|
429533|ENG|Medical Subject Headings|
429606|ENG|Medicament poisoning|
429829|ENG|Medication|
430127|ENG|Medicinal poisoning|
430186|ENG|Medicine|
430246|ENG|Medicines|
430663|ENG|Medium|
430753|ENG|MedlinePlus|
430754|ENG|MEDLINEPLUS|
430756|ENG|MedlinePlus Health Topics|
433596|ENG|Melaena|
4350718|ENG|CANCER, HEPATOCELLULAR|
435591|ENG|Melena/black tarry stools|
435592|ENG|Melena (disorder)|
435594|ENG|melena|
435595|ENG|Melena|
435596|ENG|MELENA|
435606|ENG|Melenas|
4362684|ENG|CLEFT LARYNX, POSTERIOR|
437263|ENG|Membranous colitis|
437264|ENG|Membranous Colitis|
4392300|ENG|Coding system.original:Type:Point in time:Cancer.To be specified in another part of the message.anatomic site:Nominal|
4392303|ENG|Coding system.original:Type:Pt:Cancer.XXX.anatomic site:Nom|
4392311|ENG|Coding system|
4393369|ENG|Congenital MeSH qualifier|
4404545|ENG|Decreased serum immunoglobulin|
4407707|ENG|Dipalmitoylphosphatidylcholine:MCnc:Pt:Ser:Qn|
4407708|ENG|Dipalmitoylphosphatidylcholine:Mass Concentration:Point in time:Serum:Quantitative|
4409046|ENG|ALOE VERA LIQUID,ORAL|
440970|ENG|Mental Disorder, Child|
441040|ENG|Mental Disorders and Manifestations|
441041|ENG|Mental Disorders, Child|
441044|ENG|Mental Disorders Diagnosed in Childhood|
441153|ENG|Mental Health and Behavior|
4414922|ENG|Endo|
4420625|ENG|FDA Structured Product Labels|
444453|ENG|Mercaleukim|
444454|ENG|Mercaleukin|
444466|ENG|mercaptan|
444467|ENG|Mercaptans|
444469|ENG|Mercaptina|
444472|ENG|Mercapto-6-purine|
444489|ENG|Mercapto Compounds|
444491|ENG|mercaptoethane sulfonate|
444493|ENG|mercaptoethanesulfonate|
444494|ENG|Mercaptoethane Sulfonate|
444495|ENG|Mercaptoethanesulfonate|
444496|ENG|mercaptoethanol|
444497|ENG|Mercaptoethanol|
444499|ENG|Mercaptoethylamines|
444553|ENG|mercaptopurine|
444554|ENG|Mercaptopurine|
444555|ENG|MERCAPTOPURINE|
444595|ENG|Mercaptopurine (product)|
444599|ENG|Mercaptopurine (substance)|
444602|ENG|Mercaptopurinum|
444622|ENG|Mercapturic Acid|
444624|ENG|Mercapurin|
444627|ENG|Mercasolyl|
444631|ENG|Mercazolyl|
445476|ENG|Merkazolil|
445573|ENG|Mern|
445975|ENG|Merycism|
4463462|ENG|Infection with clostridium difficile|
446853|ENG|MeSH Descriptors Class 1|
446857|ENG|MeSH Descriptors|
446868|ENG|MeSH|
447316|ENG|mesilate|
447317|ENG|Mesilate|
447322|ENG|Mesilates|
4474118|ENG|LIVER CANCER|
447681|ENG|Mesna 100 MG/ML|
447685|ENG|Mesna 100 MG/ML Injectable Solution|
447688|ENG|Mesna 100 MG/ML Injectable Solution [Mesnex]|
447689|ENG|Mesna 100mg/mL injection solution 10mL ampoule|
447690|ENG|Mesna 100mg/mL injection solution 10mL ampule|
447691|ENG|Mesna 100mg/mL injection solution 10mL ampule (product)|
447692|ENG|Mesna 100mg/mL injection solution 4mL ampoule|
447693|ENG|Mesna 100mg/mL injection solution 4mL ampule|
447695|ENG|Mesna 100mg/mL injection solution 4mL ampule (product)|
447696|ENG|MESNA 100MG/ML INJ|
447700|ENG|Mesna 16.67 MG/ML|
447701|ENG|Mesna 1g/10mL injection|
447702|ENG|Mesna 1g injection|
447703|ENG|Mesna 1g injection solution 10mL vial|
447704|ENG|Mesna 1g injection solution 10mL vial (product)|
447706|ENG|Mesna 1g injection solution 20mL vial|
447707|ENG|Mesna 1g injection solution 20mL vial (product)|
447713|ENG|Mesna 200mg injection|
447714|ENG|Mesna 200mg injection solution 2mL ampoule|
447715|ENG|Mesna 200mg injection solution 2mL ampule|
447717|ENG|Mesna 200mg injection solution 2mL ampule (product)|
447720|ENG|Mesna 200 MG/ML|
447721|ENG|Mesna 200 MG/ML Inhalant Solution|
447722|ENG|Mesna 200 MG/ML Injectable Solution|
447723|ENG|Mesna 400mg/4mL injection|
447724|ENG|Mesna 400mg/amp injection|
447725|ENG|Mesna 400mg/amp injection solution 4mL vial|
447726|ENG|Mesna 400mg/amp injection solution 4mL vial (product)|
447728|ENG|Mesna 400 MG|
447733|ENG|Mesna 400 MG Oral Tablet|
447735|ENG|Mesna 400 MG Oral Tablet [Mesnex]|
447736|ENG|MESNA 400MG TAB|
447737|ENG|Mesna 400mg tablet|
447740|ENG|Mesna 400mg tablet (product)|
447742|ENG|Mesna 50 MG/ML|
447743|ENG|Mesna 50 MG/ML Nasal Solution|
447745|ENG|Mesna 600 MG|
447746|ENG|Mesna 600 MG Oral Tablet|
447747|ENG|Mesna 600mg tablet|
447750|ENG|Mesna 600mg tablet (product)|
447753|ENG|Mesna adverse reaction (disorder)|
447754|ENG|Mesna adverse reaction|
447755|ENG|MESNA-albumin|
447756|ENG|Mesna allergy (disorder)|
447757|ENG|Mesna allergy|
447762|ENG|mesna|
447763|ENG|Mesna|
447764|ENG|MESNA|
447765|ENG|Mesna Inhalant Solution|
447768|ENG|Mesna Injectable Solution|
447772|ENG|Mesna Nasal Solution|
447775|ENG|Mesna Nova Plus|
447777|ENG|Mesna Oral Tablet|
447780|ENG|Mesna (product)|
447784|ENG|Mesna (substance)|
447786|ENG|Mesnex 100 MG/ML Injectable Solution|
447788|ENG|Mesnex 400 MG Oral Tablet|
447790|ENG|Mesnex|
447793|ENG|Mesnil|
447796|ENG|Mesnum|
448032|ENG|meso Dimercaptosuccinic Acid|
448033|ENG|meso-Dimercaptosuccinic Acid|
4488968|ENG|MTHSPL|
4491570|ENG|Malignant gastrointestinal tract tumors|
4491901|ENG|Abdomen pain|
4492673|ENG|Medication allergy|
4492818|ENG|Medications|
449285|ENG|mesylate|
449286|ENG|Mesylate|
449299|ENG|Mesylates|
4493062|ENG|Mental health.behavior|
4493956|ENG|Metathesaurus FDA Structured Product Labels|
449517|ENG|Metabolic disease (disorder)|
449518|ENG|Metabolic disease|
449519|ENG|Metabolic Disease|
449530|ENG|Metabolic Diseases|
449567|ENG|metabolic disorder|
449568|ENG|Metabolic disorder|
449569|ENG|Metabolic Disorder|
449609|ENG|Metabolic disorder NOS|
449633|ENG|Metabolic disorders|
449634|ENG|Metabolic Disorders|
449649|ENG|Metabolic disorder, unspecified|
449812|ENG|metabolism disorder|
449828|ENG|metabolism|
450359|ENG|meta-hydroxy-MPTP|
4504158|ENG|NEOPLASIA|
4510832|ENG|Nutritional problems|
4525279|ENG|PROTECTIVE AGENTS|
452618|ENG|metastatic|
4527603|ENG|Pain symptoms|
4530031|ENG|Peritoneal inflammation|
4533922|ENG|Polyarticular arthritis|
4534141|ENG|Poor swallowing|
454099|ENG|Metathesaurus|
454105|ENG|Metathesaurus HCPCS Hierarchical Terms|
454106|ENG|Metathesaurus Names|
454107|ENG|Metathesaurus Source Terminologies|
454108|ENG|Metathesaurus Source Terminology Names|
454109|ENG|Metathesaurus Version of Minimal Standard Terminology Digestive Endoscopy, 2001|
454110|ENG|Metathesaurus Version of Minimal Standard Terminology Digestive Endoscopy|
4551608|ENG|SKELETAL|
455722|ENG|methane sulfonate|
455731|ENG|Methanesulfonates|
4559569|ENG|Sequence number central.patient:Arb:Pt:Cancer.XXX:Ord|
4559570|ENG|Sequence number central.patient:Arbitrary:Point in time:Cancer.To be specified in another part of the message:Ordinal|
4561063|ENG|Sinuses|
4561100|ENG|Site coding system.current:Type:Point in time:Cancer.To be specified in another part of the message.anatomic site:Nominal|
4561101|ENG|Site coding system.current:Type:Pt:Cancer.XXX.anatomic site:Nom|
4561233|ENG|Skeletal abnormalities|
456728|ENG|Methbipyranone|
4567428|ENG|Swallowing difficulties|
457489|ENG|methimazole|
457490|ENG|Methimazole|
457491|ENG|METHIMAZOLE|
457505|ENG|Methimazole (product)|
457507|ENG|Methimazole (substance)|
4580719|ENG|U.S. Department of Veterans Affairs, Veterans Health Administration National Drug File|
4582786|ENG|Unspecified constipation|
4582791|ENG|Unspecified pain|
458546|ENG|Methodologies, Computing|
458551|ENG|Methodology, Computing|
458727|ENG|Methopyrapone|
4611810|ENG|ICD9-CM|
4612048|ENG|NCIT|
4612471|ENG|sublingual|
4614594|ENG|C. difficile colitis|
4615322|ENG|clostridium difficile colitis|
4615703|ENG|Charcot joint|
461578|ENG|methyl coenzyme M|
461583|ENG|methyl CoM|
4615865|ENG|degenerative disorder|
4616052|ENG|disorder|
4617080|ENG|gastric carcinoma|
4617170|ENG|gluten-sensitive enteropathy|
4617383|ENG|herniation|
4617885|ENG|integument disorder|
4617931|ENG|internal abdominal hernia|
4617947|ENG|internal hernia|
4619222|ENG|medication|
4619536|ENG|RADLEX|
4619569|ENG|musculoskeletal degeneration|
4619730|ENG|neuropathic joint|
4620232|ENG|pancreatic transplantation|
4620711|ENG|pneumatosis intestinalis|
4623044|ENG|DABIGATRAN|
4623079|ENG|Dabigatran|
462336|ENG|Methylenesulfonates|
4623994|ENG|hepatitis B infection|
4624003|ENG|immune system disorder|
4624523|ENG|Tumor Grading System|
4627100|ENG|ZFIN|
4627101|ENG|Zebrafish Model Organism Database|
4629126|ENG|Akorn Brand of Tropicamide|
4629730|ENG|Blockers, Dopamine|
4631566|ENG|Disease, ENT|
4631574|ENG|Disease, Otolaryngological|
4631575|ENG|Disease, Otolaryngologic|
4631576|ENG|Disease, Otological|
4631577|ENG|Disease, Otologic|
4631580|ENG|Diseases, ENT|
4631584|ENG|Diseases, Otolaryngological|
4631585|ENG|Diseases, Otolaryngologic|
4631586|ENG|Diseases, Otological|
4631587|ENG|Diseases, Otologic|
4631643|ENG|Dopamine Blockers|
4631829|ENG|ENT Diseases|
4631830|ENG|ENT Disease|
463189|ENG|Methylmercaptoimidazole|
4633316|ENG|Indexes as Topic|
4633318|ENG|Indexing as Topic|
4635341|ENG|OTOLOGIC DIS|
4635363|ENG|Ocusoft Brand of Tropicamide|
4635434|ENG|Otolaryngologic Diseases|
4635435|ENG|Otolaryngologic Disease|
4635436|ENG|Otolaryngological Diseases|
4635437|ENG|Otolaryngological Disease|
4635438|ENG|Otologic Diseases|
4635439|ENG|Otologic Disease|
4635440|ENG|Otological Diseases|
4635441|ENG|Otological Disease|
464491|ENG|methylphenyltetrahydropyridine|
464492|ENG|Methylphenyltetrahydropyridine|
464494|ENG|Methylphenyltetrahydropyridine-induced parkinsonism|
464498|ENG|Methylphenyltetrahydropyridine (substance)|
4645023|ENG|Disorder of eye proper|
4645027|ENG|Disorder of mouth|
4652739|ENG|On examination - hernia-cough impulse shown|
4654252|ENG|Oral tablet (qualifier value)|
4655451|ENG|Aphthous ulcer of mouth (disorder)|
4655452|ENG|Aphthous ulcer of mouth|
4657815|ENG|Thioglycolate (substance)|
4657816|ENG|Thioglycolate|
466098|ENG|Methyl Viologen|
466113|ENG|Methymazol|
466256|ENG|Metichlorpindol|
466260|ENG|Meticlorpindol|
466964|ENG|Metopirone|
466965|ENG|Metopiron|
4674741|ENG|anatomy & histology (qualifier)|
4679045|ENG|isolation & purification analysis|
4681578|ENG|therapeutic use - qualifier|
468292|ENG|metyrapone|
468294|ENG|Metyrapone|
468295|ENG|METYRAPONE|
468301|ENG|Metyrapone (product)|
468305|ENG|Metyrapone (substance)|
468579|ENG|Mexan|
470652|ENG|MIAU - Minor aphthous ulceration|
471282|ENG|Adaptive colitis|
4714832|ENG|Dysphagia, unspecified|
472381|ENG|microbiology|
4724787|ENG|Foetor ex ore|
4738777|ENG|Acute pancreatitis (SMQ)|
4759852|ENG|Neoplasms benign, malignant and unspecified (including cysts and polyps)|
479077|ENG|MI|
480429|ENG|MILK INTOLERANCE|
4804853|ENG|Difficulty in swallowing NOS|
4805183|ENG|Biliary calculi substance|
4805312|ENG|RadLex entity|
4807863|ENG|Argimesna|
4808402|ENG|CLOPIDOL|
4809305|ENG|ARGIMESNA|
4809691|ENG|Arginine 2-mercaptoethane Sulfonate|
4810307|ENG|Gastrointestinal Fistula|
4810477|ENG|Gastrointestinal Pain|
4810513|ENG|NCF|
481290|ENG|MIMIC|
4813186|ENG|(S)-3-(1-methyl-2-pyrrolidinyl)pyridine|
4813236|ENG|1-methyl-2-(3-pyridyl)pyrrolidine|
4813293|ENG|2-(acetyloxy)benzoic Acid|
4813309|ENG|2-mercaptoethanesulfonic acid, sodium salt|
4813365|ENG|4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone|
4813923|ENG|beta-pyridyl-alpha-N-methylpyrrolidine|
4814076|ENG|drug/agent toxicity by tissue/organ|
4814426|ENG|sodium 2-mercaptoethane sulfonate|
481646|ENG|MINE-BOP protocol|
481650|ENG|MINE|
481651|ENG|MINE-ESHAP protocol|
481661|ENG|MINE protocol|
482308|ENG|MINE regimen|
4824409|ENG|Bisacodyl 5mg gastro-resistant tablet|
4825921|ENG|Fistula (disorder)|
4827535|ENG|Malignant neoplasm of gastrointestinal tract (disorder)|
4833855|ENG|Aphthous ulcers|
483518|ENG|Minor oral aphthous ulceration (disorder)|
483519|ENG|Minor oral aphthous ulceration|
483821|ENG|MINT protocol|
485365|ENG|Mistabronco|
485366|ENG|Mistabron|
4853669|ENG|Malignant dysphagia|
4853930|ENG|Mesna injection|
4855355|ENG|Neuropathic joints|
485543|ENG|Mitelman Database of Chromosome Aberrations in Cancer (MDBCAC)|
485548|ENG|AD|
485579|ENG|Mitexan|
4856490|ENG|Oral disorder|
4865241|ENG|Thoracalgia|
4867388|ENG|Z-PAK|
4869145|ENG|{6 (Azithromycin 250 MG Oral Tablet [Zithromax]) } Pack [Z-PAKS]|
4869146|ENG|{6 (Azithromycin 250 MG Oral Tablet) } Pack|
4870306|ENG|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate|
4870322|ENG|(S)-Zopiclone|
4870771|ENG|SEP-190|
4871108|ENG|anatomical structure|
4874668|ENG|Thienopyridines|
4877098|ENG|Bariatric surgery|
4877419|ENG|Gastr|
4877519|ENG|Immun|
4877667|ENG|Musc|
4877697|ENG|Neopl|
4877699|ENG|Nerv|
4878022|ENG|Radiation sickness syndrome|
4878595|ENG|CLAS|
4878866|ENG|Disorder, Joint|
4879761|ENG|Sickness Syndrome, Radiation|
4879804|ENG|Syndrome, Radiation Sickness|
4885060|ENG|Never Current Former Classification|
4899515|ENG|Aloe (substance)|
4901548|ENG|Disorder of urinary tract proper (disorder)|
4901549|ENG|Disorder of urinary tract proper|
4902075|ENG|Exposure to (contextual qualifier)|
490696|ENG|m-methoxy-MPTP|
491053|ENG|M-MPTP|
4913159|ENG|1,2-Dipalmitoylphosphatidylcholine [Chemical/Ingredient]|
4913372|ENG|1-Carboxyglutamic Acid [Chemical/Ingredient]|
4913382|ENG|1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine [Chemical/Ingredient]|
4913383|ENG|1-Methyl-4-phenylpyridinium [Chemical/Ingredient]|
4913434|ENG|1-Naphthylamine [Chemical/Ingredient]|
4914375|ENG|2,2'-Dipyridyl [Chemical/Ingredient]|
4914844|ENG|2-Pyridinylmethylsulfinylbenzimidazoles [Chemical/Ingredient]|
4915340|ENG|25-Hydroxyvitamin D 2 [Chemical/Ingredient]|
4915960|ENG|3-Mercaptopropionic Acid [Chemical/Ingredient]|
4917359|ENG|6-Mercaptopurine [Chemical/Ingredient]|
4919109|ENG|ALOE VERA CAP/TAB [VA Product]|
4919110|ENG|ALOE VERA CLEANSING PAD [VA Product]|
4919111|ENG|ALOE VERA GEL,TOP [VA Product]|
4919112|ENG|ALOE VERA LIQUID,ORAL [VA Product]|
4919113|ENG|ALOE VERA TOP GEL|
4921915|ENG|AZITHROMYCIN 250MG TAB [VA Product]|
4921916|ENG|AZITHROMYCIN 250MG TAB,PKT,6 [VA Product]|
4921990|ENG|Abdomen, Acute [Disease/Finding]|
4921994|ENG|Abdominal Pain [Disease/Finding]|
4922799|ENG|Acetylcysteine [Chemical/Ingredient]|
4926115|ENG|Alkanesulfonates [Chemical/Ingredient]|
4927512|ENG|Aminopyridines [Chemical/Ingredient]|
4928302|ENG|Analog/Derivative|
4928303|ENG|Analogs/Derivatives [Chemical/Ingredient]|
4928304|ENG|Analogs/Derivatives|
4928305|ENG|Analogue/Derivative|
4928306|ENG|Analogues/Derivatives|
4932663|ENG|Arthropathy, Neurogenic [Disease/Finding]|
4933861|ENG|Aspirin [Chemical/Ingredient]|
4935122|ENG|Azithromycin [Chemical/Ingredient]|
4936891|ENG|BISACODYL 10MG (MAGIC BULLET) RTL SUPP|
4936892|ENG|BISACODYL 10MG (MAGIC BULLET) SUPP,RTL [VA Product]|
4936893|ENG|BISACODYL 10MG EC TAB|
4936894|ENG|BISACODYL 10MG ENEMA [VA Product]|
4936895|ENG|BISACODYL 10MG RTL SUPP|
4936896|ENG|BISACODYL 10MG SUPP,RTL [VA Product]|
4936901|ENG|BISACODYL 10MG TAB,EC [VA Product]|
4936902|ENG|BISACODYL 10MG/30ML ENEMA,RTL [VA Product]|
4936905|ENG|BISACODYL 5MG EC TAB|
4936906|ENG|BISACODYL 5MG RTL SUPP|
4936907|ENG|BISACODYL 5MG SUPP,RTL [VA Product]|
4936909|ENG|BISACODYL 5MG TAB #4/BISACODYL 10MG SUPP [VA Product]|
4936910|ENG|BISACODYL 5MG TAB,EC [VA Product]|
4936911|ENG|BISACODYL 5MG TAB,EC,UD [VA Product]|
493947|ENG|MO|
4940412|ENG|Bellyache|
4940926|ENG|Betahistine [Chemical/Ingredient]|
4941170|ENG|Biliary Tract Diseases [Disease/Finding]|
4941199|ENG|Binding Activity [MoA]|
4941200|ENG|Binding Activity|
4941271|ENG|Bisacodyl [Chemical/Ingredient]|
4944931|ENG|Bruxism [Disease/Finding]|
4946104|ENG|C. diff. infections|
494699|ENG|Molecular Disease|
4947544|ENG|CASTOR OIL [VA Product]|
494808|ENG|Molecular sequence data|
494809|ENG|Molecular Sequence Data|
494810|ENG|Molecular sequence data (finding)|
494811|ENG|Molecular Sequencing Data|
4953966|ENG|Carbolines [Chemical/Ingredient]|
4954926|ENG|Castor Oil [Chemical/Ingredient]|
4956056|ENG|Celiac Disease [Disease/Finding]|
4957973|ENG|Chest Pain [Disease/Finding]|
4958053|ENG|Children and Teenagers|
4959075|ENG|Chlorpheniramine [Chemical/Ingredient]|
4960874|ENG|Clopidol [Chemical/Ingredient]|
4960894|ENG|Clostridium Difficile Infections|
4962082|ENG|Colonic Diseases [Disease/Finding]|
4962397|ENG|Common Variable Immunodeficiency [Disease/Finding]|
4963098|ENG|Congenital, Hereditary, and Neonatal Diseases and Abnormalities [Disease/Finding]|
4963257|ENG|Conotoxins [Chemical/Ingredient]|
4963266|ENG|Constipation [Disease/Finding]|
4966317|ENG|Cutaneous disorders|
4967082|ENG|Cysteine [Chemical/Ingredient]|
4967132|ENG|Cystitis [Disease/Finding]|
4970908|ENG|DULCOLAX BOWEL PREP KIT|
4971055|ENG|Dairy product intolerance|
4972523|ENG|Deglutition Disorders [Disease/Finding]|
4973238|ENG|Dermatologic disorders|
4973569|ENG|Developmental Disabilities [Disease/Finding]|
4974767|ENG|Digestive System Abnormalities [Disease/Finding]|
4974768|ENG|Digestive System Diseases [Disease/Finding]|
4974769|ENG|Digestive System Fistula [Disease/Finding]|
4974770|ENG|Digestive System Neoplasms [Disease/Finding]|
4974871|ENG|Dihydropyridines [Chemical/Ingredient]|
4974932|ENG|Dimercaprol [Chemical/Ingredient]|
4974942|ENG|Dimethindene [Chemical/Ingredient]|
4974983|ENG|Dimyristoylphosphatidylcholine [Chemical/Ingredient]|
4975511|ENG|Disease [Disease/Finding]|
4975515|ENG|Diseases, Manifestations or Physiologic States [Disease/Finding]|
4975521|ENG|Disopyramide [Chemical/Ingredient]|
4975522|ENG|Disorders of Environmental Origin [Disease/Finding]|
4976116|ENG|Dopamine [Chemical/Ingredient]|
4976456|ENG|Doxylamine [Chemical/Ingredient]|
4976822|ENG|Drug Hypersensitivity [Disease/Finding]|
4976828|ENG|Drug Toxicity [Disease/Finding]|
4976997|ENG|Dumping Syndrome [Disease/Finding]|
4977226|ENG|Dyspepsia [Disease/Finding]|
4978709|ENG|Ear Diseases [Disease/Finding]|
4980114|ENG|Encopresis [Disease/Finding]|
4980358|ENG|Endocrine System Diseases [Disease/Finding]|
4981180|ENG|Eosinophilia [Disease/Finding]|
4982014|ENG|Ergothioneine [Chemical/Ingredient]|
4982645|ENG|Esophageal Diseases [Disease/Finding]|
4984260|ENG|Eye Diseases [Disease/Finding]|
4986674|ENG|Fecal Incontinence [Disease/Finding]|
4988009|ENG|Fistula [Disease/Finding]|
4988894|ENG|Foundational Model of Anatomy Ontology|
4988895|ENG|Foundational Model of Anatomy|
4991795|ENG|Gallbladder Diseases [Disease/Finding]|
4992164|ENG|Gastric disorders|
4992217|ENG|Gastroenteritis [Disease/Finding]|
4992220|ENG|Gastroesophageal Reflux [Disease/Finding]|
4992223|ENG|Gastrointestinal Diseases [Disease/Finding]|
4992224|ENG|Gastrointestinal Hemorrhage [Disease/Finding]|
4992228|ENG|Gastrointestinal diseases|
4997856|ENG|Halitosis [Disease/Finding]|
4998179|ENG|Haloperidol [Chemical/Ingredient]|
4998846|ENG|Heartburn [Disease/Finding]|
4999104|ENG|Hematemesis [Disease/Finding]|
4999114|ENG|Hematologic Diseases [Disease/Finding]|
4999116|ENG|Hematologic diseases|
4999180|ENG|Hemic and Lymphatic Diseases [Disease/Finding]|
4999306|ENG|Hemochromatosis [Disease/Finding]|
4999367|ENG|Hemorrhage [Disease/Finding]|
4999380|ENG|Hemorrhoids [Disease/Finding]|
4999505|ENG|Hepatitis A [Disease/Finding]|
4999547|ENG|Hepatitis B [Disease/Finding]|
4999627|ENG|Hepatitis [Disease/Finding]|
4999659|ENG|Hepatolenticular Degeneration [Disease/Finding]|
4999869|ENG|Hernia [Disease/Finding]|
4999870|ENG|Hernia, Abdominal [Disease/Finding]|
4999874|ENG|Hernia, Hiatal [Disease/Finding]|
5000362|ENG|Hiccup [Disease/Finding]|
5002471|ENG|Hyperphagia [Disease/Finding]|
5002979|ENG|IFOSFAMIDE 1GM/VIL/MESNA 1GM/AMP PKG INJ [VA Product]|
5002980|ENG|IFOSFAMIDE 1GM/VIL/MESNA 200MG/AMP PKG INJ [VA Product]|
5002984|ENG|IFOSFAMIDE 3GM/VIL/MESNA 1GM/AMP PKG INJ [VA Product]|
5002985|ENG|IFOSFAMIDE 3GM/VIL/MESNA 400MG/AMP PKG INJ [VA Product]|
5004852|ENG|Immune System Diseases [Disease/Finding]|
5004899|ENG|Immunologic Deficiency Syndromes [Disease/Finding]|
5005545|ENG|Increased Renal Organic Ion Excretion [PE]|
5005757|ENG|Indinavir [Chemical/Ingredient]|
5005808|ENG|Indolizines [Chemical/Ingredient]|
5007431|ENG|Intestinal Diseases [Disease/Finding]|
5007438|ENG|Intestinal Obstruction [Disease/Finding]|
5007848|ENG|Iron overload disease|
5007872|ENG|Irritable Bowel Syndrome [Disease/Finding]|
5008108|ENG|Isonicotinic Acids [Chemical/Ingredient]|
5008587|ENG|Jaundice [Disease/Finding]|
5008658|ENG|Joint Diseases [Disease/Finding]|
5012744|ENG|Lactose Intolerance [Disease/Finding]|
501915|ENG|Adenopathy|
501926|ENG|ADENOPATHY|
5020545|ENG|Liver Cirrhosis [Disease/Finding]|
5020549|ENG|Liver Diseases [Disease/Finding]|
5022647|ENG|Lymphatic Diseases [Disease/Finding]|
5023200|ENG|M [Preparations]|
5024020|ENG|MESNA 100MG/ML INJ [VA Product]|
5024021|ENG|MESNA 400MG TAB [VA Product]|
5025400|ENG|MPTP Poisoning [Disease/Finding]|
5026373|ENG|Malabsorption Syndromes [Disease/Finding]|
5027183|ENG|Marine Toxins [Chemical/Ingredient]|
5028897|ENG|Melena [Disease/Finding]|
5029165|ENG|Mental Disorders Diagnosed in Childhood [Disease/Finding]|
5029167|ENG|Mental Disorders and Manifestations [Disease/Finding]|
5029278|ENG|Mercaptoethanol [Chemical/Ingredient]|
5029279|ENG|Mercaptoethylamines [Chemical/Ingredient]|
5029433|ENG|Mesna [Chemical/Ingredient]|
5029675|ENG|Mesylates [Chemical/Ingredient]|
5029686|ENG|Metabolic Diseases [Disease/Finding]|
5029911|ENG|Methimazole [Chemical/Ingredient]|
5030282|ENG|Metyrapone [Chemical/Ingredient]|
5031472|ENG|Milk intolerance|
5032346|ENG|Mouth Diseases [Disease/Finding]|
5033273|ENG|Musculoskeletal Diseases [Disease/Finding]|
5037281|ENG|Naphthylvinylpyridine [Chemical/Ingredient]|
5038210|ENG|Neoplasms [Disease/Finding]|
5038241|ENG|Neoplastic Syndromes, Hereditary [Disease/Finding]|
5039404|ENG|Nervous System Diseases [Disease/Finding]|
5040335|ENG|Nevirapine [Chemical/Ingredient]|
5040452|ENG|Nicotine [Chemical/Ingredient]|
5040454|ENG|Nicotinic Acids [Chemical/Ingredient]|
5040457|ENG|Nicotinyl Alcohol [Chemical/Ingredient]|
5041458|ENG|Nonodontogenic Cysts [Disease/Finding]|
5041548|ENG|Norovirus Infections|
504224|ENG|mortality|
5043010|ENG|Nutrition Disorders [Disease/Finding]|
5043012|ENG|Nutritional and Metabolic Diseases [Disease/Finding]|
5044122|ENG|Occupational Diseases [Disease/Finding]|
50445|ENG|Gut pain|
5045525|ENG|Oral Manifestations [Disease/Finding]|
5046545|ENG|Otorhinolaryngologic Diseases [Disease/Finding]|
5046707|ENG|Oxidopamine [Chemical/Ingredient]|
5051692|ENG|Pain [Disease/Finding]|
5051915|ENG|Pancreatic Diseases [Disease/Finding]|
5051961|ENG|Pancreatitis [Disease/Finding]|
5052094|ENG|Pantetheine [Chemical/Ingredient]|
5052853|ENG|Paraquat [Chemical/Ingredient]|
5052882|ENG|Parasitic Diseases [Disease/Finding]|
5054013|ENG|Pathological Conditions, Signs and Symptoms [Disease/Finding]|
5054524|ENG|Pelvic Pain [Disease/Finding]|
5054950|ENG|Peptic Ulcer [Disease/Finding]|
5055620|ENG|Peripheral Nervous System Diseases [Disease/Finding]|
5055682|ENG|Peritoneal Diseases [Disease/Finding]|
5055711|ENG|Peritonitis [Disease/Finding]|
5056522|ENG|Pheniramine [Chemical/Ingredient]|
5057118|ENG|Phosphatidylcholines [Chemical/Ingredient]|
5058269|ENG|Picolines [Chemical/Ingredient]|
5058270|ENG|Picolinic Acids [Chemical/Ingredient]|
5061009|ENG|Polyvinylpyridine N-Oxide [Chemical/Ingredient]|
5061306|ENG|Porphyrias [Disease/Finding]|
5061448|ENG|Postcholecystectomy Syndrome [Disease/Finding]|
5067483|ENG|Pyridines [Chemical/Ingredient]|
5067484|ENG|Pyridinium Compounds [Chemical/Ingredient]|
5067491|ENG|Pyridones [Chemical/Ingredient]|
5067524|ENG|Pyrithioxin [Chemical/Ingredient]|
5067959|ENG|Quinolinic Acids [Chemical/Ingredient]|
5068915|ENG|Raclopride [Chemical/Ingredient]|
5070528|ENG|Rectal Diseases [Disease/Finding]|
5071414|ENG|Respiration Disorders [Disease/Finding]|
5071438|ENG|Respiratory Tract Diseases [Disease/Finding]|
507336|ENG|1,7-Dihydro-6H-purine-6-thione|
507596|ENG|Mouse Digestive System Disorder|
5077640|ENG|S-Nitrosothiols [Chemical/Ingredient]|
5078036|ENG|SACROSIDASE 8500 UNT/ML SOLN,ORAL [VA Product]|
5078037|ENG|SACROSIDASE 8500 UNT/ML SOLN|
508378|ENG|Mouth and Tooth Diseases|
5083793|ENG|Serum Albumin, Radio-Iodinated [Chemical/Ingredient]|
508427|ENG|Mouth cyst|
508428|ENG|Mouth Cyst|
508435|ENG|mouth disease|
508437|ENG|Mouth Disease|
508438|ENG|Mouth Diseases|
508439|ENG|Mouth disorder|
508440|ENG|Mouth Disorders|
5085466|ENG|Signs and Symptoms [Disease/Finding]|
508571|ENG|Mouth Rehabilitation|
508572|ENG|Mouth Rehabilitations|
5086214|ENG|Skin Diseases [Disease/Finding]|
5086230|ENG|Skin and Connective Tissue Diseases [Disease/Finding]|
5086663|ENG|Sodium Dodecyl Sulfate [Chemical/Ingredient]|
5086708|ENG|Sodium Tetradecyl Sulfate [Chemical/Ingredient]|
5089408|ENG|Stomach Diseases [Disease/Finding]|
5089417|ENG|Stomatitis, Aphthous [Disease/Finding]|
5089420|ENG|Stomatognathic Diseases [Disease/Finding]|
5091853|ENG|Succimer [Chemical/Ingredient]|
5092227|ENG|Sulfhydryl Compounds [Chemical/Ingredient]|
5094297|ENG|Syndrome [Disease/Finding]|
5094639|ENG|Systema digestorium|
509685|ENG|MP|
5098136|ENG|Taurine [Chemical/Ingredient]|
5099712|ENG|Thiocholine [Chemical/Ingredient]|
5099729|ENG|Thioglycolates [Chemical/Ingredient]|
5099742|ENG|Thiomalates [Chemical/Ingredient]|
510069|ENG|MPP+|
5100702|ENG|Tolperisone [Chemical/Ingredient]|
5102048|ENG|Traumatic injuries|
510299|ENG|MPTP-3-OL|
510304|ENG|MPTP|
5103084|ENG|Triprolidine [Chemical/Ingredient]|
510310|ENG|MPTP Induced Parkinsonism|
510311|ENG|MPTP-induced parkinsonism|
510312|ENG|MPTP-Induced Parkinsonism|
510315|ENG|MPTP - Methylphenyltetrahydropyridine-induced parkinsonism|
510316|ENG|MPTP Neurotoxicity Syndrome|
510317|ENG|MPTP Neurotoxicity Syndromes|
510318|ENG|MPTP-N-oxide|
510319|ENG|MPTP Poisoning|
5103279|ENG|Tropicamide [Chemical/Ingredient]|
5107890|ENG|Urologic Diseases [Disease/Finding]|
5111810|ENG|Virus Diseases [Disease/Finding]|
5111900|ENG|Vitamin B 6 [Chemical/Ingredient]|
5113602|ENG|Wounds and Injuries [Disease/Finding]|
511773|ENG|MSA|
512083|ENG|MSH|
5128449|ENG|eszopiclone [Chemical/Ingredient]|
513191|ENG|MT|
513267|ENG|MTH|
513312|ENG|MTHHH|
513314|ENG|MTHICD9|
513334|ENG|MTHMST|
514523|ENG|Mucocedyl|
514765|ENG|Mucofluid|
514828|ENG|Mucolator|
514829|ENG|Mucolene|
514887|ENG|Mucolyticum|
514900|ENG|Mucomyst|
5150402|ENG|{10 (Ifosfamide 50 MG/ML Injectable Solution) / 10 (Mesna 100 MG/ML Injectable Solution) } Pack|
5150444|ENG|{2 (Ifosfamide 50 MG/ML Injectable Solution) / 6 (Mesna 100 MG/ML Injectable Solution) } Pack|
5150541|ENG|{5 (Ifosfamide 50 MG/ML Injectable Solution) / 3 (Mesna 100 MG/ML Injectable Solution) } Pack|
5150901|ENG|AZITHROMYCIN 250MG TAB PKT 6|
5150937|ENG|BISACODYL 5MG EC TAB UD|
5151396|ENG|Eosinophilic Disorders|
5151802|ENG|Skin Conditions|
5151842|ENG|ICD-O-3|
5151843|ENG|RadLex|
5152577|ENG|Cancer Therapy Evaluation Program, 2004|
5152581|ENG|Mitelman Database of Chromosome Aberrations in Cancer, 2005_12|
5152582|ENG|MGED Ontology, 131|
5153402|ENG|1H-Indene-1,3(2h)-Dione, 5,6-Dimethyl-2-Nitro-, Ion(1-)|
5153428|ENG|2-(1-(2-(2-(Dimethylamino)Ethyl)Inden-3-yl)Ethyl)Pyridine|
5154006|ENG|DIMETHINDENE|
5154643|ENG|Meso 2, 3-Dimercaptosuccinic Acid|
5154700|ENG|N,N-Dimethyl-3-(1-(2-Pyridinyl)Ethyl)-1H-Indene-2-Ethanamine|
5155252|ENG|TOLPERISONE|
5155894|ENG|Musculoskeletal System Finding|
515590|ENG|Muco Sanigen|
5156696|ENG|PACK|
5156906|ENG|Shimada Classification System|
5157161|ENG|Myochosis|
5157456|ENG|VeIP regimen|
5157457|ENG|Velban-ifosfamide-mesna-cisplatin regimen|
5158593|ENG|Oral Tab|
5159606|ENG|Pack dose form|
5160681|ENG|International Classification of Diseases, Ninth Revision, Clinical Modification|
5160683|ENG|International Classification of Diseases, Tenth Revision|
5160798|ENG|Liver Transplant|
516144|ENG|Mucosolvin|
516163|ENG|Mucous Colitides|
516164|ENG|mucous colitis|
516165|ENG|Mucous colitis|
516166|ENG|Mucous Colitis|
516367|ENG|Mucret|
5166206|ENG|SCH-23390|
5166209|ENG|SCH23390|
5173646|ENG|Melaena due to gastrointestinal haemorrhage|
517594|ENG|Multi-level CCS|
5179505|ENG|ALOE VERA CREAM,TOP|
5179506|ENG|ALOE VERA TOP CREAM|
520532|ENG|Multisystem disorder (disorder)|
520535|ENG|Multisystem disorder|
520550|ENG|Multisystem disorders|
5213906|ENG|Dipalmitoylphosphatidylcholine [Mass/volume] in Serum|
5238820|ENG|HCPCS Hierarchical Terms (UMLS)|
5243066|ENG|ICD-10-PCS|
5243069|ENG|ICD10PCS|
5243075|ENG|IFOSFAMIDE 1GM/VIL/MESNA 1GM/AMP PKG INJ_#1|
5243076|ENG|IFOSFAMIDE 1GM/VIL/MESNA 1GM/AMP PKG INJ_#2|
527158|ENG|musculoskeletal and connective tissue disorder|
527161|ENG|Musculoskeletal and connective tissue disorders|
527209|ENG|Musculoskeletal Disease|
527211|ENG|Musculoskeletal Diseases|
527213|ENG|musculoskeletal disorder|
527215|ENG|Musculoskeletal disorder|
527218|ENG|Musculoskeletal disorder NOS|
527241|ENG|Musculoskeletal finding|
527242|ENG|Musculoskeletal finding (finding)|
527290|ENG|Musculoskeletal observation|
527427|ENG|MUSCULOSKELETAL SYSTEM|
527446|ENG|Musculoskeletal system observation|
533064|ENG|Mydral|
533071|ENG|Mydriacyl|
54196|ENG|Haematemesis|
54314|ENG|Haematological disorders|
54322|ENG|Haematologic disease|
544369|ENG|NAC|
544453|ENG|N-acetyl-3-mercaptoalanine|
544707|ENG|N Acetylcysteine|
544708|ENG|N-acetylcysteine|
544709|ENG|N-Acetyl Cysteine|
544710|ENG|N-Acetylcysteine|
54522|ENG|Haematopoietic system syndrome|
545300|ENG|N Acetyl L cysteine|
545301|ENG|N-acetyl-L-cysteine|
545303|ENG|N-Acetyl-L-cysteine|
545682|ENG|Administrations, Sublingual Drug|
545693|ENG|Administrations, Sublingual|
545748|ENG|Administration, Sublingual Drug|
545759|ENG|Administration, Sublingual|
546255|ENG|NAC Zambon|
54706|ENG|Haemochromatosis|
552073|ENG|Naphthalidine|
552298|ENG|Naphthylvinylpyridine|
552317|ENG|NaPIM protocol|
5535151|ENG|Impairments|
5535253|ENG|BioCarta online maps of molecular pathways, adapted for NCI use|
5535255|ENG|Cancer Research Center of Hawaii Nutrition Terminology|
5535256|ENG|NCI Division of Cancer Prevention Program|
5535257|ENG|Digital Imaging Communications in Medicine|
5535258|ENG|U.S. Food and Drug Administration|
5535259|ENG|Jackson Laboratories Mouse Terminology, adapted for NCI use|
5535260|ENG|NCI Dictionary of Cancer Terms|
5535261|ENG|NCI Health Level 7|
5538037|ENG|PMA2010|
5538043|ENG|Portfolio Management Application, 2010|
5539647|ENG|Disease/diagnosis|
5539649|ENG|Drug/agent combination|
5539650|ENG|Drug/agent|
5539703|ENG|Research activity|
5539852|ENG|Genetic condition|
5539883|ENG|Radlex ontology entity|
5539934|ENG|acute abd|
5540592|ENG|arth|
555789|ENG|National Drug File - Reference Terminology|
5558317|ENG|Developmental Disorder|
555838|ENG|National Institute of Child Health and Human Development|
5558498|ENG|Inherited Disease|
555857|ENG|National Library of Medicine, RxNorm Project|
5558982|ENG|NCPDP Terminology|
5559223|ENG|Pediatric Disease|
5559224|ENG|Pediatric Disorder|
5560583|ENG|Neurodevelopmental Disorder|
5561050|ENG|Class of Trial Agent|
5564582|ENG|Pack Dosage Form|
5565351|ENG|Other concepts|
556679|ENG|Nausea and vomiting (disorder)|
556680|ENG|nausea and vomiting|
556681|ENG|Nausea and vomiting|
5566815|ENG|National Cancer Institute Nature Pathway Interaction Database|
556682|ENG|Nausea and Vomiting|
5566821|ENG|Nature Pathway Interaction Database|
556686|ENG|Nausea and vomiting (R11)|
556692|ENG|Nausea and vomiting symptoms|
556736|ENG|Nausea/vomiting|
556739|ENG|Nausea with vomiting|
5567488|ENG|2-amino-3-sulfanylpropanoic acid|
5567561|ENG|NPO: NanoParticle Ontology for Cancer Nanotechnology Research|
5567562|ENG|NanoParticle Ontology for Cancer Nanotechnology Research|
5568812|ENG|sulfhydryl compound|
5573830|ENG|Bladder Cancer, Gall|
5573831|ENG|Bladder Cancers, Gall|
5574661|ENG|Cancer, Gall Bladder|
5574662|ENG|Cancers, Gall Bladder|
5576341|ENG|Disease, Food-borne|
5576342|ENG|Disease, Foodborne|
5576376|ENG|Diseases, Food-borne|
5576377|ENG|Diseases, Foodborne|
5577510|ENG|Food borne Illnesses|
5577515|ENG|Food-borne Diseases|
5577516|ENG|Food-borne Disease|
5577517|ENG|Food-borne Illnesses|
5577518|ENG|Foodborne Diseases|
5577519|ENG|Foodborne Disease|
5577520|ENG|Foodborne Illnesses|
5577840|ENG|Gall Bladder Cancers|
5577841|ENG|Gall Bladder Cancer|
5579112|ENG|Illnesses, Food-borne|
5579113|ENG|Illnesses, Foodborne|
558533|ENG|NCBI|
558535|ENG|NCBI Taxonomy|
558700|ENG|NCI-C04886|
558717|ENG|NCI-GLOSS|
558741|ENG|NCISEER_1999|
558742|ENG|NCISEER|
558743|ENG|NCI SEER ICD Mappings|
558744|ENG|NCI SEER ICD Neoplasm Code Mappings, 1999|
558745|ENG|NCI SEER ICD Neoplasm Code Mappings|
558750|ENG|NCI Thesaurus|
5596032|ENG|Food borne Diseases|
559684|ENG|NDFRT|
5598226|ENG|Cullen sign|
5598890|ENG|Early satiety (finding)|
5599729|ENG|Felty syndrome|
5608769|ENG|Wilson disease|
5616806|ENG|AZITHROMYCIN 250 mg ORAL TABLET, FILM COATED|
5616935|ENG|Abdmnal pain generalized|
5616941|ENG|Abdmnal pain unspcf site|
5626848|ENG|Anom digestive syst NOS|
5629746|ENG|Arthropathy w nerve dis|
56536|ENG|Haemopoietic disease|
56538|ENG|Haemopoietic disorder|
5658291|ENG|Circulatory disease NOS|
5660965|ENG|Coding sys.original Cancer site|
5660979|ENG|Coding system.original Cancer site|
5661883|ENG|Common variabl immunodef|
56669|ENG|Haemorrhage|
56693|ENG|Haemorrhage gastrointestinal|
566938|ENG|Neo-Fluimucil|
56735|ENG|Haemorrhage NOS|
56751|ENG|Haemorrhage of digestive tract|
5675194|ENG|Digestive neoplasm NOS|
56754|ENG|Haemorrhage of gastrointestinal tract, unspecified|
5675971|ENG|Dis of gallbladder NOS|
5676198|ENG|Disorder of ear NOS|
5677910|ENG|Dysphagia NOS|
56814|ENG|Haemorrhage, unspecified|
5696050|ENG|GI mucositis (ulceratve)|
56968|ENG|Haemorrhoid|
5697112|ENG|Gastroduodenal dis NOS|
5697122|ENG|Gastrointest hemorr NOS|
56984|ENG|Haemorrhoids|
569928|ENG|neoplasia|
569929|ENG|Neoplasia|
57000|ENG|Haemorrhoids without complication|
570099|ENG|Neoplasm, Digestive System|
570112|ENG|neoplasm|
570113|ENG|Neoplasm|
570114|ENG|NEOPLASM|
570250|ENG|Neoplasm (morphologic abnormality)|
570268|ENG|Neoplasm NOS|
570269|ENG|Neoplasm, NOS|
570616|ENG|Neoplasm of digestive system (disorder)|
570617|ENG|Neoplasm of digestive system|
570618|ENG|Neoplasm of digestive tract (disorder)|
570619|ENG|Neoplasm of digestive tract|
5711269|ENG|Humoral immunity def NEC|
5711388|ENG|Hx resp system dis NOS|
5715307|ENG|Immune mechanism dis NOS|
5715320|ENG|Immunity deficiency NOS|
5716244|ENG|Inflamm polyarthrop NOS|
5716688|ENG|Informatics (discipline)|
5718149|ENG|Intest malabsorption NOS|
5718165|ENG|Intestinal disorder NOS|
5718173|ENG|Intestinal obstruct NOS|
5727600|ENG|Leukoplakia oral mucosa|
5731502|ENG|MESNA 100 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [MESNEX]|
5731503|ENG|MESNA 100 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION|
5735640|ENG|Malig neo intestine NOS|
5735646|ENG|Malig neo pancreas NOS|
574029|ENG|Neoplasm of unspecified nature of digestive system|
574043|ENG|Neoplasm of unspecified nature, site unspecified|
574253|ENG|Neoplasms benign, malignant and unspecified (incl cysts and polyps)|
574328|ENG|Neoplasms, Digestive System|
574345|ENG|Neoplasms|
574346|ENG|NEOPLASMS|
574511|ENG|Neoplasms of unspecified nature|
574512|ENG|NEOPLASMS OF UNSPECIFIED NATURE|
574832|ENG|neoplastic growth|
574833|ENG|Neoplastic growth|
574834|ENG|Neoplastic Growth|
574982|ENG|Neoplastic Syndrome, Hereditary|
574983|ENG|Neoplastic Syndromes, Hereditary|
5750353|ENG|Menstrual disorder NEC|
5750674|ENG|Mesnex 100 MG/ML Concentrate for Injectable Solution|
5765237|ENG|Oral lesions|
5765242|ENG|Oral soft tissue dis NEC|
5772588|ENG|Pancreat transplant NOS|
5772594|ENG|Pancreatic disease NOS|
5775712|ENG|Perinat GI sys dis NOS|
577801|ENG|Nerve Disease, Peripheral|
577806|ENG|Nerve Diseases|
577811|ENG|Nerve Diseases, Peripheral|
577889|ENG|nerve gas|
577890|ENG|Nerve gas|
577891|ENG|Nerve gas (substance)|
5781503|ENG|Poison-medicinal agt NOS|
578707|ENG|Nervous colitis|
578766|ENG|Nervous system and sense organ diseases (disorder)|
578767|ENG|Nervous system and sense organ diseases|
578829|ENG|Nervous system disease|
578830|ENG|Nervous System Disease|
578834|ENG|Nervous System Diseases|
578852|ENG|nervous system disorder|
578854|ENG|Nervous system disorder|
578855|ENG|Nervous System Disorder|
578858|ENG|Nervous system disorder NOS|
578862|ENG|Nervous system disorders|
578863|ENG|Nervous System Disorders|
579629|ENG|N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide|
579712|ENG|N-Ethyl-N-(4-pyridylmethyl)tropamide|
5797508|ENG|Resp system disease NOS|
579946|ENG|N-ET-MO-MPTP|
5807124|ENG|Sequence number central.patient Cancer|
5808764|ENG|Site coding system.current Cancer site|
5808943|ENG|Skin conditions|
5819348|ENG|Swallowing difficulties (dysphagia)|
582126|ENG|Neurogenic Arthropathies|
582128|ENG|Neurogenic Arthropathy|
582206|ENG|NEUROGENIC OSTEOARTHROPATHY <CHARCOT JOINTS>|
582299|ENG|Neurohepatic degeneration|
582300|ENG|Neurohepatic Degeneration|
582301|ENG|Neurohepatic Degenerations|
582599|ENG|neurological disease|
582605|ENG|Neurological disorder|
582606|ENG|Neurological Disorder|
582614|ENG|Neurological disorder NOS|
582618|ENG|Neurological Disorders|
582798|ENG|Neurologic Diseases|
582800|ENG|Neurologic Disorder|
582806|ENG|neurologic disorders|
582807|ENG|Neurologic Disorders|
58304|ENG|Haldol|
5831474|ENG|Urinary tract dis NOS|
583849|ENG|Neuropathic arthropathy|
583874|ENG|NEUROPATHIC JOINT|
58415|ENG|Half Cystine|
584168|ENG|Neuropathy peripheral|
584169|ENG|Neuropathy, Peripheral|
58417|ENG|Half-Cystine|
584171|ENG|NEUROPATHY PERIPHERAL|
585116|ENG|Neurotoxicity Syndrome, MPTP|
585122|ENG|Neurotoxicity Syndromes, MPTP|
585153|ENG|neurotoxin|
585154|ENG|Neurotoxin|
585176|ENG|neurotoxins|
585177|ENG|Neurotoxins|
585179|ENG|Neurotoxin (substance)|
586531|ENG|nevirapine|
586532|ENG|Nevirapine|
586533|ENG|NEVIRAPINE|
586542|ENG|Nevirapine (product)|
586545|ENG|Nevirapine (substance)|
5867566|ENG|{10 vials 20 ML (Ifosfamide 50 MG/ML Injectable Solution) / 10 vials 10 ML (Mesna 20 MG/ML (concentrate 100 MG/ML) Injectable Solution) } Kit|
5867593|ENG|{2 vials 60 ML (Ifosfamide 50 MG/ML Injectable Solution) / 6 vials 10 ML (Mesna 20 MG/ML (concentrate 100 MG/ML) Injectable Solution) } Kit|
5867658|ENG|{5 vials 20 ML (Ifosfamide 50 MG/ML Injectable Solution) / 3 vials 10 ML (Mesna 20 MG/ML (concentrate 100 MG/ML) Injectable Solution) } Kit|
5867894|ENG|AZITHROMYCIN ANHYDROUS 250 mg ORAL TABLET, FILM COATED|
5868034|ENG|Postcholecystectomy synd|
5868336|ENG|Hypogammaglobulinem NOS|
5868467|ENG|Arthropathy NOS-unspec|
5868734|ENG|Joint dis NOS-unspec jt|
5868846|ENG|Blood disease NOS|
5869373|ENG|Cns disorder NOS|
5869431|ENG|Mal neo esophagus NOS|
5869456|ENG|Malignant neo liver NOS|
5869578|ENG|Metabolism disorder NOS|
5869812|ENG|Dis of biliary tract NOS|
5869813|ENG|Dis porphyrin metabolism|
5869826|ENG|Disorder of globe NOS|
5871316|ENG|Gastrointestinal Bariatric Surgery|
5871644|ENG|NCPDP|
5871663|ENG|National Council for Prescription Drug Programs|
587255|ENG|New growth|
5874407|ENG|BRIDG|
5874477|ENG|Biomedical Research Integrated Domain Group Model|
5877407|ENG|VeIP|
5877586|ENG|bile duct cancer|
5877699|ENG|condition|
5877933|ENG|inherited cancer syndrome|
5877975|ENG|levels of evidence|
5878047|ENG|mucus colitis|
5878279|ENG|secrete|
5878431|ENG|thoracalgia|
5878433|ENG|thoracodynia|
5881754|ENG|abdominopelvic region|
5881755|ENG|abdominopelvis|
5881851|ENG|alimentary system|
5885257|ENG|metabolic disease|
5885714|ENG|neurological disorder|
5887284|ENG|secretory|
588744|ENG|NG - Neoplastic growth|
588745|ENG|NG - New growth|
58903|ENG|Halitoses|
58905|ENG|halitosis|
58907|ENG|Halitosis|
58908|ENG|HALITOSIS|
5891876|ENG|Acquired Hypogammaglobulinemia|
5894083|ENG|Cancer, Hepatocellular|
5894087|ENG|Cancers, Hepatocellular|
5894922|ENG|Cleft larynx, posterior|
5895043|ENG|Common Variable Hypogammaglobulinemias|
5895044|ENG|Common Variable Hypogammaglobulinemia|
5895907|ENG|Derivatives, Thienopyridine|
5898256|ENG|Hepatocellular Cancers|
5898257|ENG|Hepatocellular Cancer|
5898622|ENG|Hypogammaglobulinemia, Common Variable|
5898624|ENG|Hypogammaglobulinemias, Common Variable|
5899715|ENG|Laryngotracheoesophageal cleft pulmonary hypoplasia|
5900131|ENG|MIZE protocol|
5901800|ENG|Novak syndrome|
590502|ENG|NIC|
590591|ENG|NICHD|
5906207|ENG|Thienopyridine Derivatives|
5906322|ENG|Topical Descriptor|
5906860|ENG|Variable Hypogammaglobulinemia, Common|
5906861|ENG|Variable Hypogammaglobulinemias, Common|
5915281|ENG|1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R|
591780|ENG|Nicotine agent|
591783|ENG|Nicotine agent (substance)|
5917959|ENG|ALOE VERA CREAM,TOP [VA Product]|
591825|ENG|(-)-Nicotine|
591827|ENG|nicotine|
591828|ENG|Nicotine|
591829|ENG|NICOTINE|
591835|ENG|nicotine in any form|
591916|ENG|nicotine product|
591917|ENG|Nicotine (product)|
591946|ENG|Nicotine (substance)|
5920792|ENG|AZITHROMYCIN MONOHYDRATE 250 mg ORAL TABLET, FILM COATED_#1|
5920793|ENG|AZITHROMYCIN MONOHYDRATE 250 mg ORAL TABLET, FILM COATED_#2|
5920794|ENG|AZITHROMYCIN MONOHYDRATE 250 mg ORAL TABLET, FILM COATED|
592184|ENG|nicotinic acid|
592232|ENG|Nicotinic Acids|
592243|ENG|Nicotinic Alcohol|
592300|ENG|Nicotinyl alcohol|
592301|ENG|Nicotinyl Alcohol|
592308|ENG|Nicotinyl alcohol (product)|
5932124|ENG|Antidote [TC]|
5962743|ENG|Casanthranol [Chemical/Ingredient]|
5969322|ENG|Cirrhosis (of liver) NOS|
5990897|ENG|Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism|
5991681|ENG|Disorder of peripheral nervous system NOS|
5991686|ENG|Disorder of the skin and subcutaneous tissue, unspecified|
600001|ENG|N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|
600002|ENG|N Methyl 4 phenylpyridine|
600005|ENG|N-Methyl-4-phenylpyridine|
600006|ENG|N-Methyl-4-phenylpyridinium|
6007422|ENG|Esophageal reflux NOS|
6013606|ENG|Fecal incontinence NOS|
6013774|ENG|Felty's syndrome, unspecified site|
6013781|ENG|Female Urogenital Diseases and Pregnancy Complications [Disease/Finding]|
6015350|ENG|Foodborne Diseases [Disease/Finding]|
6028126|ENG|Hemochromatosis NOS|
6033090|ENG|ICD-10-CM TABULAR LIST of DISEASES and INJURIES|
6033091|ENG|ICD-9-CM Entry Terms|
6033096|ENG|ICD10CM|
6035363|ENG|Ifosfamide / Mesna|
6035605|ENG|Immune disease NOS|
6036063|ENG|Incontinence of feces of nonorganic origin|
6039222|ENG|International Classification of Diseases, 10th Edition, Clinical Modification|
6039225|ENG|International Classification of Diseases, Ninth Revision, Clinical Modification, Metathesaurus additional entry terms|
6039876|ENG|Irritable bowel syndrome NOS|
6049361|ENG|Lecithins [Chemical/Ingredient]|
6059697|ENG|Male Urogenital Diseases [Disease/Finding]|
60608|ENG|haloperidol|
60609|ENG|Haloperidol|
60610|ENG|HALOPERIDOL|
6063417|ENG|Mental and behavioral disorders|
60682|ENG|Haloperidol (product)|
60690|ENG|Haloperidol (substance)|
6074270|ENG|Nausea with vomiting, unspecified|
6085618|ENG|Occlusion of colon or intestine NOS|
6088061|ENG|Oral Tablet [Dose Form]|
6089554|ENG|Other abdominal pain|
6096224|ENG|Other specified diseases of the digestive system|
609742|ENG|noninfectious enteritis and colitis|
609743|ENG|NONINFECTIOUS ENTERITIS AND COLITIS|
609750|ENG|Noninfectious gastroenteritis (disorder)|
609751|ENG|Noninfectious gastroenteritis|
609799|ENG|Non-infective enteritis and colitis (disorder)|
609800|ENG|Non-infective enteritis and colitis|
609801|ENG|Noninfective enteritis and colitis|
609806|ENG|Noninfective gastroenteritis and colitis, unspecified|
6102496|ENG|Pack [Dose Form]|
610905|ENG|Nonodontogenic Cyst|
610906|ENG|Nonodontogenic Cysts|
6110493|ENG|Personal history of unspecified disease of respiratory system|
611177|ENG|Non-organic encopresis|
611178|ENG|Nonorganic encopresis|
612332|ENG|Nonspecific chest pain|
612381|ENG|Nonspecific hepatitis|
6126797|ENG|Psychogenic encopresis|
614030|ENG|nontropical sprue|
614032|ENG|Non-tropical sprue|
614033|ENG|Nontropical sprue|
614034|ENG|Nontropical Sprue|
614035|ENG|NONTROPICAL SPRUE|
6141697|ENG|Sacrosidase [Chemical/Ingredient]|
6145193|ENG|Sensory disorders|
6145331|ENG|Seq # central.patient Cancer|
6145736|ENG|Severe abdominal pain (generalized) (with abdominal rigidity)|
6174520|ENG|Unspecified abdominal pain|
6175265|ENG|Unspecified disorder of circulatory system|
6175268|ENG|Unspecified disorder of ear, unspecified ear|
6178990|ENG|Unspecified injury|
6180780|ENG|Unspecified porphyria|
6181973|ENG|Upper abdominal pain, unspecified|
6193564|ENG|azithromycin 250 MG Oral Tablet 6 Count Pack|
6197210|ENG|colfosceril palmitate [Chemical/Ingredient]|
619739|ENG|Norwalk Virus Infections|
6198601|ENG|encopresis NOS|
6200714|ENG|gastroduodenal ulcer NOS|
6201405|ENG|hernia NOS|
62024|ENG|Handicap|
6202711|ENG|intra-abdominal hernia|
620366|ENG|nosology|
6205283|ENG|neoplasm NOS|
6205307|ENG|nervous system disorder NOS|
6205384|ENG|new growth NOS|
6206266|ENG|peptic ulcer NOS|
6211105|ENG|tumor NOS|
6212566|ENG|piles|
6215595|ENG|(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide|
6215649|ENG|11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one|
6215926|ENG|BIRG 0587|
6216104|ENG|Compound J|
6216620|ENG|NVP|
6217320|ENG|CBO2011_02|
6217326|ENG|Clinical Bioinformatics Ontology, 2011_02|
6218229|ENG|CLINICAL SIGNS|
6218278|ENG|Clinical Signs|
6218543|ENG|Familial Neoplastic Syndrome|
6219592|ENG|Blood Disorder|
6220235|ENG|Digestive Disease|
6220471|ENG|Gastrointestinal System Disease|
6220472|ENG|Gastrointestinal System Disorder|
6220473|ENG|Gastrointestinal System Infection|
6220803|ENG|Liver and Intrahepatic Bile Duct Disorder|
6220848|ENG|Malignant Gastrointestinal System Neoplasm|
6221786|ENG|Endocrine System Disorder|
6221831|ENG|Hematological Disorder|
6221921|ENG|Musculoskeletal System Disorder|
6221981|ENG|Pediatric Disease or Disorder|
6222122|ENG|Viral Disorder|
6222637|ENG|Intellectual Product|
6226025|ENG|N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine|
622727|ENG|N-Oxide, Poly-2-vinylpyridine|
622728|ENG|N-Oxide, Polyvinylpyridine|
622803|ENG|AE|
6229481|ENG|dabigatran|
623665|ENG|NPO|
623800|ENG|N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine|
6240576|ENG|Abnormal degeneration|
6245523|ENG|BISACODYL 5 mg ORAL TABLET [TopCare Laxative]|
6245525|ENG|BISACODYL 5 mg ORAL TABLET, COATED [LEADER WOMENS LAXATIVE]|
6245526|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Sunmark womans laxative]|
6245527|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Up and Up womens laxative]|
6245528|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE [Medique Medi-lax]|
6245529|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE [NEW CORRECT]|
6245530|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE|
6245531|ENG|BISACODYL 5 mg ORAL TABLET, SUGAR COATED [P LAX DR]|
6245532|ENG|BISACODYL 5 mg ORAL TABLET, SUGAR COATED [Y LAX DR]|
6247330|ENG|Bisacodyl 5 mg ORAL TABLET|
6253270|ENG|Certain conditions originating in the perinatal period (P00-P96)|
6253271|ENG|Certain disorders involving the immune mechanism (D80-D89)|
6253273|ENG|Certain infectious and parasitic diseases (A00-B99)|
6253376|ENG|Charcôt's joint|
6255297|ENG|Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)|
6255399|ENG|Copper Storage Disease|
6255936|ENG|Cutaneous Disorders|
6258967|ENG|Diseases of appendix (K35-K38)|
6258969|ENG|Diseases of esophagus, stomach and duodenum (K20-K31)|
6258972|ENG|Diseases of liver (K70-K77)|
6258978|ENG|Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)|
6258979|ENG|Diseases of the circulatory system (I00-I99)|
6258981|ENG|Diseases of the ear and mastoid process (H60-H95)|
6258982|ENG|Diseases of the eye and adnexa (H00-H59)|
6258983|ENG|Diseases of the genitourinary system (N00-N99)|
6258984|ENG|Diseases of the musculoskeletal system and connective tissue (M00-M99)|
6258985|ENG|Diseases of the nervous system (G00-G99)|
6258986|ENG|Diseases of the respiratory system (J00-J99)|
6258987|ENG|Diseases of the skin and subcutaneous tissue (L00-L99)|
6259028|ENG|Disorders of gallbladder, biliary tract and pancreas (K80-K87)|
6260850|ENG|Endocrine, nutritional and metabolic diseases (E00-E89)|
6263087|ENG|Factors influencing health status and contact with health services (Z00-Z99)|
6264181|ENG|Foodborne Illness|
6264241|ENG|Foundational Model of Anatomy Ontology, 3_1|
6266003|ENG|Gastric Disorders|
6266258|ENG|Gluten Intolerance|
6268438|ENG|Hematologic Disorders|
6268445|ENG|Hemochromatosis, unspecified|
6268518|ENG|Hepatic Diseases|
6268574|ENG|Hernia (K40-K46)|
6271355|ENG|Inflammatory polyarthropathies (M05-M14)|
6272431|ENG|Intestinal infectious diseases (A00-A09)|
6272641|ENG|Iron Overload Disease|
6284158|ENG|Milk Intolerance|
6286731|ENG|Noninfective enteritis and colitis (K50-K52)|
6292816|ENG|Perioperative Nursing Data Set, 2nd edition|
6292817|ENG|Perioperative Nursing Data Set, 3rd edition, 2011|
6292832|ENG|Peritoneal Disorders|
6300275|ENG|Small Intestine Disorders|
630052|ENG|NU|
6303216|ENG|Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)|
6305308|ENG|Thienopyridines [Chemical/Ingredient]|
6311310|ENG|bisacodyl 10 mg RECTAL SUPPOSITORY [Bisacodyl Laxative]|
6311311|ENG|bisacodyl 10 mg RECTAL SUPPOSITORY [Bisacodyl]|
6313713|ENG|metomidate 1000 mg in 1 g TOPICAL POWDER [Aquacalm]|
631413|ENG|nursing care|
631480|ENG|nursing|
6320695|ENG|Cancer of digestive system|
632131|ENG|Nutritional and Metabolic Diseases|
632222|ENG|Nutritional disease|
632227|ENG|Nutritional disorder (disorder)|
632230|ENG|nutritional disorder|
632232|ENG|Nutritional disorder|
632233|ENG|Nutritional Disorder|
632236|ENG|Nutritional Disorders|
6322929|ENG|Malignant epithelial neoplasm of anus (disorder)|
6322930|ENG|Malignant epithelial neoplasm of anus|
6323021|ENG|Malignant neoplasm of digestive system (disorder)|
6323022|ENG|Malignant neoplasm of digestive system|
6323149|ENG|Medicine allergy|
632457|ENG|nutrition disorder|
632458|ENG|Nutrition Disorder|
632464|ENG|Nutrition Disorders|
6324942|ENG|Carcinoma of anus|
6325332|ENG|3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|
6325355|ENG|4-Chloropheniramine|
6325471|ENG|Allergican|
6325472|ENG|Allergisan|
6325848|ENG|Chloropheniramine|
6325849|ENG|Chlorophenylpyridamine|
6325850|ENG|Chloropiril|
6327069|ENG|Haynon|
6327070|ENG|Hayon|
6327077|ENG|Histadur|
632802|ENG|N&V - Nausea and vomiting|
632804|ENG|N+V - Nausea and vomiting|
6330618|ENG|OXIDOPAMINE|
6333137|ENG|(R)-(7-Myristoyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphatricosyl)trimethylammonium 4-oxide|
6333968|ENG|London Deauville Criteria Point Scale|
6334465|ENG|11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one|
6334471|ENG|129618-40-2|
6334563|ENG|641530|
6334564|ENG|643732|
6334579|ENG|83905-01-5|
6336556|ENG|NPO2011_12_08|
6336557|ENG|NPO: NanoParticle Ontology for Cancer Nanotechnology Research, 2011_12_08|
6337467|ENG|AZITHROMYCIN, UNSPECIFIED FORM|
6340574|ENG|Sign or Symptom|
6340575|ENG|Signs or Symptoms|
6341245|ENG|1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE|
6341247|ENG|1,2-dimyristoyl-sn-glycero-3-phosphocholine|
6341747|ENG|DMPC, L-|
6341748|ENG|DMPC, R-|
6345027|ENG|1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism (disorder)|
6345028|ENG|1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism|
6346382|ENG|Irritable bowel syndrome (disorder)|
6347749|ENG|World Health Organization tumor classification (observable entity)|
6347752|ENG|World Health Organization tumor classification|
6350989|ENG|CLINICAL FINDING|
6351211|ENG|INRG Classification System|
6351228|ENG|International Neuroblastoma Risk Group Classification System|
6351375|ENG|Neuroblastoma Risk Group|
6353562|ENG|Acid Reflux, Gastric|
6356757|ENG|Gastric Acid Reflux Disease|
6356758|ENG|Gastric Acid Reflux|
6357841|ENG|Illnesse, Occupational|
6357842|ENG|Illnesses, Occupational|
6359853|ENG|Occupational Illnesses|
6359854|ENG|Occupational Illnesse|
6361086|ENG|Reflux, Gastric Acid|
636506|ENG|Observation of hiccoughs|
6370323|ENG|AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED [Azithromycin Dihydrate]|
638302|ENG|Obstruction bowel|
638430|ENG|Obstruction intestinal|
638431|ENG|Obstruction, Intestinal|
638493|ENG|Obstruction of intestine|
638496|ENG|Obstruction of intestine or colon|
638753|ENG|OBSTRUCTIVE UROPATHY|
6390141|ENG|BISACODYL 10 mg RECTAL SUPPOSITORY|
6390142|ENG|BISACODYL 5 mg ORAL TABLET [Gentle Laxative]|
6390143|ENG|BISACODYL 5 mg ORAL TABLET [Laxative]|
6390144|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Womens Laxative]|
6390145|ENG|BISACODYL 5 mg ORAL TABLET, COATED|
6390147|ENG|BISACODYL 5 mg ORAL TABLET|
639777|ENG|Occlusion of intestine or colon|
640465|ENG|occupational disease/disorder|
640466|ENG|occupational disease|
640467|ENG|Occupational Disease|
640468|ENG|Occupational Diseases|
640469|ENG|Occupational disorder (disorder)|
640471|ENG|occupational disorder|
640472|ENG|Occupational disorder|
6407|ENG|Glossary of Clinical Epidemiologic Terms|
6408|ENG|Glossary of Methodologic Terms for Clinical Epidemiologic Studies of Human Disorders, 1992|
6409|ENG|Glossary of Methodologic Terms for Clinical Epidemiologic Studies of Human Disorders|
643794|ENG|oculopathy|
644685|ENG|Odor breath|
644765|ENG|Odour breath|
644834|ENG|Odynophagia|
644835|ENG|ODYNOPHAGIA|
646227|ENG|O/E-hernia-cough impulse shown|
647888|ENG|Oesophageal cancer|
647890|ENG|Oesophageal cancer NOS|
647921|ENG|Oesophageal discomfort|
647922|ENG|Oesophageal disease NOS|
647923|ENG|Oesophageal disorder NOS|
647946|ENG|Oesophageal hiatal hernia|
647949|ENG|Oesophageal hiatus hernia|
647987|ENG|Oesophageal neoplasms malignant|
648010|ENG|Oesophageal reflux|
648106|ENG|Oesophageal, stomach and duodenal diseases|
6495090|ENG|IMMUNODEFICIENCY, COMMON VARIABLE|
650394|ENG|Oil, Castor|
65203|ENG|HAV|
652044|ENG|Oleum ricini|
6547004|ENG|MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS|
655549|ENG|OMIM|
660150|ENG|Online Mendelian Inheritance in Man|
660151|ENG|Online Mendelian Inheritance In Man|
6626639|ENG|Universal Medical Device Nomenclature System|
6664025|ENG|{1 (Bisacodyl 10 MG Rectal Suppository) / 4 (Bisacodyl 5 MG Enteric Coated Tablet) } Pack|
6665681|ENG|Drug Product|
6665879|ENG|NCIt|
6666294|ENG|Gall bladder carcinoma (adeno)|
6666939|ENG|CTEP-SDC|
6666941|ENG|Cancer Therapy Evaluation Program - Simple Disease Classification|
6667046|ENG|CIP System|
6667051|ENG|Cahn-Ingold-Prelog Priority System|
6667149|ENG|Controlled Terminology|
6667186|ENG|Digestive System Finding|
6667198|ENG|Disorder of Digestive System|
6667204|ENG|Disorder of Immune System|
6667208|ENG|Disorder of Musculoskeletal System|
6667209|ENG|Disorder of Nervous System|
6667211|ENG|Disorder of Peripheral Nervous System|
6667213|ENG|Disorder of Reproductive System|
6667214|ENG|Disorder of Respiratory System|
6667216|ENG|Disorder of Skin|
6667219|ENG|Disorder of Urinary System|
6667677|ENG|Neoplastic Disease|
6667793|ENG|Primary Immune Deficiency Disorder|
6667959|ENG|Traumatic Injury|
6668066|ENG|Disorder of Endocrine System|
6668137|ENG|Abdominal disorder|
6668629|ENG|ISO3166-2_2012|
6668632|ENG|International Organization for Standardization 3166-2, 2012|
6668633|ENG|International Organization for Standardization 3166-2|
6674065|ENG|Poisoning by drug or medicinal substance|
6676220|ENG|Bruxism (grinding teeth)|
6680385|ENG|AE-AZ|
6680639|ENG|Abū Z̧aby|
6695996|ENG|Hepatic cancer|
6696057|ENG|Intestinal calcification|
6696545|ENG|CAHN-INGOLD-PRELOG PRIORITY SYSTEM|
6697086|ENG|Lauren Classification|
6697867|ENG|Clinical Classification for Oncology|
6698469|ENG|Tumor Regression Grade|
6701443|ENG|(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy]-1-oxa-6-azacyclopentade|
6701480|ENG|(R)-2-Amino-3-sulfanyl-propanoic acid|
6701576|ENG|3-(Alpha-(2'-Pyridyl)Ethyl)-2-(Beta-Dimethylaminoethyl)Indene|
670955|ENG|Ophthalmological disorder|
671072|ENG|Ophthalmopathy NOS|
6712742|ENG|1,2-dipalmitoyl-sn-glycero-3-phosphocholine|
6719671|ENG|Cluster, Symptom|
6719672|ENG|Clusters, Symptom|
6721509|ENG|ETC 642|
6721510|ENG|ETC-642|
6721511|ENG|ETC642|
6723624|ENG|Hernias, Hiatus|
6723649|ENG|Hiatus Hernias|
6723650|ENG|Hiatus Hernia|
672505|ENG|optical communication|
6729979|ENG|Pharmaceutical Products|
6730429|ENG|Products, Pharmaceutical|
673122|ENG|Opticyl|
673214|ENG|AG|
673232|ENG|Optipect Hustengetränk|
6732830|ENG|Symptom Clusters|
6732831|ENG|Symptom Cluster|
6732870|ENG|Syndrome, Felty|
6741749|ENG|Hernia, Hiatus|
674653|ENG|Oral aphthae|
674753|ENG|Oral Cavity Cyst|
674768|ENG|Oral Cavity Disease|
674769|ENG|Oral Cavity Disorder|
674832|ENG|Oral cavity, salivary glands and jaw diseases|
674833|ENG|Oral cavity, salivary glands and jaw diseases (navigational concept)|
674987|ENG|oral disorder|
675337|ENG|Agents, Dopamine|
675348|ENG|Agents, Dopaminergic|
675638|ENG|Oral lesion|
675639|ENG|ORAL LESION|
675674|ENG|Oral Manifestation|
675675|ENG|Oral Manifestations|
6756817|ENG|AZITHROMYCIN ANHYDROUS 250 mg ORAL TABLET, FILM COATED_#1|
6756818|ENG|AZITHROMYCIN ANHYDROUS 250 mg ORAL TABLET, FILM COATED_#2|
6756826|ENG|AZITHROMYCIN MONOHYDRATE 250 mg ORAL TABLET, FILM COATED [Azithromycin]|
675857|ENG|oral pharyngeal disorder|
676066|ENG|Oral Tablet|
676870|ENG|Agents, Protective|
677738|ENG|ordering, sorting|
6796670|ENG|Azithromycin Anhydrous 250 mg ORAL TABLET, FILM COATED|
6798126|ENG|BISACODYL 0.01 g in 2 g RECTAL SUPPOSITORY|
6798127|ENG|BISACODYL 10 mg RECTAL SUPPOSITORY [Laxative]|
6798128|ENG|BISACODYL 10 mg RECTAL SUPPOSITORY [laxative]|
6798129|ENG|BISACODYL 5 mg ORAL TABLET [The Medicine Shoppe Gentle Laxative]|
6798130|ENG|BISACODYL 5 mg ORAL TABLET [gentle laxative for women stimulant laxative]|
6798131|ENG|BISACODYL 5 mg ORAL TABLET [womans laxative]|
6798132|ENG|BISACODYL 5 mg ORAL TABLET [womens laxative]|
6798133|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Best Choice Bisacodyl Laxative]|
6798134|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Bisacody Enteric Coated]|
6798135|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Bisacodyl Enteric Coated]|
6798136|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Bisacodyl Laxative Enteric Coated]|
6798137|ENG|BISACODYL 5 mg ORAL TABLET, COATED [C-Lax Laxative]|
6798138|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Gentle Laxative Enteric Coated]|
6798139|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Gentle Laxative Stimulant Laxative]|
6798140|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Gentle Laxative]|
6798141|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Laxative Enteric Coated]|
6798142|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Laxative]|
6798143|ENG|BISACODYL 5 mg ORAL TABLET, COATED [womens laxative]|
6798146|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE [Enteric Coated Stimulant Laxative]|
6798147|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE [Gentle Laxative]|
6798148|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE [STIMULANT LAXATIVE]|
6804049|ENG|Bad Breath|
680856|ENG|Organ System, Gastrointestinal|
6811339|ENG|Bisacodyl 10 mg RECTAL SUPPOSITORY|
6812351|ENG|Blood Disorders|
6816221|ENG|Breath Odor|
68208|ENG|HBV|
6826660|ENG|C. diff. Infections|
682796|ENG|oropharyngeal disorder|
682802|ENG|OROPHARYNGEAL|
683165|ENG|orphan disease/drug|
687205|ENG|Osteoarthrosis|
6881137|ENG|Data retrieval|
6881968|ENG|Decreased serum immunoglobulins|
689334|ENG|Ostomies|
689400|ENG|ostomy|
689401|ENG|Ostomy|
689636|ENG|agonists|
6896417|ENG|Disorders of Porphyrin Metabolism|
69030|ENG|HCPCS|
690692|ENG|Other and unspecified abdominal pain|
690821|ENG|Other and unspecified diseases of the oral soft tissues|
690899|ENG|Other and unspecified gastrointestinal disorders|
6913334|ENG|ERGOTHIONEINE|
69201|ENG|HCV|
69206|ENG|HCV - Hepatitis C virus|
693229|ENG|Other deficiency of humoral immunity|
693500|ENG|Other diseases digestive system|
693523|ENG|Other diseases of digestive system|
693524|ENG|OTHER DISEASES OF DIGESTIVE SYSTEM|
693533|ENG|Other diseases of intestine|
693534|ENG|OTHER DISEASES OF INTESTINES AND PERITONEUM|
693535|ENG|Other diseases of intestines|
693543|ENG|Other diseases of lip and oral mucosa|
693587|ENG|Other diseases of the digestive system|
693750|ENG|Other disorders of intestine|
693780|ENG|Other disorders of menstruation and other abnormal bleeding from female genital tract|
6942784|ENG|Felty Syndrome [Disease/Finding]|
694861|ENG|Other gastrointestinal disorders|
696327|ENG|OTHER METABOLIC AND IMMUNITY DISORDERS|
6964752|ENG|H. Pylori Infections|
6966739|ENG|HUGO Gene Nomenclature Committee|
6972842|ENG|Healthcare Issues for Children and Teenagers|
6991096|ENG|ICD-10 Dual Coding|
6993436|ENG|Ifosfamide / Mesna Injectable Product|
6994078|ENG|Immune deficiency|
701025|ENG|Other specified diseases of digestive system|
7010954|ENG|L-CYSTEINE|
7041649|ENG|MESNA 100 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Mesna]|
7041651|ENG|MESNA 400 mg ORAL TABLET, FILM COATED [MESNEX]|
7047131|ENG|Malig neoplasm of liver, not specified as primary or sec|
7047235|ENG|Malignant neoplasm of esophagus, unspecified site|
7057813|ENG|Mesna Inhalant Product|
7057814|ENG|Mesna Injectable Product|
7057815|ENG|Mesna Nasal Product|
7057817|ENG|Mesna Oral Product|
7057818|ENG|Mesna Pill|
7057819|ENG|Mesnex Injectable Product|
7057820|ENG|Mesnex Oral Product|
7057821|ENG|Mesnex Pill|
706008|ENG|Other viral infections|
707021|ENG|Otorhinolaryngological Disease|
707022|ENG|Otorhinolaryngological Diseases|
707030|ENG|Otorhinolaryngologic Disease|
707031|ENG|Otorhinolaryngologic Diseases|
707156|ENG|ototoxin|
7083198|ENG|Nervous system diseases|
7094233|ENG|Norwalk virus infections|
709928|ENG|overeating|
709929|ENG|Overeating|
709930|ENG|Overeating (finding)|
709933|ENG|Overeats|
7106054|ENG|OralTablet|
713267|ENG|oxidopamine|
713268|ENG|Oxidopamine|
713804|ENG|AI|
71444|ENG|health and disease|
714782|ENG|Ailmentary System|
71523|ENG|Healthcare Common Procedure Coding System|
7152823|ENG|Pregnancy, childbirth and the puerperium (O00-O9A)|
71604|ENG|Healthcare Information Systems|
7173365|ENG|Rectal Disorders|
717570|ENG|Airbron|
7214514|ENG|Sodium Lauryl Sulphate|
7216087|ENG|Source of Payment Typology, 5|
7216088|ENG|Source of Payment Typology|
723010|ENG|Pack|
723148|ENG|Packs|
723902|ENG|PA|
724872|ENG|Pain abdo|
724880|ENG|Pain abdominal|
724882|ENG|Pain, Abdominal|
724987|ENG|Pain chest|
724988|ENG|Pain, Chest|
725087|ENG|pain|
725088|ENG|Pain|
725089|ENG|PAIN|
725120|ENG|Pain (finding)|
725167|ENG|Painful|
725252|ENG|Painful swallowing|
725397|ENG|Pain in pelvis|
725398|ENG|Pain in pelvis (finding)|
725502|ENG|Pain localized to other parts of lower abdomen|
725505|ENG|Pain localized to upper abdomen|
725573|ENG|Pain NOS|
725578|ENG|Pain observations|
725668|ENG|Pain on swallowing|
725688|ENG|Pain pelvic|
725689|ENG|Pain, Pelvic|
725821|ENG|Pains, Abdominal|
725834|ENG|Pains, Chest|
725907|ENG|Pains, Pelvic|
726107|ENG|Pain, unspecified|
7267084|ENG|Unspecified anomaly of digestive system|
728053|ENG|palmitoylpalmitoleoylphosphatidylcholine|
7291521|ENG|azithromycin dihydrate 250 mg ORAL TABLET, FILM COATED [Zithromax]|
729441|ENG|Pancreas cancer|
729493|ENG|pancreas disorder|
729494|ENG|Pancreas disorder|
729528|ENG|Pancreas|
729557|ENG|pancreas grafting|
729560|ENG|Pancreas Grafting|
729561|ENG|Pancreas Graftings|
729634|ENG|Pancreas neoplasm malignant|
729708|ENG|pancreas transplantation|
729709|ENG|Pancreas Transplantation|
729710|ENG|Pancreas Transplantations|
729712|ENG|Pancreas transplant|
729842|ENG|pancreatic cancer|
729843|ENG|Pancreatic cancer|
729844|ENG|Pancreatic Cancer|
729949|ENG|Pancreatic Disease|
729950|ENG|Pancreatic Diseases|
729953|ENG|pancreatic disorder|
729954|ENG|Pancreatic disorder|
729955|ENG|Pancreatic Disorder|
729956|ENG|Pancreatic disorder NOS|
729960|ENG|Pancreatic disorders (not diabetes)|
730269|ENG|Pancreatic Islets Transplantation|
730271|ENG|pancreatic islet transplantation|
730272|ENG|Pancreatic Islet Transplantation|
730572|ENG|Pancreatic transplant|
730573|ENG|Pancreatic transplant, not otherwise specified|
7306686|ENG|ergothioneine|
730908|ENG|Pancreatitides|
730951|ENG|Pancreatitis (disorder)|
730955|ENG|pancreatitis|
730956|ENG|Pancreatitis|
730957|ENG|PANCREATITIS|
730981|ENG|Pancreatitis NOS|
73178|ENG|heartburn|
73179|ENG|Heartburn|
73180|ENG|HEARTBURN|
73181|ENG|Heartburn (finding)|
73185|ENG|Heartburn (R12)|
73186|ENG|Heartburn symptom|
7325037|ENG|sodium lauryl sulfate|
7325039|ENG|sodium lauryl sulphate|
732567|ENG|Pantetheine|
7334546|ENG|Fixed bowel loop|
7334940|ENG|Hepatic tumour malignant|
7338593|ENG|MGFA Clinical Classification|
7339229|ENG|Myasthenia Classification System|
7339230|ENG|Myasthenia Class|
7339231|ENG|Myasthenia Gravis Foundation of America Clinical Classification|
7341549|ENG|Thyroid or other glandular disorders|
7342249|ENG|Xaluprine|
7342409|ENG|stomach or intestinal disorder|
7343348|ENG|FDA Device Classification|
7343352|ENG|FDADEVCL|
7344468|ENG|Rituximab-Ifosfamide-Carboplatin-Etoposide Regimen|
7345534|ENG|ALTERNATIVE association reference set (foundation metadata concept)|
7345535|ENG|ALTERNATIVE association reference set|
7346318|ENG|CTV3 simple map reference set (foundation metadata concept)|
7346319|ENG|CTV3 simple map reference set|
7346320|ENG|CTV3 simple map|
7346682|ENG|Complication of pregnancy, childbirth and/or the puerperium (disorder)|
7346683|ENG|Complication of pregnancy, childbirth and/or the puerperium|
7346708|ENG|Concept inactivation indicator attribute value reference set (foundation metadata concept)|
7346709|ENG|Concept inactivation indicator attribute value reference set|
7346710|ENG|Concept inactivation indicator reference set|
7347035|ENG|Description format reference set (foundation metadata concept)|
7347036|ENG|Description format reference set|
7347037|ENG|Description format|
7347040|ENG|Description inactivation indicator attribute value reference set (foundation metadata concept)|
7347041|ENG|Description inactivation indicator attribute value reference set|
7347042|ENG|Description inactivation indicator reference set|
7347186|ENG|Disease of the digestive system complicating pregnancy, childbirth and/or the puerperium (disorder)|
7347187|ENG|Disease of the digestive system complicating pregnancy, childbirth and/or the puerperium|
7347431|ENG|Early satiety (fullness)|
7348475|ENG|GB English|
7348555|ENG|Great Britain English language reference set (foundation metadata concept)|
7348556|ENG|Great Britain English language reference set|
7348982|ENG|ICD-10 complex map reference set (foundation metadata concept)|
7348983|ENG|ICD-10 complex map reference set|
7348986|ENG|ICD-10-CM complex map reference set (foundation metadata concept)|
7348987|ENG|ICD-10-CM complex map reference set|
7348990|ENG|ICD-9-CM equivalence complex map reference set (foundation metadata concept)|
7348991|ENG|ICD-9-CM equivalence complex map reference set|
7348993|ENG|ICD-O simple map reference set (foundation metadata concept)|
7348994|ENG|ICD-O simple map reference set|
7350044|ENG|MOVED FROM association reference set (foundation metadata concept)|
7350045|ENG|MOVED FROM association reference set|
7350046|ENG|MOVED TO association reference set (foundation metadata concept)|
7350047|ENG|MOVED TO association reference set|
7350829|ENG|Module dependency reference set (foundation metadata concept)|
7350830|ENG|Module dependency reference set|
7350831|ENG|Module dependency|
7351545|ENG|Oral lesion (finding)|
7351582|ENG|POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)|
7351583|ENG|POSSIBLY EQUIVALENT TO association reference set|
7352273|ENG|REFERS TO concept association reference set (foundation metadata concept)|
7352274|ENG|REFERS TO concept association reference set|
7352275|ENG|REPLACED BY association reference set (foundation metadata concept)|
7352276|ENG|REPLACED BY association reference set|
7352391|ENG|Reference set descriptor reference set (foundation metadata concept)|
7352392|ENG|Reference set descriptor reference set|
7352393|ENG|Reference set descriptor|
7352702|ENG|SAME AS association reference set (foundation metadata concept)|
7352703|ENG|SAME AS association reference set|
7352740|ENG|SNOMED RT ID simple map|
7352741|ENG|SNOMED RT identifier simple map (foundation metadata concept)|
7352742|ENG|SNOMED RT identifier simple map|
7353841|ENG|US English|
7353856|ENG|United States of America English language reference set (foundation metadata concept)|
7353857|ENG|United States of America English language reference set|
7353991|ENG|WAS A association reference set (foundation metadata concept)|
7353992|ENG|WAS A association reference set|
7354430|ENG|GI Bleed|
7354932|ENG|WHO Classification of Tumors|
7354981|ENG|Gastrointestinal Bleed|
7355437|ENG|Gall Bladder Disorder|
7356403|ENG|GI-bleed|
7357093|ENG|anatomic structure|
7359949|ENG|chest pain|
7360029|ENG|clinical finding|
7360184|ENG|congenital agammaglobulinemia|
7360193|ENG|congenital disease|
7360719|ENG|disorder of endocrine system|
7360720|ENG|disorder of immune function|
7360721|ENG|disorder of liver|
7360723|ENG|disorder of peritoneum|
7360724|ENG|disorder of porphyrin metabolism|
7360727|ENG|disorder of reproductive system|
7360728|ENG|disorder of respiratory system|
7363142|ENG|immune function disorder|
7363143|ENG|immunodeficiency disease|
7363144|ENG|immunodeficiency disorder|
7363174|ENG|infection due to virus|
7365944|ENG|liver disease|
7367430|ENG|multisystem disorder|
7368369|ENG|odynophagia|
7368559|ENG|pathophysiologic finding|
7368971|ENG|peritoneum disorder|
7372831|ENG|sinus tract|
7377354|ENG|disorder of nervous system|
7377494|ENG|SNOMED Clinical Terms US Edition|
7377495|ENG|SNOMEDCT_US|
7377496|ENG|US Edition of SNOMED CT|
7379000|ENG|Codes for special purposes|
7380459|ENG|Felty's syndrome; Site unspecified|
7380982|ENG|ICD10, 2010|
7380983|ENG|ICD10_2010|
7381575|ENG|Joint disorder, unspecified; Site unspecified|
7381951|ENG|Malignant neoplasm: Esophagus, unspecified|
7381979|ENG|Malignant neoplasm: Intestinal tract, part unspecified|
7381997|ENG|Malignant neoplasm: Liver, unspecified|
7382035|ENG|Malignant neoplasm: Oesophagus, unspecified|
7382091|ENG|Malignant neoplasm: Pancreas, unspecified|
7382444|ENG|Mental and behavioural disorders|
7386681|ENG|Musculoskeletal degeneration|
7386909|ENG|1,7 dihydro-6H-purine-6-thione monohydrate|
7386966|ENG|3H purine-6-thiol|
7386981|ENG|6 thiohypoxanthine|
7386985|ENG|6-mercaptopurine monohydrate|
7386987|ENG|6-purinethiol|
7386988|ENG|6-thiopurine|
7386989|ENG|6-thioxopurine|
7386990|ENG|603-50-9|
7386999|ENG|6H-purine-6-thione, 1,7-dihydro- (9CI)|
7387001|ENG|7-mercapto-1,3,4,6-tetrazaindene|
7387680|ENG|purine-6-thiol Monohydrate|
7387681|ENG|purine-6-thiol, monohydrate|
7387842|ENG|purine-6-thiol (8CI)|
7388637|ENG|CARELEX|
7389237|ENG|Content Archive Resource Exchange Lexicon|
7392610|ENG|Purixan|
7393447|ENG|Secondary Hypogammaglobulinemia|
7395615|ENG|PI-RADS|
7395618|ENG|PIRADS|
7395728|ENG|Prostate Imaging-Reporting and Data System|
7400347|ENG|Acid, meso-Dimercaptosuccinic|
740070|ENG|Alactasia|
7401298|ENG|Bariatric Surgical Procedures|
7401299|ENG|Bariatric Surgical Procedure|
7401462|ENG|Bronzed Cirrhoses|
7401489|ENG|Butanedioic Acid, 2,3-Dimercapto-, (R*,S*)-Isomer|
7402178|ENG|Chemically Induced Disorders|
7402179|ENG|Chemically-Induced Disorders|
7402180|ENG|Chemically-Induced Disorder|
7402250|ENG|Cirrhoses, Bronzed|
7402251|ENG|Cirrhoses, Pigmentary|
7402252|ENG|Cirrhosis, Bronzed|
7402320|ENG|Common Variable Immune Deficiency|
7402747|ENG|Dairy Product Intolerance|
7403015|ENG|Disease, Von Recklenhausen-Applebaum|
7403036|ENG|Diseases, Von Recklenhausen-Applebaum|
7403050|ENG|Disorder, Chemically-Induced|
7403051|ENG|Disorder, Iron Storage|
7403052|ENG|Disorder, Porphyrin|
7403054|ENG|Disorders, Chemically-Induced|
7403055|ENG|Disorders, Iron Storage|
7403056|ENG|Disorders, Porphyrin|
7404181|ENG|Gene Ontologies|
7404449|ENG|Haemochromatoses|
7404518|ENG|Hemochromatose|
7404535|ENG|Hepatolenticular Degeneration Syndrome|
7404832|ENG|Hypolactasia|
7405152|ENG|Iron Storage Disorders|
7405153|ENG|Iron Storage Disorder|
7406306|ENG|Metabolic Surgeries|
7406307|ENG|Metabolic Surgery|
7406353|ENG|Milk Sugar Intolerance|
7407454|ENG|Ontologies, Gene|
7407460|ENG|Ontology, Gene|
7408025|ENG|Pigmentary Cirrhoses|
7408026|ENG|Pigmentary Cirrhosis|
7408115|ENG|Porphyrin Disorders|
7408116|ENG|Porphyrin Disorder|
7408224|ENG|Procedure, Bariatric Surgical|
7408225|ENG|Procedures, Bariatric Surgical|
740829|ENG|paraquat|
740830|ENG|Paraquat|
740851|ENG|Paraquat (substance)|
7408694|ENG|Recklenhausen-Applebaum Disease, Von|
7408695|ENG|Recklenhausen-Applebaum Diseases, Von|
7409647|ENG|Storage Disorder, Iron|
7409648|ENG|Storage Disorders, Iron|
7409701|ENG|Surgeries, Metabolic|
7409703|ENG|Surgery, Metabolic|
7409705|ENG|Surgical Procedure, Bariatric|
7409706|ENG|Surgical Procedures, Bariatric|
7409818|ENG|Syndrome, Troisier-Hanot-Chauffard|
7409882|ENG|Syndromes, Troisier-Hanot-Chauffard|
7410417|ENG|Troisier Hanot Chauffard Syndrome|
7410418|ENG|Troisier-Hanot-Chauffard Syndromes|
7410419|ENG|Troisier-Hanot-Chauffard Syndrome|
7410800|ENG|Von Recklenhausen Applebaum Disease|
7410801|ENG|Von Recklenhausen-Applebaum Diseases|
7410802|ENG|Von Recklenhausen-Applebaum Disease|
741189|ENG|parasitic disease|
741191|ENG|Parasitic disease|
741193|ENG|Parasitic Disease|
741213|ENG|Parasitic disease NOS|
741219|ENG|Parasitic Diseases|
741405|ENG|Parasitosis|
7415829|ENG|Bronzed Cirrhosis|
7416072|ENG|Cirrhosis, Pigmentary|
7416243|ENG|(Ifosfamide 50 MG/ML Injectable Solution) / (Mesna 100 MG/ML Injectable Solution) Pack Includes 10/10 & 5/3 Kit|
7422627|ENG|AZITHROMYCIN 250MG TAB UD|
7422628|ENG|AZITHROMYCIN 250MG TAB,UD [VA Product]|
7422629|ENG|AZITHROMYCIN 250MG TAB,UD|
7422639|ENG|AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED [Zithromax]_#1|
7422640|ENG|AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED [Zithromax]_#2|
7422641|ENG|AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED [Zithromax]|
7422642|ENG|AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED|
7422653|ENG|AZITHROMYCIN, UNSPECIFIED FORM 250 mg ORAL TABLET, FILM COATED [Zithromax]|
7447107|ENG|BISACODYL 10 mg RECTAL SUPPOSITORY [bisacodyl stimulant laxative]|
7447108|ENG|BISACODYL 10 mg RECTAL SUPPOSITORY [equaline laxative]|
7447109|ENG|BISACODYL 5 mg ORAL TABLET [stimulant laxative enteric coated]|
7447110|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Bisacodyl]|
7447111|ENG|BISACODYL 5 mg ORAL TABLET, COATED [C Lax Laxative]|
7447112|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Gentle and Effective Laxative Enteric Coated]|
7447113|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Laxative for Women]|
7447114|ENG|BISACODYL 5 mg ORAL TABLET, COATED [SIMPEX Bisacodyl laxative]|
7447115|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Stimulant Laxative Enteric Coated]|
7447116|ENG|BISACODYL 5 mg ORAL TABLET, COATED [WOMANS LAXATIVE]|
7447117|ENG|BISACODYL 5 mg ORAL TABLET, COATED [WOMENS GENTLE LAXATIVE]|
7447118|ENG|BISACODYL 5 mg ORAL TABLET, COATED [WOMENS LAXATIVE]|
7447119|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Womens Gentle Laxative]|
7447120|ENG|BISACODYL 5 mg ORAL TABLET, COATED [womans laxative]|
7447121|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE [Bisacodyl Stimulant Laxative]|
744784|ENG|Parkinsonism, MPTP-Induced|
746640|ENG|Part hurts|
7477074|ENG|Chemically-Induced Disorders [Disease/Finding]|
748784|ENG|Parvolex|
751529|ENG|Pathological Conditions, Signs and Symptoms|
751920|ENG|pathology|
751942|ENG|Pathology processes|
751974|ENG|pathophysiology|
753875|ENG|Pattern Recognition, Automated|
753876|ENG|Pattern Recognition/Display/Analysis|
753877|ENG|Pattern Recognition|
755575|ENG|PC|
755819|ENG|PC-MPTP|
7563527|ENG|Injection, mesna, 200 mg|
756630|ENG|PD 147693|
756631|ENG|PD-147693|
757178|ENG|PD|
757527|ENG|PDQ|
757530|ENG|PDQ Information System|
757531|ENG|PDQ (Physician Data Query)|
7578207|ENG|Liver inflammation|
7591538|ENG|Methods aspects|
7594913|ENG|Minimal Standard Terminology (UMLS)|
759945|ENG|pediatric disorder|
762115|ENG|Albumin, Radio-Iodinated Serum|
762126|ENG|Albumin, Radioiodinated Serum|
7629361|ENG|Pharmacokinetic aspects|
763019|ENG|Pelvic and perineal pain|
763020|ENG|Pelvic and perineal pain (finding)|
763422|ENG|Pelvic pain|
763423|ENG|Pelvic Pain|
763424|ENG|PELVIC PAIN|
763427|ENG|Pelvic pain NOS|
763429|ENG|Pelvic Pains|
7671329|ENG|SOdium Lauryl Sulfate|
7680101|ENG|Sodium lauryl Sulfate|
76858|ENG|Helicobacter pylori infection|
76859|ENG|Helicobacter Pylori Infection|
76862|ENG|Helicobacter Pylori Infections|
7708965|ENG|Vaccines Administered|
771245|ENG|Peptic ulceration|
771260|ENG|Peptic ulcer disease|
771261|ENG|Peptic Ulcer Disease|
771262|ENG|PEPTIC ULCER DISEASE|
771263|ENG|Peptic ulcer (disorder)|
771264|ENG|peptic ulcer|
771266|ENG|Peptic ulcer|
771267|ENG|Peptic Ulcer|
771268|ENG|PEPTIC ULCER|
771302|ENG|Peptic Ulcers|
771304|ENG|Peptic ulcer, site unspecified|
771307|ENG|Peptic ulcer syndrome|
7738393|ENG|meso-2,3-dimercaptosuccinic acid|
7754429|ENG|COSTAR_1989-1995|
7754431|ENG|MTHMST_2001|
7754432|ENG|SPN_2003|
7754434|ENG|PNDS_2011|
7754435|ENG|CSP_2006|
7754436|ENG|CST_1995|
7754437|ENG|DXP_1994|
7754438|ENG|ICPC_1993|
7754440|ENG|UWDA_1_7_3|
7754441|ENG|AOD_2000|
7754442|ENG|AOT_2003|
7754445|ENG|QMR_1996|
7754450|ENG|SOP_5|
7754451|ENG|MCM_1992|
7754454|ENG|CCS_2005|
7754457|ENG|FMA_3_1|
7754595|ENG|PDQ_2014_08_29|
7754603|ENG|Physician Data Query, 2014_08_29|
7754836|ENG|vinblastine-ifosfamide-cisplatin regimen|
7755240|ENG|Periumbilical bruising|
7755658|ENG|Bradyphagia|
7755994|ENG|CTRP Agent Terminology|
7755997|ENG|CTRP Terminology|
7756026|ENG|Childhood Disorder|
7756064|ENG|Clinical Trial Reporting Program Agent Terminology|
7756067|ENG|Clinical Trial Reporting Program Terminology|
7756515|ENG|Exposure as Collected Domain|
7757909|ENG|Polyarticular Arthritis|
7759536|ENG|Acid reflux (finding)|
7763697|ENG|Dabigatran (substance)|
776758|ENG|Alcohol and Other Drug Thesaurus, 2000|
776769|ENG|Alcohol and Other Drug Thesaurus|
7767953|ENG|Hereditary cancer-predisposing syndrome (disorder)|
7767954|ENG|Hereditary cancer-predisposing syndrome|
7767965|ENG|Hereditary neoplastic syndrome|
7772638|ENG|Milk intolerance (disorder)|
7773531|ENG|Neurodevelopmental disorder (disorder)|
7776392|ENG|Pyritinol (substance)|
7777096|ENG|Route of administration reference set (foundation metadata concept)|
7777097|ENG|Route of administration reference set|
7777192|ENG|SNOMED CT has been created by combining SNOMED RT and a computer-based nomenclature and classification known as Read Codes Version 3, which was created on behalf of the U.K. Department of Health.|
7779280|ENG|Tolperisone (substance)|
7780153|ENG|Viral hepatitis type B|
7780737|ENG|Viral hepatitis type B (disorder)|
7781329|ENG|Clostridium difficile Infection|
7782988|ENG|{PACK}|
7783001|ENG|{Pack}|
7783618|ENG|C. diff Infection|
7784233|ENG|Digestive System Infection|
7785532|ENG|Pain In Chest|
7785539|ENG|Pathologic Fistula|
7786219|ENG|Teeth Grinding|
778659|ENG|Perinatal digestive system disorders|
778662|ENG|Perinatal digestive system disorder, unspecified|
778670|ENG|Perinatal disorder of digestive system|
778673|ENG|Perinatal disorders of digestive system|
7786752|ENG|Malignant Digestive System Neoplasm|
7788902|ENG|Bio Informatics|
7788903|ENG|Bio-Informatic|
7788904|ENG|Bioinformatic|
7789900|ENG|Curation, Data|
7790094|ENG|Data Curation|
7793615|ENG|Polyphagias|
7798306|ENG|-- Esophageal Cancer|
7798313|ENG|-- Irritable Bowel Syndrome|
7804795|ENG|AZITHROMYCIN DIHYDRATE 250 ORAL TABLET, FILM COATED|
7804796|ENG|AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED_#1|
7804797|ENG|AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED_#2|
7826205|ENG|Bisacodyl 10 MG Delayed Release Oral Tablet|
7826206|ENG|Bisacodyl 10 mg RECTAL SUPPOSITORY [Stratuscare Bisacodyl]|
7826228|ENG|Bisacodyl 5 MG Delayed Release Oral Tablet|
7826229|ENG|Bisacodyl 5 mg ORAL TABLET, COATED [Correctol]|
783128|ENG|Peripancreatic fluid collection|
783609|ENG|Peripheral nerve disease (disorder)|
783610|ENG|Peripheral nerve disease|
783611|ENG|Peripheral Nerve Disease|
783612|ENG|Peripheral Nerve Diseases|
783614|ENG|Peripheral nerve disorder NOS|
783616|ENG|Peripheral Nerve Disorders|
783809|ENG|Peripheral Nervous System Disease|
783812|ENG|Peripheral Nervous System Diseases|
783813|ENG|peripheral nervous system disorder|
783816|ENG|Peripheral Nervous System Disorder|
783820|ENG|Peripheral Nervous System Disorders|
783932|ENG|Peripheral neuropathies|
783933|ENG|Peripheral Neuropathies|
783934|ENG|Peripheral neuropathies NEC|
783940|ENG|peripheral neuropathy|
783941|ENG|Peripheral neuropathy|
783942|ENG|Peripheral Neuropathy|
783943|ENG|PERIPHERAL NEUROPATHY|
783952|ENG|Peripheral neuropathy NOS|
784635|ENG|Peristalsis visible|
784913|ENG|Peritoneal Disease|
784914|ENG|Peritoneal Diseases|
784916|ENG|peritoneal disorder|
784917|ENG|Peritoneal Disorder|
784918|ENG|Peritoneal disorder NOS|
785170|ENG|Alcohol, Nicotinic|
785181|ENG|Alcohol, Nicotinyl|
785267|ENG|Peritonitis (disorder)|
785278|ENG|peritonitis|
785279|ENG|Peritonitis|
785280|ENG|PERITONITIS|
785302|ENG|Peritonitis NOS|
785304|ENG|Peritonitis of undetermined cause|
785305|ENG|Peritonitis of unspecified cause|
785352|ENG|Peritonitis, unspecified|
788113|ENG|personal health|
788872|ENG|personnel|
79065|ENG|Hematemeses|
79071|ENG|Hematemesis (disorder)|
79073|ENG|hematemesis|
79074|ENG|Hematemesis|
79075|ENG|HEMATEMESIS|
79080|ENG|Hematemesis/vomiting blood|
791755|ENG|Pfizer Brand of Azithromycin Dihydrate|
791756|ENG|Pfizer Brand of Azithromycin|
79311|ENG|Hematological Disease|
79313|ENG|Hematological Diseases|
79321|ENG|Hematological disorders|
79356|ENG|Hematologic disease|
79357|ENG|Hematologic Disease|
79358|ENG|Hematologic Diseases|
79360|ENG|Hematologic Disorder|
79362|ENG|HEMATOLOGIC DISORDER|
79395|ENG|HEMATOLOGIC PROBLEM|
79396|ENG|HEMATOLOGIC PROBLEM, NOS|
794472|ENG|Pharmaceutical / biologic product|
794473|ENG|Pharmaceutical / biologic product (product)|
794510|ENG|Pharmaceutical Preparations|
794552|ENG|Pharmaceutic Preparations|
794622|ENG|pharmacokinetics|
794666|ENG|pharmacology|
794686|ENG|pharmacotherapeutic|
794689|ENG|pharmacotherapy|
7957375|ENG|Skin diseases|
797691|ENG|PH|
797902|ENG|pheniramine|
797903|ENG|Pheniramine|
797905|ENG|PHENIRAMINE|
798012|ENG|Pheniramine (product)|
798021|ENG|Pheniramine (substance)|
7980646|ENG|Z-PAK 6 Count Pack|
7982994|ENG|aloe vera 75 % Topical Cream|
7984267|ENG|azithromycin 250 MG Oral Tablet|
7987679|ENG|bisacodyl 5 MG Delayed Release Oral Tablet|
7987680|ENG|bisacodyl 5 MG Enteric Coated Oral Tablet|
799046|ENG|Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester)|
7998145|ENG|hyaluronidase 0.1 % Topical Lotion|
8001175|ENG|mesna 600 MG Oral Tablet|
80020|ENG|Hematopoietic system syndrome|
80045|ENG|Hematoporphyria|
8013390|ENG|{1 (Bisacodyl 10 MG Rectal Suppository) / 4 (Bisacodyl 5 MG Delayed Release Oral Tablet) } Pack|
8013643|ENG|mesna 400 MG Oral Tablet|
8014424|ENG|NDFRT_FDASPL|
8014425|ENG|NDFRT_FMTSME|
8014426|ENG|National Drug File - FDASPL|
8014427|ENG|National Drug File - FMTSME|
8017435|ENG|Gastrointestinal wall thickening|
8017436|ENG|Gastrointestinal wall thinning|
8027044|ENG|Digestive manifestation of classical cystic fibrosis|
8027045|ENG|Digestive system manifestation co-occurrent and due to cystic fibrosis (disorder)|
8027046|ENG|Digestive system manifestation co-occurrent and due to cystic fibrosis|
8027130|ENG|Disorder of digestive system specific to foetus OR newborn|
8033731|ENG|Inflammation of pancreas|
8033760|ENG|Information system (physical object)|
8033763|ENG|Information system|
8048275|ENG|Ulcerative gastrointestinal mucositis (disorder)|
8048276|ENG|Ulcerative gastrointestinal mucositis|
8050200|ENG|© 2002-2015 International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.|
8050454|ENG|HPO|
8051792|ENG|Butanedioic Acid, 2,3-Dimercapto-, (2R,3S)-rel-|
8051801|ENG|C. diff Colitis|
8052255|ENG|Clostridium difficile Colitis|
8052319|ENG|DEGENERATION|
8052352|ENG|Decreased PO Intake|
805336|ENG|1-amino-4-phenyl-1,2,3,6-tetrahydropyridine|
8053504|ENG|Mouse Urological Syndrome (MUS)|
8053743|ENG|Oral Intake Reduced|
80567|ENG|Hemic and Lymphatic Diseases|
8057017|ENG|Cancer of the pancreas|
8057705|ENG|Classic hemochromatosis|
8057843|ENG|Combined variable immune deficiency|
8057845|ENG|Common variable hypogamma-globulinemia|
8057846|ENG|Common variable immune deficiency|
8060118|ENG|Gall bladder cancer|
8060300|ENG|Gluten-induced enteropathy|
8060659|ENG|Hemochromatosis classic|
8061187|ENG|Hypogamma-globulinemia, acquired|
8061972|ENG|Laryngo-tracheo-esophageal cleft - pulmonary hypoplasia|
8063901|ENG|Oral pharyngeal disorders|
8065147|ENG|Rare Diseases Research|
8065314|ENG|Rheumatoid arthritis, splenomegaly and neutropenia|
8065405|ENG|Rumination syndrome|
8066079|ENG|Splenomegaly-neutropenia-rheumatoid arthritis syndrome|
8066394|ENG|Systemic polyarthritis|
8067318|ENG|Cancer of the anus|
8067615|ENG|GARD|
8067616|ENG|GARD_2015_04|
8067618|ENG|Genetic and Rare Diseases Information Center, 2015_04|
8067619|ENG|Genetic and Rare Diseases Information Center|
8068997|ENG|Decreased Oral Intake|
8069064|ENG|Difficulty Swallowing|
8069340|ENG|Familial Tumor Syndrome|
8069831|ENG|Hereditary Tumor Syndrome|
8071120|ENG|Pneumatosis Intestinalis|
8071127|ENG|Poor Oral Intake|
8073135|ENG|ICDO_3_1|
8073138|ENG|International Classification of Disease for Oncology, 3_1|
8073228|ENG|Neoplasms, NOS|
8078803|ENG|CTCAE (Common Terminology Criteria for Adverse Events)|
8080051|ENG|Common Terminology Criteria for Adverse Events (assessment scale)|
8085216|ENG|Inflammatory arthritis of multiple joints|
8089863|ENG|SNOMED Clinical Terms US Edition, September 1, 2015|
8089864|ENG|SNOMED Clinical Terms version: 20150731 [R] (July 2015 Release)|
8089865|ENG|SNOMEDCT_US_2015_09_01 to ICD10CM_2014 Mappings|
8089866|ENG|SNOMEDCT_US_2015_09_01 to ICD10_2010 Mappings|
8089867|ENG|SNOMEDCT_US_2015_09_01 to ICD9CM_2013 Mappings|
8089868|ENG|SNOMEDCT_US_2015_09_01|
8091500|ENG|US Edition of SNOMED CT, 2015_09_01|
8091745|ENG|Urinary system disorder|
8093545|ENG|GENC|
8093546|ENG|Geopolitical Entities, Names, and Codes Standard|
8097206|ENG|232632, BMS|
809812|ENG|Phosphatidylcholine, Dipalmitoyl|
809817|ENG|phosphatidyl choline|
809818|ENG|phosphatidylcholine|
809819|ENG|Phosphatidylcholine|
809820|ENG|PHOSPHATIDYLCHOLINE|
8098377|ENG|73547, CGP|
809842|ENG|Phosphatidylcholines|
809854|ENG|Phosphatidylcholine (substance)|
8099146|ENG|Aloe vera gel|
8099178|ENG|Analyses, System Dynamics|
8099181|ENG|Analysis, System Dynamics|
8099245|ENG|Approach, Systems Oriented|
8099246|ENG|Approach, Systems|
8099248|ENG|Approachs, Systems Oriented|
8099249|ENG|Approachs, Systems|
8100572|ENG|CGP73547|
8101855|ENG|Disorder, Neurodevelopmental|
8101871|ENG|Disorders, Neurodevelopmental|
8101875|ENG|Disorders, Rumination|
8101984|ENG|Dynamics Analyses, System|
8101985|ENG|Dynamics Analysis, System|
8102956|ENG|GLA-AF adjuvant|
8103086|ENG|Gas, Nerve|
8103104|ENG|Gene Ontology, 2015_04_04|
8103376|ENG|HUGO Gene Nomenclature Committee, 2015_03|
8103468|ENG|Healthcare Common Procedure Coding System, 2015|
8104459|ENG|LOINC, 252|
8105203|ENG|MeSH, 2016_2015_08_18|
8105233|ENG|Medical Subject Headings, 2016_2015_08_18|
8105257|ENG|MedlinePlus Health Topics, 20141119|
8105303|ENG|Metathesaurus HCPCS Hierarchical Terms, 2015|
8105847|ENG|NCBI Taxonomy, 2015_03_23|
8106033|ENG|Nerve Gas|
8106043|ENG|Neurodevelopmental Disorders|
8106316|ENG|Online Mendelian Inheritance in Man, 2015_03_18|
8107806|ENG|RxNorm Vocabulary, 15AA_150908F|
8108618|ENG|Sulfate, Atazanavir|
8108716|ENG|System Dynamics Analyses|
8108717|ENG|System Dynamics Analysis|
8108727|ENG|Systems Approachs|
8108728|ENG|Systems Approach|
8108731|ENG|Systems Oriented Approachs|
8108732|ENG|Systems Oriented Approach|
8108733|ENG|Systems Thinkings|
8108734|ENG|Systems Thinking|
8109115|ENG|Thinking, Systems|
8109116|ENG|Thinkings, Systems|
8109424|ENG|UMDNS: product category thesaurus, 2015|
8109605|ENG|Vaccines Administered, 2015_07_27|
811256|ENG|Phosphoglycerides, Choline|
8116501|ENG|6- mercaptopurine|
8120292|ENG|AZITHROMYCIN MONOHYDRATE 250 mg ORAL TABLET|
8120772|ENG|Abnormal joint morphology|
8121379|ENG|Abnormality of skeletal morphology|
8121680|ENG|Abnormality of the gastrointestinal tract|
8121738|ENG|Abnormality of the intestine|
8121748|ENG|Abnormality of the joints|
8121999|ENG|Abnormality of the skeletal system|
8123700|ENG|Acid reflux disease|
8132930|ENG|Anal incontinence|
8134147|ENG|Anomaly of the joints|
8143791|ENG|BISACODYL 10 mg RECTAL SUPPOSITORY [Bisacodyl]|
8143792|ENG|BISACODYL 10 mg in 2000 mg RECTAL SUPPOSITORY [CVS Gentle Laxative]|
8143793|ENG|BISACODYL 10 mg in 2000 mg RECTAL SUPPOSITORY [CVS fast relief laxative]|
8143794|ENG|BISACODYL 10 mg in 2000 mg RECTAL SUPPOSITORY [Leader Gentle Laxative]|
8143795|ENG|BISACODYL 10 mg in 2000 mg RECTAL SUPPOSITORY [Premier Value Bisacodyl Laxative]|
8143796|ENG|BISACODYL 5 mg ORAL TABLET [Laxative Gentle]|
8143797|ENG|BISACODYL 5 mg ORAL TABLET [Laxative Womens]|
8143798|ENG|BISACODYL 5 mg ORAL TABLET [Womens Laxative]|
8143800|ENG|BISACODYL 5 mg ORAL TABLET, COATED [HEALTH SENSE DUCODYL]|
8143801|ENG|BISACODYL 5 mg ORAL TABLET, COATED [Unit Dose Bisacodyl]|
8143802|ENG|BISACODYL 5 mg ORAL TABLET, DELAYED RELEASE [Bisacodyl]|
8143803|ENG|BISACODYL 5 mg ORAL TABLET, SUGAR COATED [Gentle Laxative]|
8143804|ENG|BISACODYL 5 mg ORAL TABLET, SUGAR COATED [Laxative]|
8151114|ENG|Bisacodyl 5 mg ORAL TABLET, COATED [Bisacodyl Enteric Coated]|
81576|ENG|Hemochromatoses|
81584|ENG|Hemochromatosis (disorder)|
81585|ENG|hemochromatosis|
81586|ENG|Hemochromatosis|
81587|ENG|HEMOCHROMATOSIS|
8159207|ENG|CVX_2015_07_27|
816189|ENG|Phylogenies|
816190|ENG|phylogeny|
816191|ENG|Phylogeny|
817003|ENG|1 Aminonaphthalene|
817114|ENG|1-Aminonaphthalene|
817709|ENG|Physician Data Query|
8179043|ENG|Cystitis of the urinary bladder|
8181773|ENG|Decreased immunoglobulin level|
818328|ENG|physiology|
8197759|ENG|Eye disease|
820090|ENG|Picoline Compound|
820093|ENG|Picoline|
820094|ENG|Picolines|
820104|ENG|Picolinic Acids|
8201687|ENG|Functional digestive disorders, NEC in ICD9CM_2014|
8201714|ENG|Functions of the digestive system|
8203167|ENG|GO_2015_04_04|
820399|ENG|PID|
8208747|ENG|HCPCS_2015|
8210024|ENG|HGNC_2015_03|
8210173|ENG|HL7 Vocabulary Version 3.0, 2014_08|
8210176|ENG|HL7V3.0_2014_08|
8210794|ENG|HPO2015_04_20|
821359|ENG|Alimentary system|
821370|ENG|Alimentary System|
821637|ENG|Piles|
821638|ENG|Piles - haemorrhoids|
821639|ENG|Piles - hemorrhoids|
8218071|ENG|Human Phenotype Ontology, 2015_04_20|
8218072|ENG|Human Phenotype Ontology|
8223475|ENG|ICD-10-PCS, 2015|
8223476|ENG|ICD-9-CM, 2014|
8223477|ENG|ICD10CM_2015|
8223478|ENG|ICD10PCS_2015|
8223479|ENG|ICD9CM_2014|
8225551|ENG|Inflammation of the peritoneum|
8226353|ENG|International Classification of Diseases, 10th Edition, Clinical Modification, 2015|
8226354|ENG|International Classification of Diseases, Ninth Revision, Clinical Modification, 2014|
8226355|ENG|International Classification of Diseases, Ninth Revision, Clinical Modification, Metathesaurus additional entry terms, 2014|
8231178|ENG|LNC_2_52|
8239018|ENG|Lymphatic disease|
8239823|ENG|MEDLINEPLUS_2014_11_19|
8240835|ENG|MSH_2016_2015_08_18|
8240905|ENG|MTHCMSFRF_2014|
8240906|ENG|MTHCMSFRF|
8240916|ENG|MTHHH_2015|
8240917|ENG|MTHICD9_2014|
8240918|ENG|MTHSPL_2015_08_28|
8240919|ENG|MTH_2015AB|
8240965|ENG|MULTISYSTEM DISORDER|
8240990|ENG|MVX2015_07_27|
8242503|ENG|Manufacturers of Vaccines, 2015_07_27|
8242504|ENG|Manufacturers of Vaccines|
8245822|ENG|Metathesaurus CMS Formulary Reference File, MTHCMSFRF_2014|
8245823|ENG|Metathesaurus CMS Formulary Reference File|
8245824|ENG|Metathesaurus FDA Structured Product Labels, 2015_08_28|
8253853|ENG|NCBI_2015_03_23|
8253857|ENG|NDFRT_2015_09_07|
8253858|ENG|NDFRT_FDASPL_2015_09_07|
8253859|ENG|NDFRT_FMTSME_2015_09_07|
8254876|ENG|National Drug File - FDASPL, 2015_09_07|
8254877|ENG|National Drug File - FMTSME, 2015_09_07|
8254878|ENG|National Drug File, 2015_09_07|
8256160|ENG|Neoplasia of the pancreas|
825617|ENG|piperidine|
825618|ENG|Piperidine|
8256204|ENG|Neoplasm of the pancreas|
825625|ENG|Piperidine (substance)|
8260325|ENG|OMIM_2015_03_18|
8263610|ENG|Organ abnormality|
826901|ENG|Piritinol|
8269121|ENG|Pancreatic disease|
8275899|ENG|Phenotypic abnormality|
8293678|ENG|RXNORM_2015AA_2015_09_08F|
829421|ENG|PK|
8294706|ENG|Reduced immunoglobulin levels|
830348|ENG|Alkanesulfonates|
8307905|ENG|Skeletal anomalies|
8317643|ENG|Swallowing difficulty|
8330856|ENG|UMD_2015|
8330865|ENG|UMLS Metathesaurus, 2015AB|
8330973|ENG|USP Medicare Model Guidelines, 2014|
8330974|ENG|USP Medicare Model Guidelines|
8330977|ENG|USPMG_2014|
8331852|ENG|Urinary bladder inflammation|
8332252|ENG|VANDF_2015_07_16|
8333496|ENG|Veterans Health Administration National Drug File, 2015_07_16|
833385|ENG|plant disease|
833386|ENG|Plant Disease|
833387|ENG|Plant Diseases|
8342766|ENG|aphthous ulcers|
8344966|ENG|bad breath|
8345223|ENG|bisacodyl 10 MG Enema|
8345224|ENG|bisacodyl 10 MG Rectal Suppository|
8345227|ENG|bisacodyl 10 MG per 30 ML Enema|
8345228|ENG|bisacodyl 10 MG per 30 mL Enema|
8345229|ENG|bisacodyl 5 MG Rectal Suppository|
834526|ENG|Alkylsulfonate Compound|
834537|ENG|alkyl sulfonate|
834560|ENG|Alkyl Sulfonates|
8347030|ENG|dermatopathy|
8347031|ENG|dermopathy|
8357018|ENG|mesna 100 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Mesna]|
8357019|ENG|mesna 100 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION|
8367344|ENG|{6 (Azithromycin 250 MG Oral Tablet [Zithromax]) } Pack [Z-PAK]|
8367887|ENG|Gastrointestinal disease|
8367891|ENG|Genitourinary disease|
8367978|ENG|Peripheral nervous system disease|
8368611|ENG|Gastrointestinal somatic symptom disorder|
8368737|ENG|MDR_19_0|
8368766|ENG|Medical Dictionary for Regulatory Activities Terminology (MedDRA), 19.0|
8368771|ENG|Metabolic surgery|
8369092|ENG|RADLEX_3_13_1|
8369093|ENG|RadLex, 3_13_1|
8369702|ENG|BRIDG_2016_04D|
8369765|ENG|BioC_2016_04D|
8369766|ENG|BioCarta online maps of molecular pathways, adapted for NCI use, 2016_04D|
8369767|ENG|Biomedical Research Integrated Domain Group Model, 2016_04D|
8369884|ENG|CARELEX_2016_04D|
8369918|ENG|CDC_2016_04D|
8369932|ENG|CDISC_2016_04D|
8369984|ENG|CRCH_2016_04D|
8370020|ENG|CTCAE_2016_04D|
8370022|ENG|CTEP-SDC_2016_04D|
8370046|ENG|Cancer Research Center of Hawaii Nutrition Terminology, 2016_04D|
8370047|ENG|Cancer Therapy Evaluation Program - Simple Disease Classification, 2016_04D|
8370192|ENG|Clinical Data Interchange Standards Consortium, 2016_04D|
8370238|ENG|Common Terminology Criteria for Adverse Events, 2016_04D|
8370266|ENG|Content Archive Resource Exchange Lexicon, 2016_04D|
8370303|ENG|DCP_2016_04D|
8370316|ENG|DICOM_2016_04D|
8370344|ENG|DTP_2016_04D|
8370437|ENG|Digital Imaging Communications in Medicine, 2016_04D|
8370890|ENG|FDA_2016_04D|
8371078|ENG|GENC_2016_04D|
8371151|ENG|Geopolitical Entities, Names, and Codes Standard, 2016_04D|
8371726|ENG|ICH_2016_04D|
8371849|ENG|International Conference on Harmonization, 2016_04D|
8371878|ENG|JAX_2016_04D|
8371885|ENG|Jackson Laboratories Mouse Terminology, adapted for NCI use, 2016_04D|
8371900|ENG|KEGG Pathway Database, 2016_04D|
8371901|ENG|KEGG_2016_04D|
8372292|ENG|NCI Developmental Therapeutics Program, 2016_04D|
8372293|ENG|NCI Dictionary of Cancer Terms, 2016_04D|
8372294|ENG|NCI Division of Cancer Prevention Program, 2016_04D|
8372295|ENG|NCI Health Level 7, 2016_04D|
8372296|ENG|NCI-GLOSS_2016_04D|
8372297|ENG|NCI-HL7_2016_04D|
8372300|ENG|NCI_2016_04D|
8372303|ENG|NCPDP_2016_04D|
8372312|ENG|NICHD_2016_04D|
8372365|ENG|National Cancer Institute Nature Pathway Interaction Database, 2016_04D|
8372366|ENG|National Cancer Institute Thesaurus, 2016_04D|
8372367|ENG|National Council for Prescription Drug Programs, 2016_04D|
8372373|ENG|National Institute of Child Health and Human Development, 2016_04D|
8372867|ENG|PID_2016_04D|
8373204|ENG|RENI_2016_04D|
8373270|ENG|Registry Nomenclature Information System, 2016_04D|
8373898|ENG|U.S. Centers for Disease Control and Prevention, 2016_04D|
8373899|ENG|U.S. Food and Drug Administration, 2016_04D|
8373905|ENG|UCUM_2016_04D|
8373935|ENG|Unified Code for Units of Measure, 2016_04D|
8374259|ENG|ZFIN_2016_04D|
8374264|ENG|Zebrafish Model Organism Database, 2016_04D|
840126|ENG|All|
840137|ENG|ALL|
840148|ENG|Allen & Hanburys Brand of Acetylcysteine|
843713|ENG|PMA|
844865|ENG|Pneumatosis intestinalis|
846885|ENG|PNS Disease|
846886|ENG|PNS Diseases|
846887|ENG|PNS disorder|
846902|ENG|PNS (Peripheral Nervous System) Diseases|
84738|ENG|Abu Dhabi|
848231|ENG|PO|
848716|ENG|Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|
849408|ENG|Poisoning by drug AND/OR medicinal substance (disorder)|
849409|ENG|Poisoning by drug AND/OR medicinal substance|
850528|ENG|Poisoning by unspecified drug or medicinal substance|
850734|ENG|poisoning|
850794|ENG|Poisoning / injury|
850795|ENG|Poisoning / injury (navigational concept)|
850810|ENG|Poisoning, MPTP|
853046|ENG|Poly 2 vinylpyridine N Oxide|
853048|ENG|Poly-2-vinylpyridine N-Oxide|
853732|ENG|Polyarthritides|
853742|ENG|polyarthritis|
853743|ENG|Polyarthritis|
853744|ENG|POLYARTHRITIS|
853760|ENG|Polyarthritis, unspecified|
858572|ENG|polyphagia|
858573|ENG|Polyphagia|
858574|ENG|POLYPHAGIA|
86103|ENG|Hemopoietic disease|
86105|ENG|Hemopoietic disorder|
861057|ENG|Polyvinylpyridine N Oxide|
861058|ENG|Polyvinylpyridine N-Oxide|
864022|ENG|porphyria|
864023|ENG|Porphyria|
864024|ENG|PORPHYRIA|
864051|ENG|Porphyria NOS|
864060|ENG|Porphyrias|
864100|ENG|porphyrin disorder|
864124|ENG|Porphyrin metabolism disorder NOS|
864132|ENG|Porphyrinopathy (disorder)|
864133|ENG|Porphyrinopathy|
86447|ENG|hemorrhage|
86450|ENG|Hemorrhage|
86451|ENG|HEMORRHAGE|
864704|ENG|Portfolio Management Application (PMA)|
86521|ENG|Hemorrhage gastrointestinal|
86522|ENG|Hemorrhage, Gastrointestinal|
866455|ENG|Postcholecystectomy syndrome (disorder)|
866459|ENG|Post cholecystectomy syndrome|
866460|ENG|Post Cholecystectomy Syndrome|
866461|ENG|Post-cholecystectomy syndrome|
866462|ENG|Post-Cholecystectomy Syndrome|
866463|ENG|Postcholecystectomy syndrome|
866464|ENG|Postcholecystectomy Syndrome|
866465|ENG|Post-Cholecystectomy Syndromes|
866466|ENG|Postcholecystectomy Syndromes|
86684|ENG|Hemorrhage (morphologic abnormality)|
86709|ENG|Hemorrhage (NOS)|
86710|ENG|Hemorrhage NOS|
86711|ENG|HEMORRHAGE NOS|
86742|ENG|Hemorrhage of digestive tract|
86748|ENG|Hemorrhage of gastrointestinal tract|
86750|ENG|Hemorrhage of gastrointestinal tract, unspecified|
86989|ENG|Hemorrhages|
87142|ENG|Hemorrhage, unspecified|
873011|ENG|post-transfusion hepatitis non A non B virus|
87625|ENG|hemorrhoid|
87627|ENG|Hemorrhoid|
87628|ENG|HEMORRHOID|
87657|ENG|Hemorrhoids (diagnosis)|
87658|ENG|Hemorrhoids (disorder)|
87660|ENG|hemorrhoids|
87661|ENG|Hemorrhoids|
87662|ENG|HEMORRHOIDS|
87697|ENG|Hemorrhoids NOS|
87709|ENG|Hemorrhoids without complication (disorder)|
87710|ENG|Hemorrhoids without complication|
879937|ENG|Allergic drug reaction|
880523|ENG|PPA-GPC|
880995|ENG|PP|
881481|ENG|Allergic reaction to drug|
881720|ENG|PPTP|
882481|ENG|Allergies, Drug|
883281|ENG|Allergy, Drug|
886152|ENG|Predominantly B-cell defect|
887047|ENG|All (external causes of injury and poisoning)|
887185|ENG|Pregnancy, childbirth and the puerperium|
888780|ENG|1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-|
890583|ENG|Preparations, Pharmaceutical|
890584|ENG|Preparations, Pharmaceutic|
893332|ENG|PREV|
895711|ENG|Primary immune deficiency disorder (disorder)|
895712|ENG|Primary immune deficiency disorder|
895717|ENG|Primary immunodeficiency|
895718|ENG|Primary immunodeficiency syndromes|
898669|ENG|1 Carboxyglutamic Acid|
89874|ENG|Hepatic breath|
89876|ENG|hepatic cancer|
89877|ENG|Hepatic Cancer|
898781|ENG|1-Carboxyglutamic Acid|
89879|ENG|Hepatic Cancers|
89911|ENG|Hepatic Cirrhoses|
89913|ENG|hepatic cirrhosis|
89914|ENG|Hepatic cirrhosis|
89915|ENG|Hepatic Cirrhosis|
89918|ENG|Hepatic cirrhosis NOS|
89953|ENG|Hepatic disease|
89954|ENG|Hepatic disease NOS|
89956|ENG|hepatic disorder|
89957|ENG|Hepatic Disorder|
89958|ENG|Hepatic disorder NOS|
90257|ENG|Hepatic neoplasm malignant|
90259|ENG|Hepatic neoplasm malignant NOS|
90266|ENG|Hepatic neoplasms malignant|
903510|ENG|Process, Copying|
903516|ENG|Process, Duplicating|
903541|ENG|Processes, Copying|
903545|ENG|Processes, Duplicating|
903662|ENG|Process of secretion|
90420|ENG|Hepatic transplantation|
90421|ENG|Hepatic Transplantation|
90422|ENG|Hepatic Transplantations|
90431|ENG|Hepatic tumor malignant|
90477|ENG|HEPATIC WILSONS DISEASE|
90487|ENG|Hepatitides|
90489|ENG|Hepatitides, Infectious|
905286|ENG|Produpharm Lappe Brand of Acetylcysteine|
90552|ENG|hepatitis A|
90553|ENG|Hepatitis A|
90554|ENG|HEPATITIS A|
907107|ENG|Progressive lenticular degeneration|
907108|ENG|Progressive Lenticular Degeneration|
90954|ENG|hepatitis B|
90955|ENG|Hepatitis B|
90956|ENG|HEPATITIS B|
91059|ENG|Hepatitis B Infection|
910991|ENG|Aloe|
911004|ENG|ALOE|
911359|ENG|Aloe Extract|
911397|ENG|Propanoic acid, 3-mercapto-|
911729|ENG|Properties, Intellectual|
911741|ENG|Property, Intellectual|
911829|ENG|Propheniramine|
911837|ENG|Prophenpyridamine|
912028|ENG|prophylaxis|
912893|ENG|ALOE VERA CAP/TAB|
912915|ENG|ALOE VERA CLEANSING PAD|
913170|ENG|ALOE VERA|
913181|ENG|ALOE VERA EXTRACT|
913326|ENG|aloe vera gel|
913338|ENG|Aloe Vera Gel|
913349|ENG|ALOE VERA GEL|
913393|ENG|ALOE VERA GEL,TOP|
913671|ENG|Aloe Vera, oral liquid|
913682|ENG|ALOE VERA ORAL LIQUID|
914037|ENG|Aloe vera preparation 750 MG/ML Topical Cream|
914081|ENG|Aloe vera preparation|
91620|ENG|Hepatitis C|
91780|ENG|hepatitis C virus|
91781|ENG|Hepatitis C virus|
91784|ENG|Hepatitis C Virus|
91785|ENG|HEPATITIS C VIRUS|
91791|ENG|Hepatitis C viruses|
91802|ENG|hepatitis C virus HCV|
91803|ENG|Hepatitis C virus (HCV)|
91814|ENG|Hepatitis C virus (organism)|
918532|ENG|Protective agent|
918533|ENG|Protective Agent|
918534|ENG|Protective agent (product)|
918535|ENG|Protective Agents|
918538|ENG|Protective agent (substance)|
918573|ENG|Protective drug|
918574|ENG|Protective Drug|
918575|ENG|Protective Drugs|
92044|ENG|hepatitis|
92045|ENG|Hepatitis|
92046|ENG|HEPATITIS|
92151|ENG|Hepatitis infectious|
92152|ENG|Hepatitis, Infectious|
92153|ENG|HEPATITIS INFECTIOUS|
92157|ENG|Hepatitis infectious NOS|
92213|ENG|Hepatitis nonspecific|
92215|ENG|Hepatitis NOS|
92277|ENG|Hepatitis, unspecified|
92519|ENG|Hepatocerebral degeneration|
92520|ENG|Hepatocerebral Degeneration|
92521|ENG|Hepatocerebral Degenerations|
92663|ENG|hepatolenticular degeneration|
92665|ENG|Hepato-lenticular degeneration|
92666|ENG|Hepatolenticular degeneration|
92667|ENG|Hepatolenticular Degeneration|
92668|ENG|Hepatolenticular degeneration syndrome|
92764|ENG|Hepato Neurologic Wilson Disease|
92765|ENG|Hepato-Neurologic Wilson Disease|
92766|ENG|Hepato-Neurologic Wilson Diseases|
92779|ENG|Hepatopathy|
928236|ENG|PS|
929114|ENG|1-cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridine|
934650|ENG|Pseudoscleroses, Cerebral|
934651|ENG|Pseudosclerosis, Cerebral|
934652|ENG|Pseudosclerosis|
935337|ENG|alpha,alpha Dipyridyl|
935348|ENG|alpha,alpha-Dipyridyl|
936805|ENG|Psychiatry and Psychology (MeSH Category)|
937185|ENG|Psychogenic rumination (disorder)|
937186|ENG|Psychogenic rumination|
937564|ENG|psychology|
943077|ENG|Publication|
943339|ENG|publishing|
943340|ENG|Publishing|
943601|ENG|PUD|
943604|ENG|PUD - Peptic ulcer disease|
94730|ENG|Hereditary Cancer Syndrome|
94731|ENG|Hereditary Cancer Syndromes|
947795|ENG|PU - Peptic ulcer|
94835|ENG|Hereditary disease (disorder)|
94836|ENG|Hereditary disease|
94837|ENG|Hereditary Disease|
948411|ENG|Purimethol|
94847|ENG|Hereditary Diseases|
948505|ENG|Purine, 6-mercapto-|
948508|ENG|Purine-6-thiol (8CI)|
948509|ENG|Purine-6-thiol Monohydrate|
948510|ENG|Purine-6-thiol, monohydrate|
948511|ENG|Purine-6-thiol, Monohydrate|
94852|ENG|hereditary disorder|
94854|ENG|Hereditary disorder NOS|
948754|ENG|Purinethiol|
948757|ENG|Puri-Nethol|
948759|ENG|Purinethol|
950501|ENG|PX|
950987|ENG|PY|
95185|ENG|Hereditary Neoplastic Syndrome|
95186|ENG|Hereditary Neoplastic Syndromes|
952817|ENG|Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-|
952818|ENG|Pyridine, 1,2,3,6-tetrahydro-4-phenyl-1-propyl-, erythro-|
952821|ENG|Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, (E)-|
952856|ENG|Pyridine, 2-ethenyl-, 1-oxide, homopolymer|
952866|ENG|Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-|
952876|ENG|Pyridine 3 Methanol|
952877|ENG|Pyridine-3-Methanol|
952881|ENG|Pyridine, 4-(2-(1-naphthalenyl)ethenyl)-|
952894|ENG|Pyridine and derivatives|
952895|ENG|Pyridine and derivatives (substance)|
952900|ENG|pyridine carboxylate|
952907|ENG|pyridine|
952908|ENG|Pyridine|
952961|ENG|Pyridines|
953006|ENG|Pyridinium, 1-methyl-4-phenyl-|
953054|ENG|pyridinium compounds|
953055|ENG|Pyridinium Compounds|
953110|ENG|pyridinone|
953111|ENG|Pyridinones|
953179|ENG|Pyridones|
953262|ENG|pyridostigmine|
953263|ENG|Pyridostigmine|
953264|ENG|PYRIDOSTIGMINE|
953276|ENG|Pyridostigmine (product)|
953278|ENG|Pyridostigmine (substance)|
953593|ENG|Pyridoxinedisulfide|
954055|ENG|Pyridylcarbinol|
954912|ENG|Pyrithioxine|
954913|ENG|pyrithioxin|
954915|ENG|Pyrithioxin|
954927|ENG|pyritinol|
954928|ENG|Pyritinol|
954929|ENG|PYRITINOL|
95504|ENG|Hereditary splenic hypoplasia (disorder)|
95506|ENG|Hereditary splenic hypoplasia|
955595|ENG|Pyroses|
955598|ENG|Pyrosis|
95697|ENG|heritable disorder|
957220|ENG|QMR|
95843|ENG|Hernia, Abdominal|
95884|ENG|hernia|
95885|ENG|Hernia|
95886|ENG|HERNIA|
95906|ENG|Hernia hiatal|
95907|ENG|Hernia, Hiatal|
95945|ENG|Hernia NOS|
959501|ENG|Quick Medical Reference|
959502|ENG|Quick Medical Reference (QMR), 1996|
959504|ENG|Quick Medical Reference (QMR)|
95952|ENG|Hernia of abdominal cavity (disorder)|
95953|ENG|hernia of abdominal cavity|
95954|ENG|Hernia of abdominal cavity|
95955|ENG|HERNIA OF ABDOMINAL CAVITY|
96002|ENG|Hernias, Abdominal|
96010|ENG|Hernias|
96013|ENG|Hernias, Hiatal|
96052|ENG|Herniated tissue|
96063|ENG|Herniation|
960805|ENG|quinolinate|
960806|ENG|Quinolinate|
960887|ENG|Quinolinic Acids|
96113|ENG|Hernia, with obstruction (disorder)|
96114|ENG|Hernia, with obstruction|
961596|ENG|R 1625|
961597|ENG|R-1625|
964054|ENG|raclopride|
964055|ENG|Raclopride|
964986|ENG|Radiation dysphagia|
965376|ENG|radiation therapy|
965736|ENG|alpha Naphthylamine|
965747|ENG|alpha-Naphthylamine|
966500|ENG|radiography|
966831|ENG|Radio-Iodinated Serum Albumin|
966832|ENG|Radioiodinated Serum Albumin|
967521|ENG|radionuclide imaging|
967997|ENG|radiotherapy|
968545|ENG|RA|
979823|ENG|Receptor Antagonists, Dopamine|
984515|ENG|Rectal Disease|
984516|ENG|Rectal Diseases|
984517|ENG|rectal disorder|
984518|ENG|Rectal disorder|
984519|ENG|Rectal disorder NOS|
985219|ENG|Rectum|
986682|ENG|Recurrent mouth ulcers (disorder)|
986683|ENG|Recurrent mouth ulcers|
986767|ENG|Recurrent oral ulceration|
989575|ENG|RE|
992380|ENG|Reflux, Gastro-Esophageal|
992382|ENG|Reflux, Gastroesophageal|
992384|ENG|Reflux, Gastro-oesophageal|
994558|ENG|1-ethyl-4-(3-methoxyphenyl)-1,2,3,6-tetrahydropyridine|
994647|ENG|Altered blood in stool|
994725|ENG|Altered blood passed per rectum|
995455|ENG|rehabilitation|
995456|ENG|Rehabilitation|
995476|ENG|Rehabilitation, Mouth|
995523|ENG|Rehabilitations, Mouth|
995669|ENG|1-ethyl-4-phenyl-1,2,3,6-tetrahydropyridine|
999|ENG|IN|
